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Summary 
Nociception  involves  detection  of  tissue  damage  by  specialized  receptors; 
nociceptors. These convey information to the first synaptic relays in the dorsal 
horn of the spinal cord. Within the dorsal horn itself are the dorsal horn neurons 
which can be divided into two broad classes, based on their axonal projections: 
projection neurons and interneurons.  
The neurokinin 1 receptor (NK1r), the main target for substance P, is expressed 
by most projection neurons and many interneurons in the dorsal horn. These 
NK1r-expressing neurons show a bimodal size distribution in lamina I. The 1
st 
part of the project tested the hypothesis that large NK1r-immunoreactive cells 
in this lamina are projection neurons, while the small cells are interneurons. 
Rats were anaesthetised and received injections of tracers into two supraspinal 
areas that are likely to label all contralateral lamina I projection neurons. The 
rats  were  re-anaesthetized  and  perfused  3  days  later  and  1341  NK1r-positive 
cells were analysed, of which 441 were retrogradely labelled. Cross-sectional 
soma areas of projection neurons were larger than those of cells that were not 
retrogradely labelled. This difference was highly significant. Nearly all (99.4%) of 
the NK1r-expressing cells that were not retrogradely labelled had soma areas 
<200 µm
2, while only 9.8% of the retrogradely labelled NK1r-expressing cells had 
somata <200 µm
2. These results provide a means of distinguishing lamina I NK1r-
expressing  projection  neurons  from  interneurons  based  on  their  soma  sizes 
without the need of retrograde tracing surgeries.  
Lamina I contains another population of projection neurons that lack or weakly 
express the NK1 receptor and consists of very large cells: giant cells, which are 
coated  with  the  glycine  and  gamma-aminobutyric  acid  (GABA)  receptor 
associated  protein,  gephyrin.  There  is  also  a  group  of  large  NK1r-expressing 
projection  neurons  with  cell  bodies  in  laminae  III-IV  and  dendrites  that  pass 
dorsally  to  enter  lamina  I.  Extracellular  signal-regulated  kinase  (ERK)  is 
expressed in dorsal horn neurons and is activated (phosphorylated) by noxious 
stimuli. In the 2
nd part of the project, ERK phosphorylation in NK1r-expressing 
neurons as well as in lamina I giant cells was investigated following different 
type of noxious stimuli. Anaesthetised rats received noxious cutaneous, deep or iii 
visceral stimuli. They remained anaesthetized for 5 min after the end of the 
stimulus,  and  were  then  fixed  by  perfusion.  Spinal  cord  sections  were 
immunoreacted to reveal NK1r, gephyrin and phosphorylated ERK (pERK). Among 
the  NK1r-expressing  lamina  I  neurons,  pERK  was  detected  in  both  projection 
(somata  >200  µm
2)  neurons  and  interneurons,  with  a  significantly  higher 
proportion in the larger cells, after all types of noxious stimulation. There was 
no significant difference in the frequency of pERK expression between the three 
morphological  classes  (fusiform,  pyramidal  and  multipolar)  of  lamina  I  NK1r-
expressing  projection  neurons  after  these  stimuli.  Most  of  the  giant  cells 
contained pERK after noxious cutaneous stimuli, but few did so following noxious 
deep stimulation. Only a few of laminae III-IV NK1r-expressing projection cells 
contained pERK after noxious deep or visceral stimulation, and the labelling in 
these  was  very  weak.  Results  from  the  present  study  indicate  that  different 
types of neurons have different roles in conveying nociceptive information.   
The superficial dorsal horn (SDH) is also a vital area for modulating nociception 
and contains large number of excitatory and inhibitory interneurons. Glutamate, 
released by primary afferents and local excitatory neurons, acts on G-protein-
coupled metabotropic glutamate receptors (mGlus). Group I mGlus (mGlu1 and 
mGlu5) are strongly expressed in the SDH. It has been reported that intrathecal 
administration of the mGlu1/5 agonist 3,5-dihydroxyphenylglycine (DHPG) induces 
spontaneous nociceptive behaviours, which are ERK-dependent. In the 3
rd part of 
the  project,  ERK  phosphorylation  in  mGlu5-expressing  neurons  following  the 
administration  of  DHPG  was  investigated.  Anaesthetized  rats  underwent  a 
laminectomy procedure. DHPG or saline was applied to their exposed lumbar 
cord for 8 minutes after which they were perfused. Sections from the lumbar 
spinal  cord  were  immunoreacted  to  reveal  mGlu5,  pERK  and  one  of  various 
markers  for  excitatory  or  inhibitory  interneurons.  Following  DHPG  (but  not 
saline), numerous pERK-positive cells were seen in the SDH, particularly lamina 
II, and the great majority of these were mGlu5-positive. ERK phosphorylation was 
detected  in  both  inhibitory  and  excitatory  mGlu5-expressing  cells,  suggesting 
that type I mGlus have a complex role in nociceptive processing. iv 
Acknowledgements 
     ا      ا  ا     .  
In the name of God, the most merciful, the most kind.   
I would like to start by thanking my supervisor/friend: Professor Andrew Todd 
for  his  endless  encouragement  and  support.  I  learnt  a  lot  from  him  on  daily 
bases. Professor Andrew’s dedication to science is inspiring to every one who has 
passed through his laboratory. He encouraged me to ask questions “even the silly 
ones!” and was always there to answer them with a smile. Thank you Professor 
Andrew, I am honoured to work with you. I would also like to thank Dr John 
Riddell, my 2
nd supervisor. He always managed to find time in his busy schedule 
for me, and never hesitated in offering assistance. I am also grateful to Dr Erika 
Polgar for assisting this project in numerous ways. She listened with care to my 
problems as if they were hers and always provided instant solutions.  
The importance of the technical support provided by Mrs Christine Watt and Mr 
Robert Kerr can not be overemphasised. Thank you Robert for practicing your 
patience skills while teaching me (the 1
st left-handed student) the art of spinal 
cord dissection! Thank you Christine for the fruitful conversations which were 
held in the lab while rinsing the specimens! Thank you again Christine for always 
offering help when it got late in the lab and it was time for me to pick up Layla, 
my daughter, from nursery. The spinal cord group also includes lovely colleagues 
and friends. For you dear friends, I am grateful. 
I have been blessed with an incredibly supportive family and friends who have 
encouraged me throughout my life. Thanks dear friends, you know yourselves. 
My parents, thank you for encouraging me to follow my dreams. For you, words 
are not enough, prayers … maybe! Tareq, my beloved understanding husband, 
thank you for believing in me. For this I am very grateful. My sister, niece and 
brothers, thank you for being there whenever I needed you. A big thank you to 
you ‘Layla’ for your unconditional love, and for coping with Mama’s occasional 
bad moods over the last 3 years.      v 
I wish to thank all my colleagues at my home university: University of Dammam 
for their support. Funding for this project was provided by the Ministry of Higher 
Education of Saudi Arabia, and for that I am thankful.  
Finally, the ability and motivation required to complete this thesis are a gift 
from  God,  and  for  that  I  will  always  be  grateful.  I  would  like  to  end  these 
acknowledgements with a quote from the ‘Quran’: 
"    أ    إو   آ             إ         و  ."  
 “My success can only come from Allah: in Him I trust and unto Him I turn”.vi 
Author's declaration 
I  declare  that  the  work  presented  in  this  thesis  is  my  own  work,  with  the 
exception  of  part  of  the  data  that  are  presented  in  Figure  3-7,  which  was 
pooled, with permission, from work published by Al-Khater and Todd, (2009).  
Prof.  Andrew  Todd  performed  the  retrograde  tracing  surgery,  and  Dr  John 
Riddell  performed  the  laminectomy  procedure.  This  thesis  has  not  been 
submitted in any previous application for any other degree in the University of 
Glasgow or any other institution.    vii 
Dedication 
This thesis is dedicated to you Layla ☺, you always said: ‘Mama, Be Brave!’ viii 
Table of Contents 
1.  Introduction  1 
1.1  Nociception and the spinal cord  2 
1.2  Primary afferents fibres  3 
1.2.1  Nociceptive unmyelinated primary afferents  5 
1.2.2  Nociceptive myelinated primary afferents  6 
1.2.3  Non-nociceptive primary afferents  7 
1.2.4  Neurochemistry of primary afferents  9 
1.2.5  Receptors on primary afferents  11 
1.3  Dorsal horn projection neurons  13 
1.3.1  Dorsal horn projection neurons in lamina I  13 
1.3.2  Dorsal horn projection neurons in laminae III-IV  17 
1.4  Dorsal horn interneurons  18 
1.4.1  Interneurons in lamina I  19 
1.4.2  Interneurons in lamina II  20 
1.4.3  Interneurons in lamina III-IV  24 
1.4.4  Neurochemical classification of the SDH interneurons  24 
1.5  Markers of neuronal activity  27 
1.5.1  Fos  27 
1.5.2  pERK  28 
1.5.3  Fos and pERK: pros and cons  33 
1.6  Aims of the project  37 
 
2.  General Methods  38 
2.1  Perfusion of the animals  39 
2.2  Tissue processing and immunocytochemistry  39 
2.3  Antibody characterisation  41 
2.4  Confocal microscopy and analysis  42 
2.5  Statistical analysis  42 
 
3.  Soma size distinguishes lamina I NK1r-expressing projection neurons 
  from interneurons  44 
3.1  Introduction  45 
3.2  Experimental procedures  47 
3.2.1  Animals and operative procedures  47 ix 
3.2.2  Tissue processing and immunocytochemistry  48 
3.2.3  Confocal microscopy and analysis  49 
3.3  Results  51 
3.3.1  Injection sites  51 
3.3.2  NK1r-immunoreactivity in lamina I  51 
3.3.3  Retrograde labelling  52 
3.3.4  Soma cross-sectional areas  53 
3.3.5  Morphology of NK1r-negative projection neurons  54 
3.4  Discussion  70 
3.4.1  Choice of the retrograde tracers and injection targets  70 
3.4.2  NK1r-mmunoreactive neurons  72 
3.4.3  Projection neurons that lack the NK1r  74 
 
4.  ERK phosphorylation in NK1r-expressing dorsal horn neurons and    
  lamina I giant cells after noxious stimulation  76 
4.1  Introduction  77 
4.2  Experimental procedures  84 
4.2.1  Animals and noxious stimulation  84 
4.2.2  Tissue processing and immunocytochemistry  85 
4.2.3  Confocal microscopy and analysis  86 
4.3  Results  90 
4.3.1  pERK in lamina I NK1r-expressing neurons  90 
4.3.2  pERK in lamina I giant cells  91 
4.3.3  pERK in laminae III-IV NK1r-expressing neurons  92 
4.4  Discussion  112 
4.4.1  pERK as a marker of neuronal activity  112 
4.4.2  Lamina I NK1r-expressing projection neurons  115 
4.4.3  Lamina III-IV NK1r-expressing projection neurons  121 
4.4.4  Lamina I giant cells  123 
4.4.5  Lamina I NK1r-expressing interneurons  125 
4.4.6  Technical considerations and future directions  126 
 
5.  Responses of mGlu5-expressing neurons to spinal application of DHPG  130 
5.1  Introduction  131 
5.2  Experimental procedures  133 
5.2.1  Animals and DHPG application  133 x 
5.2.2  Tissue processing and immunocytochemistry  134 
5.2.3  Confocal microscopy and analysis  134 
5.3  Results  136 
5.3.1  pERK
+ mGlu5-expressing neurons  136 
5.3.2  Neurochemistry of mGlu5-expressing cells  137 
5.4  Discussion  153 
5.4.1  Spinal mGlu5-expressing neurons  153 
5.4.2  pERK
 in mGlu5-expressing excitatory and inhibitory neurons  156 
 
6.  Concluding remarks  159 
 
7.  List of references  162 
 
8.  List of publications  196 
 
 
 xi 
List of Tables 
Table 1-1     Comparison of the specificity, distribution and time course of Fos     
               and pERK  36 
 
Table 2-1     Primary antibodies used in this study       43 
 
Table 3-1     Quantitative retrograde labelling data  61 
Table 3-2     NK1r-immunoreactivity in projection neurons  62 
Table 3-3     Proportions of lamina I NK1r
+ interneurons and NK1r
+ projection  
               neurons in regard to their soma sizes  67 
 
Table 4-1     Spinal cord segments studied in regard to different types of                          
               noxious stimuli used   89 
Table 4-2     Proportions of pERK
+ NK1r-expressing projection neurons of      
               various morphological classes after noxious stimulation  95 
Table 4-3     Proportions of pERK
+  giant cells after noxious stimulation          100 
Table 4-4     Proportions of pERK
+ laminae III-IV NK1r-expressing cells after 
               noxious stimulation  107 
 
Table 5-1     Proportions of pERK
+ mGlu5-expressing cells in lamina II after  
               DHPG application  141 
Table 5-2     Calretinin-immunostaining in mGlu5-expressing cells and in                             
               pERK
+ mGlu5-expressing neurons after DHPG application  144 
Table 5-3     Calbindin-immunostaining in mGlu5-expressing cells and in                         
               pERK
+ mGlu5-expressing neurons after DHPG application  147 
Table 5-4     GABA-immunostaining in mGlu5-expressing cells and in pERK
+                   
               mGlu5-expressing neurons after DHPG application  150 
 
 
 
 xii 
List of Figures 
Figure 1-1    Rexed’s laminae and the laminar termination pattern of primary  
               afferents  4 
Figure 1-2    Examples of mechanisms of ERK activation in the spinal cord  33 
 
Figure 3-1    Drawings of Fluorogold and CTb injection sites in the three  
               experiments  55 
Figure 3-2    Examples of CTb and Fluorogold injection sites  57 
Figure 3-3    Immunoreactivity of the NK1 receptor, CTb and Fluorogold  59 
Figure 3-4    Examples of retrogradely labelled neurons  63 
Figure 3-5    Frequency histogram showing the soma cross-sectional areas  
               for different groups of lamina I neurons  65 
Figure 3-6    Drawings of NK1r-negative retrogradely labelled pyramidal  
               cells  68 
Figure 3-7    Box and whisker plot of the soma sizes of retrogradely labelled 
               pyramidal cells  69 
 
Figure 4-1    Histogram showing the percentages of pERK
+ NK1r-expressing 
               small and large cells in lamina I after noxious stimulation   93 
Figure 4-2    Examples of pERK-immunoreactivity in lamina I NK1r-expressing  
               cells following noxious pinch  96 
Figure 4-3    Examples of pERK-immunoreactivity in lamina I NK1r-expressing  
               cells following capsaicin injection  98 
Figure 4-4    Example of pERK-immunoreactivity in a lamina I giant cell  
               following noxious pinch  101 
Figure 4-5    Example of pERK-immunoreactivity in a lamina I giant cell 
               after the injection of mustard oil into the knee joint  103 
Figure 4-6    Examples of pERK-immunoreactivity in a lamina I giant cell and 
               in NK1r-expressing cells after noxious pinch  105 
Figure 4-7    Examples of pERK-immunoreactivity in lamina III NK1r-expressing 
               cells after the injection of mustard oil into the knee joint  108 
Figure 4-8    Example of the lack of pERK-immunoreactivity in a lamina III      
               NK1r-expressing cell after the injection of mustard oil into            
               the knee joint  110 xiii 
 
Figure 5-1    Examples of pERK-immunoreactivity in lamina II after DHPG 
               application  139     
Figure 5-2    Examples of pERK-immunoreactivity in mGlu5-expressing cells 
               following DHPG application  142 
Figure 5-3    Examples of calretinin-immunoreactivity in pERK
+ mGlu5-    
               expressing cells following DHPG application  145   
Figure 5-4    Examples of calbindin-immunoreactivity in pERK
+ mGlu5-     
               expressing cells following DHPG application  148    
Figure 5-5    Examples of GABA-immunoreactivity in pERK
+ mGlu5-expressing 
               cells following DHPG application  151   
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 xiv 
List of abbreviations 
AMPA    α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate 
BDNF    brain-derived neurotrophic factor 
BNPI    brain-specific Na
+-dependent inorganic phosphate transporter I 
CFA    complete Freund’s adjuvant 
CGRP    calcitonin gene-related peptide 
CNS    central nervous system 
CREB    cAMP response element binding protein  
CRD    colorectal distension  
CTb    cholera toxin subunit B 
CVLM    caudal ventrolateral medulla 
DHPG   3,5-dihydroxyphenylglycine 
DRG    dorsal root ganglion 
DRt    dorsal reticular nucleus 
ERK    extracellular signal-related kinase 
GABA    gamma-aminobutyric acid 
LPb    lateral parabrachial nucleus 
LTMs    low-threshold mechanoreceptors 
MAPK    mitogen activated protein kinase xv 
mGlu    metabotropic glutamate receptor 
mRNA   messenger ribonucleic acid 
NADPH-d  nicotineamide adenine dinucleotide phosphate diaphorase 
NGF    nerve growth factor 
NK1r    neurokinin 1 receptor 
NMDA   N-methyl-D-aspartic acid 
nNOS   neuronal nitric oxide synthase 
NPY    neuropeptide Y 
NTS    nucleus of the solitary tract 
PAG    periaqueductal grey matter 
PB    phosphate buffer 
PBS    phosphate-buffered saline 
pERK    phosphorylated form of extracellular signal-related kinase 
PKC    protein kinase C 
PoT    posterior triangular nucleus     
SDH    superficial dorsal horn 
SP-SAP  substance P conjugated to the cytotoxin saporin 
STT    spinothalamic tract       
TrkB    tropomyosin-related kinase B xvi 
TRPs    transient receptor potential receptors 
TSA    tyramide signal amplification 
VGAT   vesicular GABA transporter 
VGLUT  vesicular glutamate transporter1 
1. Introduction                                                                                            
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     2 
Pain is among the most complex perceptions, and its research brings together 
elements of many disciplines. It is defined by the International Association for 
the  Study  of  Pain  as  “An  unpleasant  sensory  and  emotional  experience 
associated with actual or potential tissue damage, or described in terms of such 
damage”.  Nociception  on  the  other  hand  is  defined  as  “The  processes  of 
encoding and processing of noxious stimuli, which is an actual or potential tissue 
damaging event, by the nervous system” (Treede, 2009). The SDH of the spinal 
cord  represents  the  first  area  of  the  central  nervous  system  (CNS)  where 
transmission and modulation of pain-related information occurs.   
1.1 Nociception and the spinal cord 
Nociception involves detection of tissue damage by specialized receptors. Both 
somatic  and  visceral  nociceptors  can  be  activated  by  noxious  chemical, 
mechanical  or  thermal  stimulation  in  addition  to  stimuli  that  only  threaten 
damage. Nociceptors convey this information to the first synaptic relays in the 
dorsal  horn  of  the  spinal  cord.  In  order  to  understand  the  mechanisms  of 
nociception and to produce more selective analgesics for use in the treatment of 
both  animal  and  human  pain,  it  is  essential  to  develop  various  nociception 
eliciting  models.  These  include  models  of  acute  and  chronic  pain  such  as 
applying  noxious  or  innocuous  stimuli  to  the  hindpaw  of  a  rodent,  or  using 
peripheral nerve injury induced models of pain (Garry et al., 2004).  
The dorsal horn of the spinal cord is a major relay region for nociceptive inputs 
and in the 1950s there was a need to develop a widely accepted scheme that 
divided its grey matter into distinct regions. In 1952, Rexed divided the dorsal 
horn of the cat spinal cord into a series of six parallel laminae based on certain 
cytoarchitectonic  characteristics.  This  scheme  was  then  adapted  to  other 
species including the rat (Steiner and Turner, 1972; Clark, 1984; Molander et al., 
1984). Lamina I, which is sometimes referred to as the marginal zone, is located 
at the most dorsal aspect of the dorsal horn, and it represents an important 
nociceptive area. Lamina II, which is also known as ‘Substantia Gelatinosa of 
Rolando’ after Luigi Rolando (Caputi et al., 1995) has a very low concentration 
of myelinated fibres, thus it appears translucent under the microscope in thick 
wet sections. Lamina II is further divided into two layers: lamina II outer (IIo) 
with densely packed small cells and predominant primary afferent input from C-    3 
fibres, and lamina II inner (IIi) with slightly larger neurons and a significant input 
from myelinated fibres. Laminae III and IV are known as the ‘Nucleus Proprius’. 
Most cells in lamina III are small and densely packed with some scattered large 
neurons compared to the more heterogenous lamina IV cells. Laminae V and VI 
are referred to as the neck and base of the dorsal horn, respectively.  
The  SDH,  which  includes  laminae  I  and  II,  is  the  main  target  of  nociceptive 
primary afferents. Some nociceptive primary afferents also terminate in deeper 
laminae  (III-VI),  indicating  that  this  region  has  an  important  role  in  both 
physiological and pathological pain states (Light and Perl, 1979a, 1979b; Cervero 
and Iggo, 1980; Sugiura et al., 1986).  
In addition to the primary afferent input to the dorsal horn, it receives pain 
modulating descending axons from various parts of the brain (Fields et al., 2006; 
Heinricher et al., 2009). The dorsal horn contains neurons which, based on their 
axonal projections, can be divided into two broad classes: interneurons, with 
axons that remain in the spinal cord and projection neurons with axons travelling 
to supraspinal targets such as the brainstem and thalamus. Projection neurons 
are  less  numerous  than  interneurons  and  are  known  to  be  excitatory  while 
interneurons can be either excitatory or inhibitory (Todd, 2006). In order for us 
to  understand  the  neural  circuits  that  link  incoming  primary  afferents  to 
projection  neurons,  these  two  broad  classes  have  to  be  further  divided  into 
distinct functional populations (Todd, 2010). 
1.2 Primary afferents fibres 
Primary afferent fibres have a remarkable capacity of detecting and transmitting 
sensory information from the periphery to the spinal cord, thus linking external 
and internal environments to the CNS. The somata of primary afferent neurons 
are  located  in  the  trigeminal  ganglion  and  the  dorsal  root  ganglia  (DRG).  A 
central branch from the axons of these neurons travels through a dorsal root to 
enter the spinal cord where it forms axodendritic or axosomatic synapses with 
second-order  neurons.  Primary  sensory  fibres  are  most  commonly  classified 
based on the conduction velocity of their axons, which is directly related to the 
axonal diameter and whether or not the axon is myelinated. Sensory fibres in 
cutaneous and visceral nerves are routinely divided into Aα/β-, Aδ- and C-fibres.     4 
The  Aα/β  group  consists  of  large  myelinated  axons  that  have  the  fastest 
conduction  velocities  (25-100  m/s)  and  most  of  these  are  classified  as  low-
threshold  mechanoreceptors  (LTM),  responding  to  touch,  pressure,  stretch  or 
hair movement. Aδ-fibres are thinly myelinated and conduct at an intermediate 
velocity  (5-25  m/s).  C-fibres  are  the  smallest,  unmyelinated  and  most  slowly 
conducting fibres (<2.5 m/s). The majority of Aδ [excluding the down (D) hair 
afferents]  and  most  C-fibres  are  classified  as  nociceptors  or  thermoreceptors 
(Todd and Koerber, 2006). Different terminology is  used for sensory fibres in 
muscles and joint nerves. Their myelinated afferents are subdivided into groups 
I, II and III, while group IV corresponds to the unmyelinated afferents (Willis and 
Coggeshall,  2004).  Figure  1-1  shows  Rexed’s  laminae  and  the  laminar 
termination pattern of primary afferents in the rat dorsal horn.   
 
Figure   1-1 Rexed’s laminae and the laminar termination pattern of primary afferents. 
The image shows the central terminations of the major primary afferent neurons, the dashed 
lines show laminar boundaries. Modified from Todd (2010). 
Primary  afferent  fibres  are  either  nociceptive  or  non-nociceptive  and  can  be 
divided  into  somatic  (cutaneous  or  deep)  or  visceral  depending  on  their 
peripheral targets. When a stimulus is applied to a sensory receptor, it elicits a 
response  through  stimulus  transduction,  which  is  the  process  of  converting  a 
physical stimulus into a generated potential leading to an action potential. Some 
fibres have specialized response properties since they only respond to one type 
of  stimulus,  while  most  nociceptors  respond  to  different  sensory  modalities     5 
including  mechanical,  thermal  and  chemical  stimuli,  and  are  considered 
polymodal.  In  most  early  studies  of  nociceptors,  primary  afferents  that 
responded  to  both  mechanical  and  thermal  stimulation  were  referred  to  as 
mechano-heat-sensitive  fibres.  These  were  also  considered  polymodal 
nociceptors because if an afferent responded to mechanical and heat stimuli, it 
would, in most cases, respond to chemical stimuli as well (Davis et al., 1993).  
The term ‘nociceptive nerves’ was first introduced by Sir Charles Sherrington in 
1906 (Burke, 2007).  Nociceptors are specialized primary sensory neurons that 
detect  damaging  or  potentially  damaging  stimuli,  which  may  result  in  the 
perception of pain and subsequently initiate protective responses. Nociceptors 
play an important role in this protective function of the pain pathway. They are 
able  to:  (1)  detect  various  physical  and  chemical  stimuli,  (2)  set  specific 
response thresholds for each stimulus, thus being able to distinguish between 
noxious and innocuous events, and even (3) reset these thresholds in order to 
protect against further damage, a phenomenon known as sensitization (Julius 
and McCleskey, 2006).   
1.2.1 Nociceptive unmyelinated primary afferents  
The majority of cutaneous C-fibres are classified as nociceptors since they can 
be activated exclusively by intense mechanical, thermal or chemical stimuli and 
are typically polymodal (Lynn and Carpenter, 1982; Fleischer et al., 1983). It 
was also reported that some of the small diameter afferents from muscles and 
tendons (Mense and Meyer, 1985) as well as from joints (Schaible and Schmidt, 
1985)  are  considered  nociceptors,  while  others  fall  under  the  low-threshold 
receptor category.  
C-fibres are divided into two major neurochemical groups: peptidergic, which 
innervate various tissues including the epidermis and deeper regions of the skin, 
and non-peptidergic, which innervate mainly the epidermis (Rice et al., 1997; 
Zylka et al., 2005). Peptidergic C-fibres express either one or a combination of 
the  following  peptides:  calcitonin  gene-related  peptide  (CGRP),  substance  P, 
somatostatin,  galanin,  cholecystokinin,  and  vasoactive  intestinal  polypeptide 
/peptide histidine isoleucine (Ju et al., 1987; Bennett et al., 1996). CGRP is the 
most useful marker for detecting peptidergic afferents for two reasons: first, it     6 
appears to be present in all of these, including those that contain substance P or 
somatostatin  (Ju  et  al.,  1987),  and  second,  within  the  dorsal  horn,  CGRP  is 
exclusively  present  in  primary  afferents  (Chung  et  al.,  1988).  Lawson  et  al. 
(2002) reported that CGRP was detected in less than half of the nociceptive DRG 
neurons  of  the  guinea-pig  including  those  with  C-fibres.  The  majority  of 
peptidergic C nociceptors terminate in lamina I and lamina IIo (Figure 1-1).  
Most  non-peptidergic  C-fibres  bind  the  plant  lectin  IB4  from  Bandeiraea 
simplicifolia  (Plenderleith  and  Snow,  1993).  These  can  be  recognized  by  the 
presence of IB4-binding and the lack of CGRP-immunoreactivity (Sakamoto et 
al.,  1999).  However,  Dhaka  et  al.  (2008)  identified  a  subpopulation  of  non-
peptidergic C-fibres in the mice that lack peptides and do not bind IB4. Zylka et 
al.  (2005)  identified  another  population  of  IB4-positive  non-peptidergic  C 
nociceptors  that  was  revealed  by  axonal  tracers  targeted  to  Mrgprd,  a  Mas-
related  gene  which  is  expressed  in  specific  subsets  of  nociceptive  sensory 
neurons in mice (Zylka et al., 2003). These Mrgprd
+ fibres exclusively innervate 
the epidermis and project centrally to lamina II of the spinal cord suggesting a 
central  topographic  segregation  of  the  projection  of  peptidergic  and  non-
peptidergic nociceptive sensory neurons to the spinal cord (Figure 1-1).    
The central arborisations of peptidergic primary afferents are concentrated in 
lamina I and the outer half of lamina II (IIo), and also extend to laminae III-IV. 
These  peptidergic  fibres  form  simple  (non-glomerular)  endings  that  rarely 
receive axo-axonic synapses (Ribeiro-da-Silva et al., 1989). In contrast, the IB4-
binding non-peptidergic C-fibres that correspond to the subpopulation identified 
by Zylka et al. (2005) terminate in a narrow band that occupies the central part 
of lamina II and form central axons of type I synaptic glomeruli (Ribeiro-da-Silva 
and Coimbra, 1982). These axons are postsynaptic to GABAergic boutons at axo-
axonic  synapses  and  therefore  are  targets  to  classical  presynaptic  inhibition 
(Todd, 1996).  
1.2.2 Nociceptive myelinated primary afferents 
Myelinated  nociceptors  include  both  the  slow  Aδ-fibres,  which  were  first 
identified by Burgess and Perl (1967), and a propotion of the fast Aα/β-fibres 
(Djouhri and Lawson, 2004). A-fibre nociceptors respond to external stimulation     7 
with  higher  discharge  frequencies,  compared  to  the  responses  of  C-fibre 
nociceptors. This suggests that A-fibre nociceptors provides more discriminable 
information  regarding  stimulus  intensity  and  they  are  thought  to  signal  fast 
pricking or sharp pain (Slugg et al., 2000; Lumpkin and Caterina, 2007).  
Although the neurochemistry of myelinated nociceptors is not yet fully known, it 
has been reported that substance P and CGRP are among the neuropeptides that 
are expressed by these nociceptors (Lawson et al., 1997; Lawson et al., 2002). 
The central projections of myelinated nociceptors were initially described in the 
cat and monkey by Light and Perl (1979b). Their study reported that lamina I, 
the most dorsal part of lamina II as well as lamina V of the spinal cord received 
projections  from  relatively  slow  conducting  myelinated  primary  afferent 
nociceptors; the Aδ type. More recently, a second type of A-fibre nociceptors 
was  identified,  which  resembled  myelinated  LTMs  in  its  central  projections, 
since these fibres projected to deeper laminae. However, they also projected to 
the SDH, suggesting a more diffuse pattern of central projection (Woodbury and 
Koerber, 2003; Woodbury et al., 2008). 
One of the methods for identifying the central terminals of myelinated primary 
afferents is by their ability to transport peripherally injected cholera toxin B 
subunit (CTb). CTb is a protein that binds specifically to ganglioside GM1, which 
is expressed by most myelinated afferents but not by intact C-fibres in somatic 
nerves  of  rodents.  However,  the  transganglionic  labelling  with  CTb  seen  in 
lamina I (which is thought to be contained in terminals of Aδ nociceptors) rarely 
colocalised with CGRP or substance P, suggesting that peptidergic Aδ afferents 
do  not  normally  express  the  GM1  ganglioside  and  therefore  could  not  be 
identified with CTb (Shehab and Hughes, 2011).  
1.2.3 Non-nociceptive primary afferents 
Non-nociceptive  primary  afferents  are  mostly  low-threshold  thermoreceptors 
and/or LTMs. Most fibres projecting to the skin and skeletal muscles from the 
DRG are LTMs (Djouhri and Lawson, 2004). Cutaneous LTMs respond to innocuous 
mechanical stimulation such as light brushing of the limb fur, light pressure with 
blunt objects or distortion.      8 
LTMs of the fast conducting myelinated type (Aα/β) make up a large proportion 
of  cutaneous  and  muscle  fibres.  A  smaller  proportion  of  fibres  in  skin  and 
muscles are of the slowly conducting Aδ group (Perl, 1992). Cutaneous LTMs of 
the Aα/β type can be divided into rapidly adapting and slowly adapting fibres 
(Willis and Coggeshall, 2004). 
Brown (1981) summarized the findings of numerous studies of LTMs in the cat, 
and reported that these fibres migrate medially within the dorsal columns as 
they  move  away  from  their  point  of  entry  in  the  spinal  cord.  Most  of  them 
bifurcate to give rostral and caudal branches within the dorsal horn. Collaterals 
from  these  fibres  terminate  in  dense  arborisations  that  lie  within  a  region 
extending  from  lamina  III  to  lamina  V,  with  fibres  innervating  hair  follicles 
terminating more superficially than those innervating slowly adapting receptors. 
Shortland et al. (1989) studied the central projections of hair follicle afferents 
in the rat, and reported that these afferents formed narrow sagittal sheets of 
arbors extending from lamina IIi to lamina IV. In addition, Hughes et al. (2003) 
found that in the rat, the termination zone of afferents with hair follicle-like 
morphology extended dorsally into the ventral half of lamina II (Figure 1-1).                                        
LTMs of the Aδ type include D-hair afferents and are found in hairy skin. They 
are sensitive to the slow movements of hairs (Rethelyi et al., 1982). These fibres 
were found to project extensively into laminae IIi and III-IV of the dorsal spinal 
cord (Light et al., 1979; Woodbury and Koerber, 2003). They gave rise to large 
varicosities that formed the central terminals of type II glumeruli (Rethelyi et 
al., 1982).    
LaMotte  et  al.  (1982)  reported  that  the  threshold  of  warm  receptors  in  the 
monkey is below the pain threshold (41-49°C), and these receptors responded 
better to painless heat than to painful heat. The conduction velocity of these 
receptors  in  the  glabrous  skin  of  the  monkey  is  of  the  Aδ  range.  The  low-
threshold  cold  receptors,  which  discharged  statically  at  20-30°C  skin 
temperature, also had a homogenous distribution of conduction velocities of the 
Aδ range in the glabrous skin of the monkey (LaMotte and Thalhammer, 1982).      9 
It was reported that in the cat, a fraction of C-fibres responded to both low-
threshold mechanical stimulation and thermal stimulation, and did not respond 
uniquely to noxious stimulation (Bessou and Perl, 1969; Bessou et al., 1971). A 
subclass of these low-threshold C-fibres was recently found to respond vigorously 
to  slow  and  light  stroking  of  the  hairy  skin  in  humans  (Loken  et  al.,  2009). 
Additionally, selective stimulation of these fibres activated the insular cortex; 
an area known to process positive emotions (Olausson et al., 2002). 
Recently,  certain  molecular  and  histological  markers  of  subtypes  of 
unmyelinated  LTMs  (Seal  et  al.,  2009)  and  rapidly  adapting  myelinated 
mechanoreceptors (Bourane et al., 2009; Luo et al., 2009) have been identified 
in the mice. Seal et al. (2009) reported that a subset of glutamatergic C-fibre 
LTMs that terminated in laminae I and IIi of the spinal cord of the mice appear to 
be important for the onset of hypersensitivity caused by spared nerve injury. 
1.2.4 Neurochemistry of primary afferents 
Glutamate is the principal excitatory neurotransmitter in the CNS and it is used 
by all primary afferents. Glutamate and substance P, a neuropeptide involved in 
nociception  transmission,  coexist  in  many  primary  afferent  terminals  in  the 
superficial laminae of the spinal cord (De Biasi and Rustioni, 1988) and these will 
be discussed in more detail.  
1.2.4.1  Glutamate  
Glutamate  was  discovered  in  1907  by  the  Japanese  chemist  Kikunae  Ikeda 
(Kurihara, 2009). After its synthesis in the presynaptic cytoplasm, glutamate is 
transported  into  the  synaptic  vesicles  for  its  exocytotic  release.  Glutamate 
transport requires a specific energy generating system that uses the H
+-ATPase 
pump.  Certain  proteins  have  been  shown  to  function  as  vesicular  glutamate 
transporters  (VGLUTs)  and  were  named  VGLUT1,  VGLUT2  and  VGLUT3 
(Takamori, 2006). VGLUT1 was originally characterized as a brain-specific Na
+-
dependent  inorganic  phosphate  transporter  I  (BNPI)  (Ni  et  al.,  1994),  while 
VGLUT2  was  known  originally  as  differentiation-associated  Na
+-dependent 
inorganic phosphate transporter I, a protein that highly resembled BNPI (Aihara 
et al., 2000). Subsequently, VGLUT3 was identified and found to be expressed in     10 
a more restricted pattern in the CNS in addition to its expression in the DRG 
(Gras  et  al.,  2002).  Antibodies  against  VGLUTs  helped  in  identifying 
glutamatergic  axons  in  anatomical  studies.  VGLUT1  has  been  found  to  be 
expressed by all low-threshold myelinated fibres, while VGLUT2 is expressed by 
lamina I Aδ-fibres as well as by axons of most glutamatergic spinal neurons in the 
rat  (Oliveira  et  al.,  2003;  Todd  et  al.,  2003;  Alvarez  et  al.,  2004).  The 
expression of VGLUT2 by unmyelinated primary afferents is found to be weak in 
the rat and the mouse, and these fibres do not express VGLUT1 (Todd et al., 
2003; Brumovsky et al., 2007). VGLUT3, however, is found to be expressed by a 
population of unmyelinated primary sensory neurons projecting to lamina I and 
the inner part of lamina II of the mice dorsal horn (Seal et al., 2009).    
Glutamate acts on both ionotropic and metabotropic receptors. These are the 
most  widespread  excitatory  neurotransmitter  receptors  in  the  CNS,  thus  they 
contribute  to  both  normal  and  pathological  neural  activities.  Ionotropic 
receptors are subdivided into three groups: AMPA (α-amino-3-hydroxyl-5-methyl-
4-isoxazole-propionate),  Kainate  and  NMDA  (N-methyl-D-aspartic  acid).  AMPA 
receptors  are  made  up  from  4  different  subunits:  GluA1-4  (GluR1-4),  with 
receptors lacking the GluA2 (GluR2) subunit being permeable to Ca
2+ (Burnashev 
et al., 1992). They are tetramers that exist either as homomeric, containing 
single  receptor  subtype,  or  heteromeric  receptors.  Kainate  receptor  subtypes 
include  GluK1-5  (GluR5-7,  KA1  and  KA2)  (Pinheiro  and  Mulle,  2006).  NMDA 
receptor subunits include GluN1-3 (NR1-3), and GluN2 is further divided into 4 
subunits  (GluN2A-D).  NMDA  receptors  are  heteromeric  complexes,  which  are 
composed of the GluN1 subunit and one or more of the GluN2 subunits (Matsuda 
et al., 2002). There are 8 cloned metabotropic glutamate receptors (mGlus) that 
are classified into 3 groups. Group I: mGlu1 and mGlu5 (mGluR1 and mGluR5), 
group  II:  mGlu2  and  mGlu3  (mGluR2  and  mGluR3)  and  group  III:  mGlu4,  6-8 
(mGluR4, 6-8) (Conn and Pin, 1997). mGlus will be discussed in Chapter 5. 
1.2.4.2  Substance P 
Substance P is an undecapeptide that is involved in nociception; it acts on the 
NK1  receptor.  Substance  P  is  a  member  of  the  mammalian  tachykinin  group 
which include two other peptides: neurokinin A and neurokinin B, which act on 
the  neurokinin  2  and  3  receptors  (NK2R  and  NK3R),  respectively  (Nakanishi,     11 
1991).  Substance  P  and  neurokinin  A  are  both  derived  from  the  same  gene 
(preprotachykinin  I),  while  neurokinin  B  is  derived  from  a  different  gene, 
preprotachykinin  II  (Helke  et  al.,  1990).  Substance  P  and  neurokinin  A  are 
expressed by both primary afferents and dorsal horn neurons, while neurokinin B 
is found in the SDH interneurons of the rat (Ogawa et al., 1985; Moussaoui et al., 
1992).  Substance  P  was  discovered  by  von  Euler  and  Gaddum  (1931)  and  its 
sequence was identified by Chang and Leeman (1970). In the rat, substance P is 
colocalised with CGRP in many of the small DRG neurons. It is packed into the 
large dense-core vesicles at the trans-Golgi network in the cell bodies. It is then 
transported to the peripheral terminals of C-fibres in tissues, and to the central 
terminals in laminae I-II of the spinal cord (Todd, 2002, 2006). Substance P is 
stored in these terminals and can be released into the dorsal horn of the spinal 
cord following intense peripheral stimulation (Duggan et al., 1987; Duggan et 
al., 1988; Liu et al., 1994; Mantyh et al., 1995). Substance P plays a role in 
nociceptive  signal  transmission  by  promoting  central  hyperexcitability  and 
increasing  sensitivity  to  pain  (Salter  and  Henry,  1991;  Ma  and  Woolf,  1995). 
Traub (1996)  also  reported  that  substance  P,  released upon  peripheral  tissue 
insult, contributes mainly to generation but not maintenance of hyperalgesia, by 
facilitating the activation of NMDA receptors, leading to SDH hyperexcitabilty.   
1.2.5 Receptors on primary afferents  
Most studies of receptors on primary afferents have been performed in the DRG, 
since locating these receptors on terminals of primary fibres in the spinal cord 
requires the development of specific antibodies against them (Ribeiro-da-Silva 
and  De  Koninck,  2009).  A  number  of  primary  afferent  receptors  have  been 
reported to play a role in peripheral modulation of nociception. These include 
glutamate  receptors,  opioid  receptors,  cholinergic  receptors,  α2-adrenergic 
receptors,  somatostatin  receptors  and  transient  receptor  potential  receptors 
(TRPs)  (Meyer  et  al.,  2006;  Todd  and  Koerber,  2006).  The  TRPs,  particularly 
TRPV1, will be discussed in more detail since capsaicin, which acts on TRPV1, is 
used in this study as a peripheral noxious stimulus.        12 
1.2.5.1  Transient receptor potential receptors (TRPs)  
TRPs are members of a family of transducer protein molecules which are present 
in the surface membranes of nociceptors, thermoreceptors and thermoreceptive 
neurons. These receptors are essential for nociceptive excitation after chemical 
or  thermal  stimuli.  There  are  four  vanillin  TRPs  that  form  a  group  of 
thermosensitive channels in mammals: TRPV1, TRPV2, TRPV3 and TRPV4. Non-
vanilloid TRPs include TRPM8 and TRPA1 (also called ANKTM1).  
In  mammals,  each  of  the  thermally  sensitive  TRPs  responds  to  a  distinct 
temperature  range  from  cold  to  noxious  heat,  and  most  are  expressed  in 
cutaneous sensory neurons (Patapoutian et al., 2003). TRPV1, formerly known as 
the vanilloid receptor, is among the earliest proteins that were known to play a 
major role in heat transduction. It is highly expressed on many nociceptive Aδ 
and C-fibres (Caterina and Julius, 2001). In addition to its activation by noxious 
heat  (temperatures  ≥42°C),  TRPV1  is  also  activated  by  chemicals  such  as 
capsaicin  [the  active  substance  in  chilli  peppers  (8-methyl-N-vanillyl-6-
nonenamide)] and its agonist resiniferatoxin (Caterina et al., 1997) as well as by 
some endogenous lipids (Vennekens et al., 2008). The function of TRPV1 in the 
peripheral  nervous  system  has  been  extensively  studied.  It  is  specifically 
activated by capsaicin, a lipophillic vanilloid compound found in a wide variety 
of red peppers of the genus capsicum. Binding of capsaicin to TRPV1 activates 
nonselective  cation  channels,  leading  to  Na
+  and  Ca
2+  influx,  which  triggers 
action  potential  firing  and  the  consequent  burning  sensation  associated  with 
spicy food (Holzer, 1991). Caterina et al. (2000) reported that TRPV1
–/– (knock-
out)  mice  exhibited  no  capsaicin/vanilloid  evoked  pain  behaviour  and  an 
impaired response to noxious thermal stimuli, but responded normally to noxious 
mechanical stimuli. In the spinal cord dorsal horn, the role of TRPV1 in pain 
transmission and modulation is not yet fully understood (Spicarova and Palecek, 
2008).  Recently,  Cavanaugh  et  al.  (2011)  found  that  during  development,  a 
substantial  percentage  of  IB4-binding,  non-peptidergic  neurons  lose  the 
expression  of  functional  TRPV1  and  that  in  adult  mice,  TRPV1  expression  is 
restricted to a subset of peptidergic primary afferent neurons in the DRG. 
In the periphery, TRPV2 is strongly expressed on a subset of Aδ nociceptors as 
well as in other neuronal and non-neuronal cells (Caterina and Julius, 2001).     13 
TRPV2  is  only  activated  by  intense  noxious  heat  (temperatures  ≥52°C),  while 
TRPV3 and TRPV4 respond to lower temperatures. However, TRPV3 responses 
continue to increase with increasing temperatures that reach the noxious range, 
suggesting  that  it  may  play  a  role  in  nociception  (Patapoutian  et  al.,  2003). 
TRPM8 is known to play a role in cold transduction (McKemy et al., 2002; Peier 
et al., 2002). The TRPM8 channel, which is expressed almost exclusively in a 
subpopulation of C-fibres, can be activated by low temperatures (15-30°C) and 
by other chemicals that produce a cooling sensation such as menthol (Lumpkin 
and  Caterina,  2007).  Further,  the  exposure  to  temperatures  below  18°C 
activates another member of the TRP family, TRPA1, suggesting that TRPA1 may 
contribute  to  TRPM8-independent  cold  transduction  of  the  noxious  cold 
temperature range (Story et al., 2003; Lumpkin and Caterina, 2007). 
Thermal or chemical activation of the TRP receptors, which are expressed on C- 
and  Aδ-fibres,  subsequently  results  in  the  release  of  glutamate  and  peptides 
including substance P, neurokinin A and CGRP into the dorsal horn, contributing 
to the excitation of second order sensory neurons (Sorkin and McAdoo, 1993; Sun 
et al., 2004; Yan et al., 2006). 
1.3 Dorsal horn projection neurons  
Dorsal horn projection neurons have axons that ascend to various areas of the 
brain. These neurons are not uniformly distributed throughout the grey matter 
of the spinal cord, and this has been shown by injecting retrograde tracers into 
all known supraspinal targets. In the rat, neurons with axons projecting to the 
brain are present in relatively large numbers in lamina I, are largely absent from 
lamina II and are scattered throughout the remainder of the dorsal horn (Todd, 
2010).  
1.3.1 Dorsal horn projection neurons in lamina I  
It  has  been  estimated  that  projection  neurons  make  up  around  5-10%  of  the 
neuronal population in lamina I (Bice and Beal, 1997a, 1997b; Spike et al., 2003; 
Al-Khater et al., 2008). Many lamina I neurons have axons that remain in the 
spinal  cord,  and  these  interneurons  are  thought  to  play  a  major  role  in 
modulating the process of nociception.      14 
Projection neurons in lamina I have axons that cross the midline ascending to a 
variety  of  supraspinal  targets.  These  include:  (1)  The  caudal  ventrolateral 
medulla  (CVLM),  an  area  that  may  play  a  significant  role  in  modulating 
cardiovascular responses to nociceptive stimulation (Lima et al., 1991; Lima et 
al., 2002; Spike et al., 2003). (2) The dorsal reticular nucleus (DRt) and the 
nucleus  of  the  solitary  tract (NTS),  which partially  but  significantly  mediates 
cardiorespiratory  reflex  responses  to  noxious  stimulation  (Lima,  1990;  Boscan 
and Paton, 2001; Gamboa-Esteves et al., 2004). (3) The lateral parabrachial area 
of  the  pons  (LPb),  which  in  turn  projects  to  areas  in  the  brain  involved  in 
emotional aspects and autonomic components of pain such as the amygdala and 
hypothalamus (Cechetto et al., 1985; Hylden et al., 1989; Bernard and Besson, 
1990; Bester et al., 1995; Ding et al., 1995; Gauriau and Bernard, 2002). (4) The 
midbrain periaqueductal grey matter (PAG), which forms part of a descending 
analgesic  pathway  that  projects  via  the  rostral  ventromedial  medulla, 
modulating nociceptive transmission within the spinal cord dorsal horn (Todd et 
al., 2000; Spike et al., 2003; Al-Khater and Todd, 2009; Drew et al., 2009). (5) 
Certain  nuclei  in  the  thalamus,  which  in  the  rat  include  the  ventral 
posterolateral nucleus that projects to the primary somatosensory cortex and 
the posterior triangular nucleus (PoT) projecting to the 2
nd somatosensory area. 
The  ventral  posterolateral  nucleus  contributes  to  the  sensory-discriminative 
aspect of pain, while PoT contributes to the affective-motivational aspect of 
pain (Burstein et al., 1990; Gauriau and Bernard, 2004; Al-Khater et al., 2008; 
Todd, 2010).  
Todd (2010) summarized the quantitative data collected from a series of studies 
of projection neurons in the L4 segment of the rat spinal cord. Most of lamina I 
projection neurons can be retrogradely labelled from the CVLM and/or the LPb. 
Almost all lamina I cells projecting to the thalamus, PAG or NTS also project to 
LPb. However, since the region of CVLM is close to the main bundle of ascending 
axons,  the  tracer  injected  into  this  area  may  be  up  taken  by  the  fibres  of 
passage rather than projection neurons axon terminals.   
Almost a century ago in 1909, Ramon Cajal described the morphology of neurons 
in the nervous system (Garcia-Lopez et al., 2011). Cells in lamina I of the spinal 
cord  were  known  traditionally  as  the  marginal  cells  of  Waldeyer.  Lamina  I 
contains  neurons  of  different  shapes  and  sizes,  and  the  morphology  of  these     15 
neurons has been examined in various species. Lima and Coimbra (1983, 1986) 
distinguished 4 morphological classes of lamina I neurons in the rat based on 
their dendroarchitecture and cell body shape: (1) Fusiform spiny cells having 
longitudinally-orientated  perikarya  with  bipolar  dendrtic  trees.  (2)  Pyramidal 
prismatic wedge shaped cells with 3 to 5 dendritic trunks arising from the apical 
and basal angles of the cell body. (3) Flattened aspiny neurons with a polygonal 
flattened body and horizontal dendritic arbor confined to lamina I. (4) Multipolar 
cells  with  a  cuboidal  cell  body  and  dense  dendritic  trees  originating  from 
numerous primary trunks. Subsequent studies of projection neurons in lamina I 
of the rat, cat and monkey confirmed the findings of Lima and Coimbra (1983, 
1986)  fusiform,  pyramidal  and  flattened  cells.  However,  flattened  cells  were 
named  as  multipolar and  Lima  and  Coimbra’s  multipolar  cells  have  not  been 
further described in the literature (Zhang et al., 1996; Zhang and Craig, 1997; 
Prescott and De Koninck, 2002; Spike et al., 2003; Almarestani et al., 2007). 
Lamina I neurons were also classified based on their soma sizes, and this means 
of classification will be further discussed in Chapter 3. In addition, a substantial 
number of lamina I neurons responded specifically to various forms of noxious 
stimuli, and their responses will be discussed in detail in Chapter 4.  
Lamina I projection neurons have been classified based on the expression of the 
NK1  receptor  into  NK1r-expressing  projection  neurons  and  projection  neurons 
that  either  lacked  or  weakly  expressed  the  receptor.  The  NK1  receptor,  on 
which  substance  P  acts,  is  a  G  protein-coupled  receptor  consisting  of  seven 
membrane spanning domains (Yokota et al., 1989).    
1.3.1.1  Lamina I NK1r-expressing projection neurons 
Cells possessing the NK1 receptor are present in all dorsal horn laminae but are 
most numerous in lamina I (Todd et al., 2002). They make up around 80% of 
lamina  I  projection  neurons,  and  project  to  the  CVLM,  NTS,  PAG,  LPb  and 
thalamus (Todd et al., 2000; Spike et al., 2003; Al-Khater et al., 2008).  
Lamina  I  NK1r-expressing  projection  neurons  selectively  receive  input  from 
peptidergic primary afferents most of which contain substance P (Todd et al., 
2002).  These  cells  also  receive  glutamatergic  input  from  lamina  II  vertical     16 
interneurons  (Lu  and  Perl,  2005).  These  glutamatergic  vertical  cells  receive 
peripheral inputs from TRPA1- and TRPV1-expressing C-fibres (Uta et al., 2010), 
as well as from Aδ-fibres, in addition to a central input from neighbouring lamina 
II glutamatergic central interneurons (Lu and Perl, 2005).  
Lamina I NK1r-expressing neurons have been studied extensively in the past few 
years. These cells have attracted attention since they responded specifically to 
noxious  stimulation  (Salter  and  Henry,  1991).  They  also  internalized  the  NK1 
receptor into their cytoplasm following acute noxious stimulation (Mantyh et al., 
1995; Abbadie et al., 1997; Allen et al., 1997). Further, the number of neurons 
with internalized NK1 receptors was proportional to the severity of the noxious 
stimuli (Wang and Marvizon, 2002). These cells also up-regulated fos (the protein 
product  of  the  immediate-early  gene  c-fos),  and  phosphorylated  ERK  after 
noxious stimulation (Doyle and Hunt, 1999; Ji et al., 2002; Todd et al., 2002; 
Polgar  et  al.,  2007).  Activation  of  NK1r-expressing  neurons  following  noxious 
stimulation will be further discussed in Chapter 4.  
It  was  reported  that  intrathecal  injection  of  substance  P  conjugated  to  the 
cytotoxin saporin (SP-SAP) selectively destroyed NK1r expressing neurons in the 
dorsal  horn  (Mantyh  et  al.,  1997;  Nichols  et  al.,  1999).  SP-SAP  injected-rats 
showed  signs  of  dramatically  reduced  hyperalgesia  in  both  inflammatory  and 
neuropathic  pain  models,  while  their  response  to  acute  painful  stimuli  was 
normal. However, mice that lacked either the NK1 receptor (De Felipe et al., 
1998) or the gene coding for substance P formation (Cao et al., 1998), showed 
little reduction in signs of hyperalgesia in inflammatory models, yet significantly 
reduced  responses  to  acute  painful  stimulation.  These  findings  suggest  that 
although  substance  P  acting  on  the  NK1r-expressing  neurons  plays  a  role  in 
nociception,  there  are  other  substances,  such  as  glutamate  released  from 
primary afferents (De Biasi and Rustioni, 1988) that are more important in the 
development of hyperalgesia. 
1.3.1.2  Lamina I giant cells 
Lamina I giant cells have been identified by Puskar et al. (2001) as a population 
of very large multipolar lamina I projection neurons that either lacked or weakly 
expressed the NK1 receptor. They are very sparse since there are only around 10     17 
of  these  cells  on  each  side  of  the  L4  segment  of  the  rat  spinal  cord.  They 
therefore make up ~2.5% of lamina I projection neurons. Most of the giant cells 
were  retrogradely  labelled  from  the  parabrachial  area  (Puskar  et  al.,  2001; 
Polgar et al., 2008).  
These cells are identified by the presence of gephyrin; the glycine and GABA 
receptor associated protein, on their cell bodies and proximal dendrites. They 
receive extensive inputs from neuronal nitric oxide synthase (nNOS)-containing 
GABAergic internurons (Puskar et al., 2001). They also receive a high density 
input  from  VGLUT2-containing  excitatory  interneurons  (Polgar  et  al.,  2008). 
However, these cells appear to receive little direct synaptic input from primary 
afferents, suggesting that their responses to noxious stimuli are mainly mediated 
by excitatory interneurons (Polgar et al., 2008; Todd, 2010).  
It was reported that after the injection of formalin to the rat hindpaw, 26 out of 
30 giant cells up-regulated fos (Puskar et al., 2001). Polgar et al. (2008) also 
reported that 38% of the giant cells contained fos after noxious heat. The above 
studies suggest that giant cells, which lack or weakly express the NK1 receptor, 
may contribute to the normal responses to acute noxious stimuli seen after the 
injection of SP-SAP, which selectively destroys NK1r-expressing neurons.   
1.3.2 Dorsal horn projection neurons in laminae III-IV  
Rexed (1952) observed that lamina III of the spinal cord contained numerous 
small cells and scattered larger ones, while lamina IV cells were more variable in 
size. Further, early Golgi studies in the cat identified large laminae III-IV neurons 
with  dorsal  dendrites  extending  to  superficial  laminae  (Szentagothai,  1964; 
Rethelyi and Szentagothai, 1969). Schoenen (1982) also reported that in humans, 
laminae  III-IV  contained  a  mixed  population  of  antenna-like  neurons  with 
dorsally oriented dendritic domains. Thereafter, these cells were identified in 
the rat (Todd, 1989) and some were found to express the neurokinin 1 receptor 
(Bleazard et al., 1994; Brown et al., 1995; Littlewood et al., 1995).  
Todd  et  al.  (1998)  reported  that  around  11%  of  lamina  III  cells  were  NK1r-
immunoreactive, while the percentage of NK1r-expressing neurons in lamina IV 
was approximately 28%. However, the population of large NK1r-immunoreactive     18 
projection  neurons  with  long  dorsal  dendrites  represents  only  approximately 
0.1% of all neurons in lamina III (Polgar et al., 2004). These cells have similar 
supraspinal targets to the lamina I projection cells, since they project to the 
CVLM, NTS, LPb, PAG and the thalamus (Marshall et al., 1996; Naim et al., 1997; 
Todd et al., 2000; Al-Khater et al., 2008; Al-Khater and Todd, 2009).  
Laminae III-IV NK1r-immunoreactive cells are densely innervated by substance P-
containing primary afferents, which appear to run ventrally along their dorsal 
dendrites (Naim et al., 1997). In addition, these cells receive a moderate input 
from myelinated LTMs (Naim et al., 1998), but they do not seem to receive any 
significant  input  from  non-peptidergic  IB4-binding  C-fibres  (Sakamoto  et  al., 
1999). These cells are also densely innervated by GABAergic interneurons that 
contain neuropeptide Y (Rowan et al., 1993; Polgar et al., 1999b). It has been 
recently  reported  that  these  neuropeptide  Y-positive  interneurons  constitute 
around 30% of laminae III-IV NK1r-immunoreactive cells’ inhibitory input (Polgar 
et al., 2011).  
Both laminae I and III-IV NK1r-expressing neurons are innervated by descending 
serotoninergic  axons  from  the  raphe  nuclei  that  selectively  depress  the 
transmission of nociceptive information (Stewart and Maxwell, 2000; Polgar et 
al., 2002). This is evidenced by the high density contacts of serotonin-containing 
axons  forming  synapses  with  the  NK1r-expressing  neurons,  suggesting  that  a 
significant  part  of  the  descending  raphe-spinal  inhibitory  system  is  mediated 
directly by serotoninergic axons (Polgar et al., 2002). These cells also receive 
some noradrenergic input from the locus coeruleus and other pontine regions 
(Stewart, 2001; Todd, 2010).  
1.4 Dorsal horn interneurons  
Interneurons have axons that remain in the spinal cord and arborize locally. They 
form  the  vast  majority  of  neurons  in  laminae  I-III.  They  include  virtually  all 
neurons in lamina II and most of laminae I and III neurons. Interneurons can be 
divided  into  two  main  functional  types:  inhibitory  cells,  using  GABA  and/or 
glycine as their principal transmitter, and excitatory cells with glutamate being 
their main neurotransmitter (Todd and Spike, 1993). Interneurons are thought to 
play an important role in pain processing. They modify incoming somatosensory     19 
information  before  it  is  relayed  to  higher  centres.  For  instance,  inhibitory 
interneurons exert a powerful control on spinal nociceptive neurons. A review by 
Sandkuhler (2009) summarized the role of inhibitory interneurons in 4 distinct 
functions.  (1)  They  attenuate  the  responses  of  nociceptive  neurons  during 
nociception. (2) They prevent spontaneous pain by muting nociceptive neurons 
during  normal  states.  (3)  They  separate  nociceptive  from  non-nociceptive 
information in order to prevent cross-talk between different sensory modalities. 
(4) They also limit the spread of excitation by inhibiting excitatory interneurons 
that cross somatotopic borders.  
Attempts  have  been  made  to  classify  interneurons  morphologically, 
electrophysiologically,  neurochemically  and  sometimes  by  combining  two 
methods of classification together. However, there is not a generally accepted 
scheme that applies to all of these cells. Neurochemical classification of laminae 
I, II and III-IV interneruons will be discussed separately, since the expression of 
most dorsal horn neurotransmitters is not confined to one lamina.  
1.4.1 Interneurons in lamina I  
The organisation of lamina I interneurons is not yet fully understood. This may 
be due to the fact that lamina I contains projection neurons and inteneurons 
that  are  not  easily  distinguished  (Todd,  2010).  Three-quarter  of  lamina  I 
interneurons  are  thought  to  be  glutamatergic  since  the  remaining  25-30%  of 
these interneurons contain GABA (Todd and Sullivan, 1990; Polgar et al., 2003).  
1.4.1.1  Morphological and electrophysiological classification 
Grudt and Perl (2002) studied a sample of 13 lamina I neurons, in spinal cord 
slices prepared from hamsters, 8 of which did not project to supraspinal targets 
and  were  therefore  presumed  to  be  interneurons.  These  cells  had  ipsilateral 
directed  axons  in  contrast  to  the  axons  of  the  projection  neurons  that  ran 
ventrally and medially toward the contralateral cord. The axonal arborisation of 
lamina I interneurons was mainly limited to lamina I with few cells having axons 
that  arborized  in  adjacent  lamina  IIo.  These  cells  had  relatively  sparse 
dendrites,  which  were  confined  mainly  to  laminae  I  and  IIo.  The  study  also 
reported  that  all  lamina  I  interneurons  produced  a  sustained  discharge  in     20 
response  to  injecting  a  depolarizing  current.  In  addition,  Ruscheweyh  and 
Sandkuhler  (2002)  reported  a  laminar  difference  in  membrane  and  discharge 
properties of neurons of the rat dorsal horn in vitro. Although the study did not 
differentiate between lamina I projection neurons and interneurons, it showed 
that most neurons in lamina I, but not in lamina II, discharged action potentials 
at  regular  intervals  throughout  the  current  pulse  (tonic  discharge).  However, 
delayed firing neurons, which showed a delayed onset of firing in response to 
current injection, were encountered in both laminae I and II. Prescott and De 
Koninck (2002) also identified 4 physiological cellular classes of lamina I neurons 
in  the  rat  in  vitro:  tonic,  delayed,  phasic  (firing  a  high  frequency  burst  of 
variable duration) and single spike (firing only one spike in response to strong 
depolarisation).  The  study  also  reported  the  existence  of  at  least  three 
morphological  cellular  classes  in  lamina  I,  which  correlated  with  the 
electrophysiological  properties  of  these  cells.  Tonic  cells  were  typically 
fusiform,  phasic cells  were  pyramidal  and  multipolar  cells  fired  in  a  delayed 
and/or single spike patterns.   
1.4.2 Interneurons in lamina II  
Most of the studies regarding dorsal horn interneurons were conducted in lamina 
II, since the majority of neurons in this lamina are interneurons. In lamina II of 
the rat, it was found that approximately 30% of the neurons were inhibitory, 
containing GABA and/or glycine (Polgar et al., 2003). The remaining neurons are 
thought to be glutamatergic (Todd et al., 2003; Maxwell et al., 2007).    
1.4.2.1  Morphological classification 
Lamina  II  interneurons  can  be  classified  morphologically  using  different 
techniques.  Gobel  (1975,  1978)  studied  the  cat  substantia  gelatinosa  and 
identified certain morphological types of cells that have distinct characteristics 
using  the  Golgi  technique.  Cells  were  identified  based  on  certain  criteria: 
dendritic and axonal branching patterns, dendritic spine distribution, geometric 
shape of the dendritic tree and the laminar distribution of the dendrites and 
axons. Three morphological types were identified in this study: islet, stalked and 
spiny cells. Islet cells, mostly found in clusters, had fusiform or rounded cell 
bodies with axons and dendrites arborising longitudinally. Stalked cells on the     21 
other hand were found individually with cone-shaped cell bodies and dendrites 
emitting numerous fine stalked-like branches and dendritic spines. Spiny cells 
were found singly between the islet cell clusters with extensive dendritic trees 
spanning  rostrocaudally  and  mediolaterally.  These  spiny  cells  have  not  been 
further mentioned in the literature that described interneuron morphology. In 
the  rat,  Todd  and  Lewis  (1986)  recognised  two  main  types  of  Golgi  stained 
neurons  in  lamina  II:  islet  and  stalked  cells  with  a  description  that  almost 
resembled  the  cells  identified  by  Gobel  (1975).  Todd  and  Lewis  (1986)  also 
identified  a  group  of  ‘unclassified’  cells  that  represented  over  one-third  of 
lamina II neuronal population.   
Cells can also be classified morphologically after being revealed by intracellular 
injection in vivo. Bennett et al. (1980) studied the responses of a population of 
22 lamina II neurons of the cat to both natural and electrical stimulation of their 
receptive fields. These neurons were then filled intracellularly with horseradish 
peroxidase and their morphology was studied. Twenty of them were recognised 
as being either islet or stalked cells. There was also a clear correlation between 
the  location  of  the  neurons’  dendritic  arborisations  and  their  responses  to 
natural and electrical stimulation. For instance, all stalked cells and those islet 
cells  with  dendritic  trees  located  superficially  (lamina  IIo)  responded  either 
specifically  to  noxious  stimulation  or  to  both  gentle  mechanical  and  tissue-
damaging stimulations (wide dynamic range neurons). On the other hand, islet 
cells with deeply located dendritic trees responded to low-threshold mechanical 
stimulation, suggesting that different layers have different functional roles. In 
agreement with Bennett et al. (1980), Rethelyi et al. (1989) reported a relation 
between  the  laminar  location  of  neuronal  dendritic  trees  and  the  nature  of 
primary afferent excitation in  the cat.  However,  there  was  no  clear  relation 
between the morphology of these cells and their responses to various types of 
noxious  and  innocuous  stimuli.  Additionally,  in  the  rat  SDH,  there  was  no 
correlation seen between function and either the cellular configuration or the 
distribution of the dendritic trees (Woolf and Fitzgerald, 1983).   
A third morphological means of classification was developed in the hamster by 
combining whole cell recording in slices obtained from in vitro preparations with 
neuronal labelling using biocytin from the patch pipette (Grudt and Perl, 2002). 
Four main classes were identified based on different dendritic morphology: islet,     22 
central, radial and vertical cells. Islet cells had elongated (>400 µm) dendritic 
trees in the rostrocaudal axis. Central cells resembled islet cells but with shorter 
(<400 µm) dendritic trees. Unlike the islet and central cells, radial cell dendrites 
were  compact  and  extended  in  several  directions  in  the  parasagittal  plane. 
Vertical cell dendrites fanned out ventrally from a dorsally placed soma located 
in lamina IIo. Some of the vertical cells were morphologically similar to Gobel’s 
stalked cells but others did not show all the features of stalked cells. Similar 
results were seen in the rat dorsal horn (Maxwell et al., 2007; Yasaka et al., 
2007; Yasaka et al., 2010). Despite the identification of the above 4  cellular 
classes, approximately one-third of the studied neuronal populations did not fall 
under any of them, and were considered as ‘unclassified’ (Grudt and Perl, 2002; 
Maxwell et al., 2007; Yasaka et al., 2007; Yasaka et al., 2010).  
Using the Golgi method, Todd and McKenzie (1989) reported that islet cells were 
GABAergic while none of the stalked cells were immunoreactive to GABA. More 
recently, Maxwell et al. (2007) and Yasaka et al. (2010) immunocytochemically 
stained axons of populations of lamina II neurons that were obtained in vitro 
preparations  (whole  cell  patch  clamp)  with  VGLUT2  and  the  vesicular  GABA 
transporter  (VGAT).  The  two  studies  concluded  that  all  islet  cells  were 
GABAergic while radial and most vertical cells were glutamatergic, and central 
cells could be either excitatory or inhibitory. In addition, all islet cells received 
monosynaptic excitatory inputs exclusively from C-fibres and primary afferent-
evoked  inhibitory  inputs  only  from  Aδ-fibres,  while  vertical  and  radial  cells 
received excitatory and inhibitory primary afferent-evoked inputs from both C- 
and Aδ-fibres (Grudt and Perl, 2002; Yasaka et al., 2007). This suggests that 
morphology may correlate with different patterns of excitatory and inhibitory 
inputs  to  lamina  II  interneurons.  Moreover,  within  the  dorsal  horn,  certain 
specific  circuits  between  the  interneurons  have  been  identified.  Lu  and  Perl 
(2003) performed simultaneous whole cell recordings from pairs of cells in vitro 
preparation  and  identified  a  specific  inhibitory  pathway  between  islet  and 
central cells in which islet cell axons formed GABAergic synapses onto central 
cells.  Lu  and  Perl  (2005)  also  reported  that  lamina  II  central  cells  excited 
vertical cells monosynaptically through glutamatergic synapses. Vertical cells in 
turn excited neurons in lamina I that were presumed to be projection neurons.        23 
1.4.2.2  Electrophysiological classification 
Dorsal horn neurons can be classified electrophysiologically based on their action 
potential discharge during the injection of a depolarizing current. During the 
injection  of  a  current,  most  lamina  II  neurons  either  discharged  tonically 
(repetitive action potential discharges), fired transiently (initial bursting after 
which  adaptation  occurs),  displayed  a  prominent  single  spike  or  exhibited  a 
delayed action potential discharge (Grudt and Perl, 2002; Graham et al., 2007). 
Yoshimura and Jessell (1989) studied the membrane properties of the substantia 
gelatinosa neurons in vitro. Their study found that the discharge properties of 
these neurons are modified by the expression of various types of voltage-gated 
currents. It has been suggested that a tonic firing pattern is mainly generated by 
a combination of a voltage gated Na
+ current with a pronounced delayed inward 
rectifier  K
+  (KDR)  current  (Ruscheweyh  and  Sandkuhler,  2002;  Melnick  et  al., 
2004). In addition, it was suggested that the response of delayed firing neurons 
to sudden depolarisation was caused by the transient outward rectifying current 
(IA) that served to delay the onset of the first action potential. This A current is 
a transient voltage-dependant outward potassium current that counteracts fast 
depolarisations  leading  to  the  delay  to  the  appearance  of  the  first  action 
potential  (Yoshimura  and  Jessell,  1989;  Ruscheweyh  and  Sandkuhler,  2002). 
Furthermore,  Hu  et  al.  (2006)  reported  that  in  the  SDH,    the  IA  current  is 
mediated by the Kv4-containing potassium channel particularly Kv4.2, and that 
genetically  eliminating  the  Kv4.2  channel  subunit  increased  the  number  of 
tonically firing neurons.   
Grudt and Perl (2002) studied the responses of certain morphological populations 
of lamina II neurons to depolarising current injections. It was observed that all 
islet  cells  studied  responded  with  a  sustained  repetition  of  action  potentials 
(tonically), while the action potentials of the radial neurons were delayed from 
the onset of the depolarising step. Central cells acted in two different ways, one 
group  went  silent  when  depolarised  while  the  other  group  responded  to  the 
depolarising  step  in  a  sustained  (tonic)  fashion.  The  vertical  cells  had  either 
tonic or delayed response patterns.     24 
In  a  recent  study,  Yasaka  et  al.  (2010)  reported  that  the  morphology  and 
neurotransmitter  type  of  lamina  II  interneurons  were  related  to  the  firing 
patterns of these neurons. Most excitatory neurons including vertical and radial 
cells but few inhibitory cells including islet cells had delayed, gap or reluctant 
pattern of firings, which was associated with A-type potassium (IA) currents.  
1.4.3 Interneurons in lamina III-IV  
Laminae III-IV contains variety of cells of different sizes and shapes including 
both  projection  neurons  and  interneurons.  A  limited  number  of  studies  have 
focused on laminae III-IV interneurons, for instance, Schneider (2008) studied 
the  local  circuit  connections  between  neurons  in  lamina  III  and  IV  of  the 
hamster. Whole cell recordings between synaptically connected pairs of neurons 
in laminae III and IV showed that these connections were mostly unidirectional 
inhibitory connections. Subsequentely, Schneider (2008) processed the biocytin 
filled-cells  histochemically  and  described  their  morphology.  Intracellular 
labelling suggested that the recording was made from local axon interneurons, 
since the neurons were relatively small in size and located within laminae III-IV. 
Each interneuron had 2 to 4 tapered dendrites and a thin cylindrical axon that 
terminated within the dorsal horn. Polgar et al. (2003) also reported that around 
40% of lamina III interneurons were GABAergic in the rat. Further, Ruscheweyh 
and  Sandkuhler  (2002)  obtained  whole  cell  patch-clamp  recordings  from  27 
lamina  III-IV  neurons  (projection  neurons  and/or  interneurons).  The  study 
reported that  some of  these  deeper neurons  generated  tonic  firing  after the 
injection of a depolarizing current, and none showed delayed firing. 
1.4.4 Neurochemical classification of the SDH interneurons  
Interneurons  can  be  classified  alternatively  based  on  their  expression  of 
neurochemical  markers,  including  various  proteins  and  neuropeptides  (Todd, 
2010). Despite the complexity of the SDH in term of its neurochemistry, specific 
populations  of  excitatory  and  inhibitory  interneurons  can  be  identified  when 
using combinations of neurochemical markers (Sardella et al., 2011b).  
Certain proteins are expressed in the dorsal horn of the spinal cord including the 
calcium-biding proteins: calbindin, calretinin, parvalbumin (Ren and Ruda, 1994)     25 
and  the  γ-isoform  of  protein  kinase  C  (PKCγ)  (Mori  et  al.,  1990).  Apart  from 
parvalbumin,  the  above  proteins  are  largely  restricted  to  glutamatergic  cells 
(Todd,  2010).  Calbindin  and  calretinin  expression  patterns  in  the  SDH  are 
known  to  partially  overlap  and  most  of  the  calbindin-  calretinin-containing 
neurons were not reactive for either GABA or glycine (Albuquerque et al., 1999). 
Moreover,  Antal  et  al.  (1991)  reported  that  the  majority  of  the  calbindin-
immunoreactive  cells  in  the  SDH  were  negative  for  GABA-immunostaining, 
suggesting that these neurons are more likely to be glutamatergic. The calcium 
binding protein Parvalbumin is expressed by a subpopulation of neurons that are 
found mainly in laminae IIi and III and ~70% of these showed both GABA and 
glycine immunoreactivity, while ~30% were non-GABAergic (Antal et al., 1991; 
Laing et al., 1994).  
Several protein kinase C isoenzymes have been identified in the SDH including 
α, βI, βII and γ (Mori et al., 1990; Polgar et al., 1999a). Among these, PKCγ γ γ γ        is 
thought to play an important role in nociceptive processing, evidenced by the 
reduction  of  signs  of  neuropathic  pain  in  mice  lacking  the  PKCγ  isoform 
(Malmberg et al., 1997). Polgar et al. (1999a) reported that the great majority 
of PKCγ-containing neurons, which are concentrated mainly in lamina IIi (Mori et 
al.,  1990),  were  likely  to  be  excitatory,  since  they  were  neither  GABA-  nor 
glycine-immunoreactive. Polgar et al. (2011) recently reported that lamina IIi 
PKCγ-expressing  interneurons  receive  input  from  a  subset  of  NPY-expressing 
inhibitory interneurons.  
Furst  (1999)  reported  that  nitric  oxide,  which  is  synthesized  by  nitric  oxide 
synthase in pre- and post-synaptic sites, is involved in certain spinal functions 
such  as  mediating  nociception.  Nitric  oxide  activates  the  enzyme  guanylyl 
cyclase which in turn increases the production of the second messenger cGMP 
(Schmidt et al., 1992). Nitric oxide synthase possesses a nicotineamide adenine 
dinucleotide phosphate (NADPH) reduction capacity. This reduction capacity is 
called  NADPH  diaphorase  (NADPH-d)  activity.  NADPH-d  is  known  to  colocalise 
with nitric oxide synthase in some areas in the CNS including the spinal cord 
(Bredt et al., 1991; Reuss and Reuss, 2001). neuronal nitric oxide synthase 
(nNOS) is one of three nitric oxide synthase isoforms which is found in neurons 
that synthesise nitric oxide and is thought to immunocytochemically correspond     26 
to NADPH-d (Valtschanoff et al., 1992a). NADPH-d was used in early studies to 
identify  nNOS-containing  neurons.  NADPH-d/nNOS-positive  neurons  are 
concentrated mainly in lamina II of the spinal cord and they were most likely 
GABAergic and glycinergic (Valtschanoff et al., 1992b; Spike et al., 1993). Puskar 
et  al.  (2001)  also  reported  that  GABAergic  axons  containing  nNOS  selectively 
innervate lamina I giant cells of the rat dorsal horn.  
The dorsal horn also contains certain neuropeptides that are found exclusively in 
glutamatergic  neurons  such  as  substance  P,  neurokinin  B,  somatostatin  and 
neurotensin  (Todd,  2010).  Somatostatin-expressing  interneurons  are  found 
throughout lamina II (Kiyama and Emson, 1990; Proudlock et al., 1993; Todd and 
Spike, 1993). Most of the somatostatin-containing axons (in laminae I and II) are 
thought  to  be  derived  from  somatostatin  interneurons  along  with  a  minor 
contribution  from  primary  afferents  (Ribeiro-da-Silva  and  Cuello,  1990). 
Neurotensin  is  thought  to  be  present  mainly  in  cells  in  the  ventral  part  of 
lamina II (Seybold and Elde, 1982; Todd and Spike, 1993) and these neurotensin-
containing  neurons  were  found  to  be  GABA-negative  (Todd  et  al.,  1992a). 
Further, Todd et al. (2003) reported that the great majority of axons that are 
likely to be derived from neurotensin- and somatostatin-containing interneurons 
were VGLUT2-immunoreactive.  
It  has  been  shown  that  certain  neuropeptides  are  restricted  to  GABAergic 
neurons, such as neuropeptide Y (NPY) and galanin (Todd, 2010). Neuropeptide 
Y is found exclusively in GABAergic neurons in laminae I-III (Rowan et al., 1993). 
It has been reported that lamina III NK1r- expressing projection neurons receive 
a  substantial  inhibitory  input  from  a  set  of  NPY-containing  GABAergic 
interneurons  (Polgar  et  al.,  1999b).  In  a  recent  study,  Polgar  et  al.  (2011) 
reported that lamina IIi PKCγ-containing interneurons also receive input from a 
presumably  different  subset  of  NPY-expressing  neurons.  Galanin  is  another 
neuropeptide which is found mainly in laminae I and IIo (Todd and Spike, 1993). 
It has been reported that all of laminae I and IIo galanin-containing cells are 
GABAergic (Simmons et al., 1995; Zhang et al., 1995) and recently, Tiong et al. 
(2011)  reported  that  these  cells  represent  a  distinct  population  of  inhibitory 
interneurons.      27 
Among the opioid peptides that are expressed by both excitatory and inhibitory 
interneurons are dynorphin and enkephalin. Dynorphin-immunoreactive neurons 
are concentrated mainly in laminae I and IIo (Todd and Spike, 1993). They can 
be  clearly  revealed  immunocyochemically  with  antibodies  against  dynorphin 
precursor proteins: prodynorphin and preprodynorphin. Preprodynorphin is also 
present in dynorphin–containing axon terminals (Li et al., 1999). Prodynorphin 
and preprodynorphin are expressed in glutamatergic (Marvizon et al., 2009) and 
galanin-containing  GABAergic  neurons  (Sardella  et  al.,  2011a),  respectively. 
Enkephalin-containing neurons are present throughout the dorsal horn but are 
concentrated  in  lamina  II  (Todd  and  Spike,  1993).  They  are  found  in  both 
excitatory (Todd et al., 2003; Marvizon et al., 2009) and inhibitory (Todd et al., 
1992b) interneurons. 
1.5 Markers of neuronal activity 
Markers of neuronal activity provide an approach for studying the functions of 
the  spinal  cord  neurons.  Neuronal  markers  such  as  fos  and  ERK  are  up-
regulated/phosphorylated  by  variety  of  noxious  stimuli,  and  have  been  used 
widely in basic research. Fos, a protein encoded by the cellular immediate-early 
gene  c-fos  (Hunt  et  al.,  1987)  and  more  recently,  ERK  (a  mitogen  activated 
protein  kinase,  MAPK)  (Ji  et  al.,  1999),  are  recognised  as  useful  markers  of 
neuronal activation. Immunocytochemical labelling of these markers has enabled 
researchers  to  investigate  their  colocalisation  with  other  cellular  markers, 
making it possible to study the characteristics of positively-labelled neurons. 
1.5.1 Fos 
Almost two decades ago, Hunt et al. (1987) reported that fos is up-regulated in 
nuclei of neurons in the dorsal horn of the rat after noxious stimulation. Since 
then, this neuronal marker of activity has been extensively used in pain studies. 
The c-fos messenger ribonucleic acid (mRNA) is typically identified using either 
northern blot analysis (Draisci and Iadarola, 1989) or in situ hybridization (Elliott 
et al., 1995), while its protein product fos is identified immunocytochemically 
(Hunt et al., 1987). It has been shown that noxious stimulation increased c-fos 
mRNA levels in the spinal dorsal horn within 30 minutes of stimulation (Draisci 
and Iadarola, 1989). The nuclear protein fos is transported from the cytoplasm,     28 
where it is synthesized, and it accumulates in the nuclei of the spinal neurons, 
reaching  its  maximal  detectible  levels  approximately  2  (1-3)  hours  after  the 
application of the stimulus (Presley et al., 1990). Following noxious thermal and 
chemical  stimulation,  Williams  et  al.  (1990)  reported  that  fos  expression 
reached  its  peak  2  hours  later,  mainly  in  laminae  I  and  II  of  lumbar  spinal 
segments  ipsilaterally,  with  more  fos-positive  neurons  in  laminae  III-IV  after 
formalin injection than after noxious heat. The study also showed that 8 hours 
after formalin injection, there was no fos-immunoreactivity in the spinal cord, 
while numerous fos-positive cells appeared, mainly in the contralateral side of 
the  deep  dorsal  horn,  8  hours  following  noxious  heat.  Fos-immunoreactivity 
lasted  for  24  hours  and  became  more  diffuse  and  symmetrical,  suggesting  a 
complex role of fos in nociception transmission. Bullitt (1991) also reported that 
during the first few hours after the peripheral stimulation of one side of the 
body, fos-positive neurons appeared in the appropriate spinal segments.  
Fos expression after somatic noxious stimulation is mostly localised to laminae I 
and IIo of the spinal cord (Harris, 1998). This neuronal distribution differs if the 
stimulus was innocuous, since fos-immunoreactive neurons were seen mainly in 
deeper laminae (IIi-IV) in response to hair brushing, gentle joint manipulation 
(Hunt et al.,  1987)  and  tactile  stimulation (Jasmin et al., 1994). It was also 
reported that itch, which was induced either by topical application of histamine 
to the skin of the rat (Nakano et al., 2008) or by the injection of histamine-
independent itch mediators to the mouse hindpaw (Akiyama et al., 2009), led to 
the expression of fos in the superficial laminae (I and II). Thus, it could therefore 
be suggested that spinal transmission of both itch and pain sensations may have 
a lot in common (Ross, 2011).  
1.5.2 pERK 
In  this  study,  phosphorylation  of  ERK  was  used  as  the  marker  of  neuronal 
activity, and it will therefore be discussed in more detail. In the past few years, 
the MAPK family of signalling cascades has received a great deal of attention. 
This  family  includes  3  major  members:  extracellular  signal-regulated  kinases 
(ERK, including ERK1/2), p38 (including p38α, p38β, p38γ and p38δ) and c-Jun N-
terminal kinases (JNK, including JNK1, JNK2, and JNK3) (Ji et al., 2009).      29 
ERK1  (also  known  as  p44  MAPK)  and  ERK2  (p42  MAPK)  belong  to  a  group  of 
serine/threonine  protein  kinases.  They  are  both  activated  by  dual 
phosphorylation  on  their  regulatory  tyrosine  and  threonine  residues  by  the 
upstream MAPK kinases: MEK1 and MEK2 (Boulton et al., 1991; Seger and Krebs, 
1995). Both ERK1 and ERK2 are usually referred to as ERK since they resemble 
each other structurally and are often activated together, as they have similar 
sensitivities to activation by MEKs (Zheng and Guan, 1993). In addition, neither 
MEK inhibitors nor pERK antibodies distinguish between ERK1 and ERK2 (Ji et al., 
2009).  However,  ERK1  knock-out  mice  are  viable,  fertile  and  of  normal  size 
(Pages et al., 1999), while ERK2 knock-out mice die before embryonic day 8.5, 
indicating that ERK2 can compensate for ERK1 loss but not vice versa (Hatano et 
al., 2003). 
Both  p38  and  JNK  are  stress-regulated  protein  kinases  that  play  a  role  in 
inflammatory responses and neuronal survival, while the ERK/MAPK cascade is 
known to regulate cellular proliferation and differentiation (Xia et al., 1995). In 
addition to its role in regulating a variety of cellular functions, the ERK/MAPK 
cascade is also involved in neuronal plasticity such as that involved in learning 
and memory (Impey et al., 1999) and in pain hypersensitivity (Ji et al., 2009). 
Ruan et al. (2010) suggested the involvement of all three members of the MAPK 
family in nociception. Their study reported that activation of ephrin receptor 
tyrosine  kinases  in  the  spinal  cord  induced  hyperalgesia  in  mice,  which  was 
accompanied  by  phosphorylation  of  p38  and  JNK  in  both  spinal  neurons  and 
astrocytes, whereas pERK appeared in spinal neurons only.  
1.5.2.1  The role of ERK in nociception  
In the nervous system, ERK pathway activation occurs in a variety of situations, 
including painful conditions. Activation of ERK produces short-term functional 
changes by phosphorylating kinases, receptors and ion channels as well as long-
term  transcriptional  changes  (Ji  et  al.,  1999).  After  exposure  to  a  noxious 
stimulus, the ERK pathway is activated at different neuraxis levels, including 
DRG,  spinal  and  supraspinal  centres,  leading  to  modulatory  changes  in  the 
nervous  system  (Cruz  and  Cruz,  2007).  Ji  et  al.  (1999)  provided  the  first 
indication of pERK involvement in nociception in the spinal cord. Their study 
showed that ERK phosphorylation was specific to noxious stimulation and that     30 
noxious stimuli of different types led to the appearance of many pERK-positive 
neurons in the SDH of the spinal cord of the rat.  
The ERK/MAPK cascade is activated by various pathways, including for instance 
those that involve activation of certain receptors or neurotransmitters. NMDA 
receptor-dependent phosphorylation of ERK occurs after the removal of the Mg
2+ 
blockade of the NMDA channels, thus opening these channels and allowing the 
entry  of  Ca
2+.  On  the  other  hand,  NMDA  receptor-independent  mechanisms 
involve the GluA2-lacking AMPA receptors that allow the influx of calcium, which 
produces lasting facilitation of synaptic transmission (Woolf and Salter, 2000). It 
also  involves  group  I  mGlus,  for  instance,  Karim  et  al.  (2001)  reported  that 
mGlu1 and mGlu5 are required for phosphorylation of ERK in the SDH. It was also 
suggested  that  group  I  mGlu-induced  ERK  activation  are  of  importance  in 
maintaining longer lasting forms of inflammatory pain. Adwanikar et al. (2004) 
showed that group I mGlus activation led to nociceptive behaviours as well as 
pERK expression in the SDH, both of which were enhanced after the injection of 
complete Freund’s adjuvant (CFA) into the mouse hindpaw.  
Substance P also plays an important role in the MAPK/ERK cascade, as evidenced 
by the induction of pERK mainly in lamina I neurons of the SDH of the rat after 
both intrathecal injection of substance P in vivo and application of substance P 
to a spinal cord slice preparation in vitro (Kawasaki et al., 2004). Wei et al. (Wei 
et al., 2006) reported that the bath application of substance P into spinal cord 
slices activated ERK in the SDH in both rat and mouse. Further, both capsaicin- 
and substance P-induced ERK activation were inhibited after the application of a 
selective NK1r antagonist (Kawasaki et al., 2004; Wei et al., 2006). However, it 
was reported by Lever et al. (2003) that after stimulating C-fibres in the mouse 
dorsal  horn  in  vitro,  ERK  was  phosphorylated  mainly  in  the  SDH,  and  this 
phosphorylation was NMDA and mGlu1 but not AMPA or NK1 receptor dependent. 
Their  study  also  reported  that  the  brain-derived  neurotrophic  factor  (BDNF) 
signalling  through  the  tropomyosin-related  kinase  B  (TrkB)  receptor,  but  not 
substance  P  signalling  through  the  NK1  receptor,  may  contribute  to  ERK 
activation in the dorsal horn neurons in this model. This discrepancy may be 
attributed  to  different  nature  of  stimuli  applied  in  each  study  as  well  as  to 
different pharmacological degrees of NK1r inhibition (Ji et al., 2009).      31 
It has been also shown that noxious stimulation led to the release of BDNF in the 
dorsal horn after its anterograde transport from the DRG (Zhou and Rush, 1996). 
It was suggested that following nociceptive stimulation, BDNF is released at the 
synaptic  cleft  in  the  dorsal  horn  and  binds  to  its  high  affinity  postsynaptic 
receptor: TrkB (Pezet et al., 2002), activating the MAPK/ERK cascade (Slack et 
al., 2004). Subsequently, Slack et al. (2005) reported that dorsal horn neurons 
that projected to the thalamus (spinothalamic tract, STT neurons) expressed the 
TrkB  receptor,  and  that  both  exogenous  and  induced-endogenous  release  of 
BDNF led to ERK phosphorylation in TrkB-containing STT neurons.  
Activation of the MAPK/ERK cascade leads to short term changes in the dorsal 
horn,  such  as  phosphorylating  receptors  or  channels,  as  well  as  long  term 
changes,  altering  the  expression  of  neuronal  genes  (Ji  et  al.,  2003).  It  was 
hypothesized that the activating ERK phosphorylates the GluN1 subunit of the 
NMDA  receptor,  thus  increasing  dorsal  horn  neuronal  excitability  (Slack  and 
Thompson, 2002; Slack et al., 2004). Recent studies have also demonstrated the 
involvement of activated ERK in phosphorylating the pore-forming subunit of the 
potassium channel Kv4.2, which is a major contributor to A-type K
+ currents that 
modulate  nociceptive  behaviours  and  pain  plasticity  and  in  the  dorsal  horn 
(Adams et al., 2000; Hu et al., 2003; Ji et al., 2003; Hu et al., 2006).  
The MAPK/ERK cascade is also involved in regulating neuronal gene expression, 
which is involved in induction and maintenance of inflammatory pain. Ji et al. 
(2002) reported that two days following noxious stimulation, which was induced 
by the injection of CFA into the hindpaw of the rat, pERK-positive neurons were 
concentrated  in  the  SDH.  Both  prodynorphin  and  NK1r  were  up-regulated  in 
these  SDH  neurons  and  their  up-regulation  was  prevented  by  blocking  ERK 
activation.  Recently,  Matsuoka  and  Yang  (2012)  reported  that  selectively 
activating  ERK1/2  led  to  nerve  growth  factor  (NGF)-induced  up-regulation  of 
BDNF mRNA in cultured DRG neurons. The study also showed that the application 
of  AZD6244,  a  MEK1/2  specific  inhibitor,  to  the  rat  spinal  cord  attenuated 
pathological  pain,  which  was  induced  by  either  chronic  constrictive  injury  or 
spared nerve injury. AZD6244 also decreased the expression of pERK in the DRG 
and BDNF in the SDH. In addition to the above study, several studies have used 
inhibitors of ERK phosphorylation, which block its upstream kinase MEK, in order 
to reverse pERK-induced pain state. For instance, intrathecal application of the     32 
MEK inhibitor PD98059 reduced the 2
nd phase of formalin-induced pain behaviour 
in  mice  (Choi  et  al.,  2006).  This  2
nd  phase  is  thought  to  result  from  central 
sensitization,  a  nociceptor-mediated  activity-dependent  increase  in  the 
excitability of spinal neurons (Woolf and Costigan, 1999).  
It is often assumed that spinal ERK phosphorylation is exclusively dependent on 
sensory  afferent  input  from  the  periphery.  However,  supraspinal  input  may 
contribute to either facilitating or inhibiting spinal ERK activation (Cruz et al., 
2006; Svensson et al., 2006). For example, Svensson et al. (2006) reported that 
formalin injection to the hindpaw of the rat evoked the activation of spinal ERK. 
This  ERK  expression  was  facilitated  by  input  from  an  excitatory  serotonergic 
descending  pathway,  which  arose  from  the  brainstem  medullary  5-
hydroxytrytamine-containing  nuclei  of  the  raphe.  It  was  shown  that  the 
intrathecal administration of a spinal 5-hydroxytrytamine 3 receptor antagonist 
decreased  ERK  activation  in  the  spinal  cord.  However,  Cruz  et  al.  (2006) 
reported that in animals with spinal cord injury, which was induced by spinal 
transection at the thoracic level, spinal ERK phosphorylation was enhanced at 
the  L6  spinal  cord  segment,  and  this  enhancement  was  more  intense  after 
stimulating the bladder. This suggests that supraspinal input through different 
mediators may play a complex role in both inhibiting and stimulating spinal ERK 
activation (Cruz and Cruz, 2007).  
Phosphorylation  of  ERK  in  the  dorsal  horn  following  various  types  of  noxious 
stimuli will be discussed in more detail in Chapter 4. Figure 1-2 shows examples 
of mechanisms of ERK activation in the spinal cord after noxious stimulation. 
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Figure   1-2 Examples of mechanisms of ERK activation in the spinal cord. 
Following  noxious  stimulation,  glutamate,  BDNF  and  substance  P  are  released  onto  the 
spinal cord and bound to their receptors activating ERK in the cytoplasm. Activated ERK 
then  phosphorylates  specific  subunits  or  subsequently  leads  to  gene  expression, 
modulating different cellular functions. From Cruz and Cruz, (2007).  
1.5.3 Fos and pERK: pros and cons 
In 1987, fos was first used as a marker of neuronal activity in the SDH (Hunt et 
al., 1987), yet 12 years later, it was shown that pERK is specifically induced by 
noxious stimulation (Ji et al., 1999). Since then, both fos and pERK have been 
extensively used as markers of neuronal activation following noxious stimulation.  
There are several advantages to using fos as a marker of neuronal activity, such 
as  the  fact  that  its  expression  in  the  SDH  is  very  robust  and  requires  high 
threshold  stimuli.  In  addition,  it  can  be  easily  revealed  and  quantified 
immunocytochemically. However, the direct role of fos in nociception is not yet 
fully understood. Fos expression is thought to be due to monosynaptic activation 
of spinal cord neurons following small-diameter high-threshold primary afferents 
stimulation  (Hunt  et  al.,  1987).  It  is  usually  assumed  that  fos  is  related  to 
nociceptive  processes,  since  its  expression  leads  to  long  term  intracellular 
changes in spinal nociceptive neurons, producing either hyperalgesia or allodynia 
(Morgan and Curran, 1991; Harris, 1998). This link between nociception and fos 
expression  in  the  dorsal  horn  is  further  strengthened  by  the  finding  that  fos 
expression is decreased after treating animals with variety of analgesics, such as 
kappa1-opioid  receptor  agonists  and  non  steroidal  anti-inflammatory  drugs 
(Catheline  et  al.,  1999;  Buritova  and  Besson,  2000).  However,  dissociation     34 
between the sensation of pain and fos expression has also been reported. For 
instance,  morphine  abolished  pain-related  behaviours  in  rats  injected  with 
formalin, yet failed to significantly decrease the expression of fos in the SDH 
(Presley  et  al.,  1990).  This  suggests  that  in  addition  to  the  direct  relation 
between fos expression in the dorsal horn and nociception, spinal fos expression 
may reflect processes that contribute indirectly to pain transmission. It is also 
essential to consider that the absence of fos expression does not always indicate 
the absence of neuronal activity, since it is expressed only in certain neurons 
following peripheral stimulation. For instance, pinching the hindpaw of lightly 
anesthetised rats led to positive withdrawal reflexes, indicating the activity of 
ventral horn motor neurons. However, there was no fos-immunoreactivity in the 
ventral horn (Bullitt, 1990). Additionally, there is a risk of false positive results, 
for  instance  Bullit  (1990)  reported  that  at  least  few  supraspinal  neurons 
expressed fos in the absence of noxious stimulation, such as following prolonged 
inhalational anaesthesia. This may be due to the time lag between the induction 
and expression of fos, making it difficult to determine which precise events were 
directly responsible for the gene induction (Cruz and Cruz, 2007). It was also 
reported that walking for an hour on a rotating rod induced fos expression in 
spinal and supraspinal areas in the rat. However, the pattern of this expression 
differed  from  fos  up-regulation  following  noxious  stimulation,  since  fos  was 
expressed in laminae IIi, V-VII as well as in motor neurons in the ventral horn 
following this innocuous stimulus (Jasmin et al., 1994).  
Like  fos  expression,  ERK  activation  requires  high-threshold  stimuli.  pERK 
expression  is  also  topographically  specific,  and  predominantly  induced  in 
somatotopically appropriate neurons (Ji et al., 1999). Unlike fos, the expression 
of pERK is more rapid and occurs in various cellular and subcellular regions. In 
addition, ERK phosphorylation is more likely to be only associated with noxious 
stimulation. Importantly, the availability of specific inhibitors of the MAPK/ERK 
pathway  has  led  to  a  clear  demonstration  of  the  role  of  pERK  in  central 
sensitization (Karim et al., 2001).  
Although it was reported that fos expression in supraspinal neurons may occur 
without the participation of ERK (Johnson et al., 1997), it was shown that the 
situation may differ in the spinal cord (Cruz and Cruz, 2007). It was reported 
that  spinal  fos  expression,  induced  by  both  noxious  somatic  and  visceral     35 
stimulation, was almost completely suppressed upon ERK blockade (Kawasaki et 
al., 2004; Cruz et al., 2007). In addition, Kominato et al. (2003) reported that 
after the injection of a MEK inhibitor in a rat model of neuritis, the increase in 
fos expression seen in the SDH neurons was significantly suppressed, while fos 
expression in deep dorsal horn neurons was ERK independent. This suggests that 
fos  expression  in  the  SDH  may  have  been  the  result  of  activation  of  the 
MAPK/ERK cascade. It was also shown that formalin-induced fos expression in 
the  SDH  of  the  rat  was  almost  blocked  after  intrathecal  injection  of  a  p38 
inhibitor (Svensson et al., 2005). Ruan et al. (2010) also reported that p38, JNK, 
ERK and fos were phosphorylated/up-regulated in the mouse SDH following the 
activation of ephrin receptor tyrosine kinases, which also led to hyperalgesia. 
Their  study  also  showed  that  inhibition  of  any  of  the  three  MAPKs  pathways 
almost  prevented  fos  expression  and  reversed  pain  behaviour.  This  therefore 
suggests  that  blocking  any  of  the  interactions  in  this  signalling  molecules 
network  will  result in  a  decreased  activation  of  the  whole  network  and pain 
behaviour relief as a result.  
The specificity, distribution and time course of fos and pERK are compared in 
Table 1-1, which is partially adapted from a review by Gao and Ji (2009). 
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Table   1-1 Comparison of the specificity, distribution and time course of fos and pERK 
  Fos  pERK 
Mechanism of action  Gene expression  phosphorylation 
Induction by noxious stimuli  Yes  Yes 
Induction by innocuous stimuli  Sometimes   No 
Stimulus intensity-dependent  Yes  Yes 
Subcellular distribution in neurons  Nucleus  Nucleus, cytoplasm, 
dendrites, and axons 
Lamina localization in the SDH            
I-II 
III-IV 
V-VI 
               
Strong 
Weak 
Medium 
                       
Strong 
Weak 
Weak  
Time course after formalin injection  
Onset 
Peak induction 
Return to base 
                    
>30 minutes 
1-2 hours 
8-24 hours 
                             
1-3 minutes 
2-10 minutes 
1-2 hours  
Correlation to pain behaviour  Partially   Closely 
Involvement in central sensitization  Unknown  Yes 
Specific inhibitors  No  Yes 
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1.6 Aims of the project  
The overall aim of the project is to investigate the role of different populations 
of spinal cord projection neurons and interneurons in nociception.  
The project initially starts with examining whether NK1r-expressing projection 
neurons can be distinguished from NK1r-expressing interneurons, in lamina I of 
the spinal cord, based on their soma sizes. The results from the first part of the 
project  are  then  used  to  assess  the  responses  of  ‘putative’  lamina  I  NK1r-
expressing  interneurons  and  projection  neurons  (categorized  based  on  their 
soma  sizes)  to  various  noxious  stimuli.  The  2
nd  part  of  the  project  also 
investigates the responses of other populations of projection neurons in the SDH 
to various noxious stimuli. These include laminae III-IV NK1r-expressing neurons 
and lamina I giant cells (both are previously known, from retrograde studies, to 
be projection neurons). Finally, and since it was reported that spinal activation 
of group I mGlus induced hyperalgesia, the role of mGlu5-expressing neurons in 
nociceptive modulation is further investigated. 
The individual aims of each part of the project will be discussed in further detail 
in the relevant Chapters. 38 
2. General Methods 
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This Chapter deals with the general methods that are used in order to pursue the 
three principal aims of the project. Specific experimental procedures that are 
applied in each part of the project are explained in detail in the corresponding 
Chapters. Overall, the following procedures are similar in every Chapter: animal 
perfusion,  tissue  processing  and immunocytochemistry  in  addition  to confocal 
microscopy and analysis. All experiments were approved by the Ethical Review 
Process Applications Panel of the University of Glasgow, and were performed in 
accordance with the UK Animals (Scientific Procedures) Act 1986. 
2.1 Perfusion of the animals 
Following  the  appropriate  survival  time  for  each  experimental  protocol 
(retrograde tracing, noxious or pharmacological stimulation), pentobarbitone- or 
urethane-anesthetized rats were perfused intracardially with a fixative at 4°C, 
preceded by a wash with Ringer’s solution* for couple of seconds. The fixative 
that  was  used  contained  4%  freshly  de-polymerised  formaldehyde*  in  0.1  M 
phosphate  buffer*  (PB).  After  completion  of  the  perfusion  process,  the 
appropriate  spinal  segments  were  removed  and  put  into  the  same  fixative 
solution  and  stored  at  4°C  overnight.  In  those  experiments  that  involved 
retrograde tracing, in order to identify the injection sites, the brain tissue was 
removed and put in 30% sucrose overnight. Detail of handling the brain tissue is 
mentioned in the next Chapter.    
2.2 Tissue processing and immunocytochemistry 
On the following day after perfusing the animals, appropriate thoracic, lumbar 
or sacral spinal segments were cut into 60 µm thick horizontal, parasagittal or 
transverse sections with a Vibratome. The choice of the plane of cutting the 
*Ringer’s solution typically contains sodium chloride, potassium chloride, calcium chloride and 
sodium bicarbonate (to balance the pH). Other additions can include chemical fuel sources for 
cells, including ATP and dextrose, as well as antibiotics and antifungals. 
 
*4% formaldehyde is made in a fume hood by heating distilled water to 68°C and adding 40 g of 
paraformaldehyde.  Few  drops  of  1  N  NaOH  are  added  at  a  time  till  the  paraformaldehyde  is 
completely dissolved. 0.2 M phosphate buffer is then added and topped up with distilled water to 
make one litre of the solution, which is then filtered. 
 
*0.1 M phosphate buffer  is made by adding 1120 ml of solution A to 2880 ml of solution B and 
mixing well after adjusting the pH to 7.4. 3000 ml distilled water is then added to the solution. 
Solution A: NaH2PO (2H2O) 37.4 g in 1200 ml H2O 
Solution B: Na2HPO4           84.9 g in 3000 ml H2O 40 
segments depended on the orientation of the cells of interest as well as on the 
purpose of processing these cells. Horizontal sections are ideal for viewing and 
assessing  the  morphology  of  lamina  I  neurons,  since  the  branches  of  their 
dendritic trees  are  oriented  mainly  rostrocaudally  and/or  mediolaterally  with 
very limited ventral spread (Cheunsuang and Morris, 2000). On the other hand 
laminae  III-IV  neurons  posses  dorsally-directed  dendrites that arborize  toward 
the superficial laminae (Todd, 1989) making them more visible in parasagittal 
sections. Transverse sections are useful for showing the laminar distribution of 
cells of interest. Prior to cutting the segments, some blocks were notched at one 
side in order to orientate the free-floating sections. Spinal blocks from animals 
that  were  unilaterally  injected  with  a  tracer  to  the  brain  were  notched 
ipsilateral  to  the  injection  site.  Blocks  from  the  stimulated  animals  were 
notched  contralateral  to  the  side  of  stimulation.  After  cutting the  segments, 
sections were immersed in 50% ethanol for 30 minutes in order to enhance the 
penetration  of  the  antibodies  (Llewellyn-Smith  and  Minson,  1992).  These 
sections were then rinsed in phosphate buffer saline (PBS) that contained 0.3 
M NaCl* three times over a period of half an hour, unless otherwise stated. They 
were then incubated at 4°C for three days in a cocktail of primary antibodies. 
Antibodies that were used in this project are listed in Table 2-1. The sections 
were then rinsed again in PBS three times over a period of half an hour followed 
by their reaction with species-specific secondary antibodies for 24 hours. These 
secondary antibodies (anti-IgG) were raised in donkey and conjugated to Alexa 
488  (Invitrogen,  Paisley,  UK),  Rhodamine  Red,  Cy5  or  DyLight  649  (Jackson 
ImmunoResearch, West Grove, PA, USA) and were used at 1:500 (Alexa 488 and 
DyLight 649 conjugates) or 1:100 (Rhodamine Red and Cy5 conjugates).  
All antibodies were made in PBS that contained 0.3% Triton® X-100* (PBST) 
unless  otherwise  stated.  Sections  were  then  rinsed  three  times  with  PBS, 
mounted  on  glass  slides,  covered-slipped  with  anti-fade  medium  (Vectashield; 
Vector Laboratories, Burlingame, CA, USA) and stored at -20°C.  
*phosphate buffer saline that contained  0.3 M NaCl  is composed of 100 ml of 0.2 M PB in 
1900 ml of distilled water with 36 g of NaCl. It is found that this concentration of NaCl reduces the 
non-specific  binding  of  antibodies  and  avoids  need  for  the  addition  of  other  proteins,  such  as 
blocking sera.  
 
*PBS that contained 0.3% Triton® X-100  is made up with 3 ml of Triton® X-100 in 1000 ml of 
PBS. 41 
Tyramide signal amplification (TSA) was used in some reactions where two of the 
primary antibodies were raised in the same species (Shindler and Roth, 1996). 
The  amplification  was  performed  with  a  TSA  kit  (PerkinElmer  Life  Sciences, 
Boston,  MA)  according  to  the  instructions  of  the  manufacturer  and  will  be 
explained further in the appropriate Chapter. 
2.3 Antibody characterisation 
Specificity of the CTb and Fluorogold antibodies is shown by the lack of staining 
in  regions  of  the  CNS  that did not contain  neurons  that  had  transported  the 
tracer, and by the presence of immunostaining in populations of neurons that 
are known to project to the injection sites.  
The NK1r antibody is raised in rabbit against amino acids 393-407 of the rat NK1 
receptor  conjugated  to  keyhole  limpet  haemocyanin.  It  has  been  shown  that 
there is no immunostaining with this antibody in sections of medulla and cervical 
spinal cord from knock-out mice compared to wild-type mice (Ptak et al., 2002).  
The  mouse  monoclonal  antibody  against  gephyrin  (mAb  7a)  was  generated 
against an extract of rat spinal cord synaptic membranes (Pfeiffer et al., 1984), 
and  has  been  shown  with  Western  blots  to  bind  to  a  93-kDa  peripheral 
membrane protein (gephyrin) in extracts of rat brain membranes (Becker et al., 
1989; Kirsch and Betz, 1993).  
The  monoclonal  pERK  antibody  detects  both  ERK1  and  ERK2  that  are  dually 
phosphorylated at Thr202 and Tyr204 sites, and does not cross-react with JNK or 
p38 MAP kinase that are phosphorylated at the corresponding residues.  
Specificity of the mGlu5 antibody is shown by the lack of staining in regions of 
the  brain  in  knock-out  mice,  as  well  as  the  lack  of  cross-reactivity  with  the 
mGlu1 antibody (manufacturer’s specification).     
The  calbindin  antibody  (CB-28kD)  detects  a  single  protein  band  at  28-kDa 
(manufacturer’s  specification).  The  specificity  of  the  calretinin  antibody  is 
shown by the absence of staining in the cerebral cortex of knock-out mice.         42 
The GABA antibody was raised against GABA conjugated with glutaraldehyde to 
porcine thyroglobulin, and shows negligible cross-reactivity against other amino 
acids, including glutamate, aspartate, glycine or taurine (Pow and Crook, 1993). 
2.4 Confocal microscopy and analysis 
Two confocal laser scanning microscopes were used in this project. For the first 
two parts of the study, sections were scanned with a Bio-Rad Radiance 2100 
confocal system equipped with blue diode (405 nm) argon multi-line, green HeNe 
(543 nm) and red diode (637 nm) lasers (Bio-Rad, Hemel Hampstead, UK), and 
connected to a Nikon Eclipse E600 microscope (Nikon UK Ltd, Surry, UK). The 
sections were scanned through dry (10×, 20×) objective lenses and a 40× oil-
immersion lens (numerical aperture [NA] 1.3). Z-series of various numbers of 
optical sections at 2 µm z-separation were produced.  
For the 3
rd part of the study, a Zeiss LSM710 confocal microscope equipped with 
argon multi-line, 405 nm diode, 561 nm solid-state and 633 nm HeNe lasers was 
used (Carl Zeiss MicroImaging, Germany). Sections were scanned through a 40× 
oil-immersion objective lens (NA 1.3) to produce z-series consisting of optical 
sections at 1 µm z-separation.  
Scans that were produced using both the Bio-Rad Radiance 2100 confocal system 
and the Zeiss LSM710 confocal microscope were saved in the form of raw images 
(Bio-Rad pic and Zeiss lsm), and viewed using Neurolucida for Confocal software 
(MicroBrightField Inc., Colchester, VT, USA). Figures were composed with Adobe 
Photoshop (CS) software and in some cases, the brightness and contrast of the 
images was adjusted.  
2.5 Statistical analysis  
For statistical comparison between different groups of data, the following tests 
were used: Kruskal–Wallis test, Post-hoc Mann–Whitney U-tests with sequential 
Bonferroni  correction  and  Chi-square  test.  A  P  value  of  less  than  0.05  was 
considered significant.  
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3. Soma size distinguishes lamina I NK1r-
expressing projection neurons from 
interneurons 
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3.1 Introduction  
Lamina I is supplied mainly by Aδ- and nociceptive peptidergic C-fibres as well as 
by  thermoreceptive  fibres  (Light  and  Perl,  1979b;  Todd  and  Koerber,  2006; 
Todd, 2010). It contains neurons that are activated by noxious and/or thermal 
stimuli  (Christensen  and  Perl,  1970;  Han  et  al.,  1998).  These  can  be  either 
projection  neurons,  which  convey  nociceptive,  thermoreceptive  and  itch 
information to higher brain centres (Craig, 1995; Willis and Coggeshall, 2004) or 
interneurons. Lamina I interneurons play a major role in modulating nociception, 
yet  they  are  not  easily  distinguished  from  projection  neurons  in  the  same 
lamina. As described previously, projection neurons make up around 5-10% of 
the  neuronal  population  in  lamina  I,  and  these  neurons  project  to  various 
supraspinal targets. 
Lamina  I  neurons  of  the  rat  that  project  to  the  LPb  respond  to  noxious 
stimulation, as evidenced by immunocytochemical (fos up-regulation) (Lanteri-
Minet et al., 1994; Bester et al., 1997) and electrophysiological (Bester et al., 
2000;  Andrew,  2009)  studies,  suggesting  the  importance  of  this  area  in 
processing  nociception.  Craig  (1995)  reported  that  the  CVLM;  specifically  the 
area between the lateral reticular and spinal trigeminal nuclei, is a major target 
for axons of lamina I neurons in the cat and the monkey. It was also reported 
that large numbers of lamina I neurons in the rat were retrogradely labelled 
from the CVLM (Lima et al., 1991; Spike et al., 2003). It was shown that in the 
rat, the thalamus (including its PoT) received fewer projections from lamina I 
neurons that were located in the lumbar region, compared to neurons in the 
cervical area (Burstein et al., 1990; Al-Khater et al., 2008). It was also found 
that in the lumbar cord of the rat, the largest numbers of labelled lamina I 
neurons were seen following tracer injections into the CVLM or LPb, compared to 
the smaller number of cells observed after the injection of a tracer into the 
PAG. In each case, most labelled cells were located in the contralateral dorsal 
horn with some cells having bilateral projections (Todd et al., 2000; Spike et al., 
2003; Polgar et al., 2010). In addition, Al-Khater and Todd (2009) reported that 
almost all (>95%) lamina I spinothalamic neurons in both lumbar and cervical 
enlargements were labelled from the LPb.  46 
Many lamina I neurons express the NK1 receptor, on which substance P acts. It 
was estimated that in the rat, around 45% of lamina I neurons express the NK1 
receptor (Todd et al., 1998), and a large number of these do not project to 
supraspinal areas. Approximately 80% of lamina I neurons that were retrogradely 
labelled from various supraspinal regions, expressed the NK1 receptor in the rat. 
NK1r-expressing neurons are of particular interest, since they are activated by 
noxious stimuli (Doyle and Hunt, 1999) and their ablation leads to a dramatic 
reduction of hyperalgesia in inflammatory and neuropathic pain models (Mantyh 
et al., 1997; Nichols et al., 1999).    
Attempts  have  been  made  to  classify  lamina  I  NK1r-expressing  neurons.  For 
instance, Cheunsuang and Morris (2000) identified two distinct populations of 
NK1r-expressing neurons in lamina I. These included small cells, which stained 
weakly for the receptor and had fusiform somata, with a mean value of their 
cross-sectional area of 81 µm
2 (in a horizontal plane), and large multipolar cells 
that  were  described  as  strongly  immunoreactive  (mean  of  the  soma  cross 
sectional area was 288 µm
2). Cheunsuang and Morris (2000) also suggested that 
many of the larger neurons may project to the thalamus and have polymodal 
nociceptive  characteristics,  thus  being  a  part  of  a  system  that  evaluates  the 
severity of an injury, and then initiates the appropriate response for protection 
and  endogenous  suppression  of  this  pain.  In  contrast,  the  study  showed  that 
smaller  neurons  had  a  very  distinctive  fusiform  morphology,  which  has  been 
suggested to be characteristic of nociceptive specific neurons (Han et al., 1998). 
Subsequently,  Polgar  et  al.  (2002)  reported  that  a  sample  of  45  NK1r-
immunoreactive lamina I neurons that were labelled from the CVLM had soma 
sizes that were similar to those of the large cells identified by Cheunsuang and 
Morris (2000). However, the study could not determine whether all of the large 
cells were projection neurons, since not all projection neurons in this lamina 
would have been labelled from the CVLM (Spike et al., 2003).  
It was reported that morphology of lamina I neurons correlated with functional 
properties in the rat, cat and monkey. For instance, pyramidal cells that lacked 
the  NK1  receptor  responded  to  innocuous  cooling  only,  while  multipolar  and 
fusiform cells were activated by noxious stimuli (Han et al., 1998; Yu et al., 
1999;  Almarestani  et  al.,  2007).  Almarestani  et al.  (2007)  also  reported that 47 
most of the spinoparabrachial NK1r-expressing neurons in the rat were either 
multipolar or fusiform, while the pyramidal projection cells were seldom NK1r-
immunoreactive. However, it was shown that in the rat, there was no difference 
between  the  morphological  classes  of  NK1r-expressing  projection  neurons  in 
either  the  density  of  contacts  from  substance  P-containing  afferents  or  the 
percentage  of  cells  that  up-regulated  fos  after  noxious  chemical  stimulation 
(Todd et al., 2002; 2005). 
The main aim of this part of the study was to test the hypothesis that all of the 
large lamina I NK1r-immunoreactive cells identified by Cheunsuang and Morris 
(2000) are projection neurons, while the small cells are interneurons. To achieve 
this, tracers were injected into both the LPb and the CVLM, since it has been 
shown that virtually all lamina I projection neurons can be labelled from these 
sites (Spike et al., 2003). It has been reported that a large number of lamina I 
pyramidal projection neurons lacked the NK1 receptor, and these cells tended to 
be  smaller  than  the  NK1r-expressing  projection  neurons  (Almarestani  et  al., 
2007). Therefore, an additional aim of this study was to further investigate the 
retrogradely  labelled  pyramidal  cells  that  were  NK1r-negative,  and  compare 
them with the NK1r-expressing projection neurons of the pyramidal class.  
3.2 Experimental procedures 
3.2.1 Animals and operative procedures 
Three adult male Wistar rats (250–280 g; Harlan, Loughborough, UK) were used 
for this part of the study. The rats were anaesthetized with Isofluorane (1.5-4%). 
They  were  then  placed  on  a  heating  pad  in  order  to  maintain  their  body 
temperature. Their heads were fixed in a stereotaxic frame, after which the 
anaesthetic was administered through a mask attached to the frame. The level 
of anaesthesia was monitored throughout the procedure by occasionally pinching 
the hindpaw and observing the appearance of any withdrawal reflexes. In order 
to  prevent  the  rat  corneas  from  drying  during  the  surgery,  their  eyes  were 
covered with Vaseline petroleum jelly. The points in the skull that corresponded 
to  the  LPb  and  the  CVLM  were  determined  using  a  standard  rat  brain  atlas 
(Paxinos and Watson, 2005). Under aseptic conditions, the two areas of interest: 
the LPb and the CVLM were made accessible by performing a craniotomy with a 48 
fine  drill  after  separating  the  underlying  fascia.  Each  rat  received  two 
injections: (1) 50 nl of 4% Fluorogold (Fluorochrome Inc, Englewood, CO, USA) 
targeted on the left LPb, and (2) 200 nl of 1% CTb (Sigma-Aldrich, Poole, UK) 
into the left CVLM. Injections to the CVLM were aimed to regions between the 
lateral reticular nucleus and the adjacent part of the spinal trigeminal nucleus 
(Spike  et  al.,  2003).  The  injections  were  made  under  pressure  using  two 
different  glass  micropipettes,  one  for  each  area.  In  order  to  prevent  the 
backflow  of  the  tracers  after  injecting  them,  the  micropipettes  were  left  in 
place for 5 minutes. At the end of the procedure, the incision was sutured and 
the  rats  were  allowed  to  recover  from  anaesthesia  after  which  they  were 
subcutaneously injected with 5 mg/kg carprofen; an analgesic. Following a 3 day 
survival period, the rats were re-anaesthetized with pentobarbitone (40 mg/kg 
ip) and perfused with 4% formaldehyde as described in the previous Chapter.  
3.2.2 Tissue processing and immunocytochemistry 
The brain and the lumbar spinal cord were dissected out and post-fixed at 4°C 
for  24  hours.  The  brain  fixative  contained  30%  sucrose  as  a  cryoprotectant, 
preventing  large  ice  crystal  formation.  The  regions  of  the  brainstem  that 
contained the injection sites were cut into 100 µm thick coronal sections with a 
freezing microtome. The brain sections were cut serially into 5 bottles and the 
series in one of the bottles was used for further analysis. Sections through the 
Fluorogold  injection  were  mounted  on  slides  with  a  glycerol-based  antifade 
medium (Vectashield, Vector laboratories, Peterborough, UK) and viewed with a 
fluorescent microscope. For detection of CTb, sections from one of the bottles 
were incubated for 3 days in goat antiserum to CTb (1:50,000). On the 3
rd day, 
the sections were rinsed 3 times in PBS over a period of half an hour, and then 
they  were  incubated  overnight  in  biotinylated  anti-goat  IgG  (Jackson 
ImmunoResearch, West Grove, PA; 1:500). On the 4
th day, and after the sections 
had been rinsed 3 times in PBS for 30 minutes, they were reacted for 3-4 hours 
with  streptavidin-horseradish  peroxidase  (Sigma-Adrich,  Poole,  UK;  diluted  in 
PBS, 1:1000). Peroxidase activity was revealed with 0.025 M diaminobenzidine in 
the  presence  of  0.001%  hydrogen  peroxide.  The  sections  were  then  rinsed  3 
times in PBS over a period of half an hour and mounted on gelatinized slides and 
air dried. On the following day, sections were rinsed in water, dehydrated in 49 
ascending concentrations of alcohol, cleared in Histo-Clear and mounted with 
Histomount.  
The spread of the tracers was plotted onto drawings of the LPb and the CVLM 
(Paxinos and Watson, 2005) and representative examples were photographed. 
The spinal L4 segment from each animal was initially notched on the left side 
(ipsilateral to the injection side), and cut into 60 µm horizontal sections with a 
Vibratome. The sections were then treated for 30 minutes with 50% ethanol. 
These were rinsed 3 times with PBS for half an hour, and then incubated free-
floating at 4°C for 3 days in a cocktail of antibodies. The primary antibodies 
consisted  of  guinea-pig  anti-Fluorogold  (1:500),  goat  anti-CTb  (1:5000)  and 
rabbit anti-NK1r (1:10,000). The sections were rinsed 3 times with PBS for 30 
minutes, reacted with fluorescent labelled species-specific secondary antibodies 
that were raised in donkey and conjugated to either Alexa 488, Rhodamine Red 
or Cy5. The sections were then rinsed 3 times with PBS, mounted and stored at -
20°C. Characteristics and suppliers of antibodies used in this part of the study 
are described in the previous Chapter.   
3.2.3 Confocal microscopy and analysis 
Horizontal sections from the L4 spinal segments were used to analyze the soma 
sizes of lamina I NK1r-expressing neurons that projected to the LPb and/or the 
CVLM, as well as the soma sizes of the NK1r-expressing neurons that were not 
retrogradely labelled.   
Sections were initially examined with a 20× objective lens using a fluorescent 
microscope.  All  of  those  on  the  contralateral  (right,  un-notched)  side  that 
contained lamina I were identified by the presence  of numerous retrogradely 
labelled  cells,  as  well  as  a  relatively  high  density  of  NK1r-immunoreactivity 
compared to lamina II. In this way, between one and three sections from each 
animal were selected for further analysis. These sections were scanned with a 
Bio-Rad  Radiance  2100  confocal  system  through  a  40×  oil-immersion  lens  to 
produce image stacks with a 2 µm z-separation. Since the area covered by this 
lens was approximately 300×300 µm
2, several overlapping fields (between 5 and 
7 from each section) were scanned in order to include most of the medial two-50 
thirds of lamina I. The lateral part of the dorsal horn was not analysed, as the 
orientation  of  the  lamina  is  different  in  this  region.  Scans  were  performed 
sequentially with each laser line to avoid fluorescent bleedthrough.  
Confocal image stacks were analysed with Neurolucida for Confocal software. 
Initially, and to avoid selection bias, only the channel corresponding to NK1r-
immunoreactivity  was  viewed  and  this  was  used  to  identify  lamina  I.  NK1r-
immunoreactive cells in lamina I were then selected and the outlines of their 
cell bodies were drawn by examining all of the optical sections through each 
cell.  Preliminary  observation  confirmed  that  there  was  a  large  population  of 
small  cells  (<200  µm
2  soma  cross-sectional  area)  that  showed  weak  NK1r-
immunoreactivity,  and  these  were  found  to  be  far  more  numerous  than  the 
larger NK1r-immunoreactive cells. For this reason, all of the larger cells (>~200 
µm
2  soma  cross-sectional  area)  together  with  a  sample  of  small  cells  were 
selected  for  analysis.  For  each  of  the  selected  cells,  the  maximum  cross-
sectional area of the soma was measured from projected confocal images of NK1 
receptor  staining  with  Neurolucida  for  Confocal  (Puskar  et  al.,  2001).  In 
addition,  the  intensity  of  NK1r-immunostaining  in  the  plasma  membrane  was 
assigned  a  score  ranging  from  4  (strong)  to  1  (very  weak),  as  described 
previously (Al-Khater and Todd, 2009). This scoring system was used because 
variation in immunofluorescence intensity at different depths of the Vibratome 
sections makes it difficult to use a more objective measure (Spike et al., 2003). 
When  all  of  the  selected  cells  in  a  field  had  been  analysed,  the  channels 
corresponding  to  Fluorogold  and  CTb  were  examined,  and  the  presence  or 
absence  of  these  tracers  in  each  of  the  selected  cells  was  determined.  In 
addition,  any  retrogradely  labelled  cells  that  had  not  been  included  in  the 
selected sample were identified and analysed in the same way. These additional 
cells included those that were NK1r-negative as well as some that showed very 
weak immunostaining and had not been recognized in the initial survey. Cells 
were excluded from the analysis if part of the soma had been removed from the 
Vibratome  section  in  such  a  way  that  the  cross-sectional  area  would  be 
underestimated. 
As described previously, Almarestani et al. (2007) reported the presence of a 
distinctive  population  of pyramidal  spinoparabrachial  neurons  that  lacked  the 51 
NK1  receptor.  In  order  to  further  investigate  this,  the  morphology  of  all 
retrogradely labelled cells that were not NK1r-immunoreactive was analysed by 
examining  confocal  image  stacks  with  Neurolucida  software.  Cells  were 
classified into multipolar, pyramidal or fusiform based on the criteria described 
by  Zhang  et  al.  (1996)  and  Zhang  and  Craig  (1997).  The  soma  size  of  these 
neurons and the number and orientation of their primary dendrites were clearly 
defined,  since  it  has  been  suggested  that  these  features  are  particularly 
important for classification (Almarestani et al., 2009). 
3.3 Results 
3.3.1 Injection sites 
The extent of spread of Fluorogold from the LPb and of CTb from the CVLM was 
plotted for each experiment. Drawings, which were based on those of Paxinos 
and  Watson  (2005),  are  illustrated  in  Figure  3-1.  Photomicrographs  of 
representative injection sites are shown in Figure 3-2.  
The Fluorogold injection, which targeted the LPb covered almost all of it in each 
case,  with  variable  spread  into  surrounding  structures,  such  as  the  superior 
cerebellar peduncle, medial parabrachial area, cuneiform nucleus, and inferior 
colliculus.  
The CTb injection, which was targeted on the CVLM filled the lateral part of the 
lateral reticular nucleus in all three cases, with spread into surrounding regions, 
including the area between this nucleus and the spinal trigeminal nucleus and 
the ventrolateral white matter. 
3.3.2 NK1r-immunoreactivity in lamina I 
The  highest  densities  of  NK1r-immunostaining,  for  both  cell  bodies  and 
dendrites, were seen in lamina I (Figure 3-3). This finding is in agreement with 
previous studies (Bleazard et al., 1994; Nakaya et al., 1994; Littlewood et al., 
1995; Todd et al., 1998). Lamina I NK1r-immunoreactive cells appeared to have 
a bimodal size distribution, with one group consisting of large neurons of various 
shapes,  and  the  other  group  consisted  of  many  smaller  fusiform  cells  that 
resembled what was described by Cheunsuang and Morris (2000). The large cells 52 
showed different somatodendritic morphology (including fusiform, pyramidal and 
multipolar types), and were also much more variable in regard to their strength 
of NK1r-immunoreactivity. This ranged from strong to very weak in contrast to 
the small cells, which were generally weakly immunoreactive. In regard to the 
smaller NK1r-expressing cells, it was observed, but not systematically analysed, 
that these cells were particularly numerous in the ventral part of lamina I (as 
reported by Cheunsuang and Morris, 2000).  
Altogether,  1341  NK1r-immunoreactive  cells  were  identified  in  lamina  I  in 
sections from the three experiments. Of these, 441 neurons were retrogradely 
labelled from the CVLM, LPb, or both. The 900 remaining cells were not labelled 
from either the CVLM or the LPb.  
3.3.3 Retrograde labelling  
In  addition  to  the  441  NK1-immunoreactive  projection  neurons,  101  NK1r-
negative retrogradely labelled cells were identified. The total number of lamina 
I projection neurons that were selected for analysis from the 3 experiments was 
therefore  542,  (156–206  per  experiment).  Of  these,  83–88%  contained  both 
tracers, while 5–6% was labelled only with CTb injected into the CVLM and 5–12% 
was labelled only with Fluorogold injected into the LPb (Table 3-1, Figure 3-4a).  
From  the  three  experiments,  between  76  and  86%  (mean  81%)  of  the 
retrogradely labelled lamina I cells were NK1r-immunoreactive. The strength of 
NK1r  expression  on  these  cells  varied  from  very  weak  to  strong  (Table  3-2). 
Examples of retrogradely labelled neurons that were NK1r-immunoreactive and 
those that lacked the NK1 receptor are shown in Figures 3-3 and 3-4.  
Of the 441 NK1r-immunoreactive retrogradely labelled neurons, 420 had been 
identified in the initial surveys of NK1r immunoreactivity in the confocal image 
stacks, as described in the experimental procedures section. The remaining 21 
(most of which showed weak NK1r-immunoreactivity) were identified only after 
the channels corresponding to CTb and Fluorogold were observed. 53 
3.3.4 Soma cross-sectional areas 
As  described  previously,  the  total  number  of  lamina  I  NK1r-immunoreactive 
neurons that had been selected in this study is 1341. Of these, 900 cells were 
not retrogradely labelled (214–390 from each experiment). The remaining 441 
NK1r-immunoreactive  neurons  were  retrogradely  labelled.  Regarding  the 
strength of the NK1r immunoreactivity, the great majority of un-labelled cells 
(784, 87%) were assigned a score of 1, while 106 (12%) were given a score of 2, 
and 10 (1%) a score of 3.  
Figure 3-5 shows the frequency distributions of soma cross-sectional areas for 
the  different  groups  of  neurons  based  on  both  their  NK1r  expression  and 
retrograde labelling. The histogram for all NK1r-immunoreactive neurons shows 
a clear bimodal distribution with two peaks. The first one corresponds to soma 
cross-sectional area values between 50 and 200 µm
2, and the second broader 
peak extends from 200 to 600 µm
2 with fewer cells having larger soma cross-
sectional areas (up to 1200 µm
2).  
Figure  3-5  also  shows  the  cross-sectional  areas  of  cell  bodies  for  the  NK1r-
immunoreactive cells that were not retrogradely labelled. These ranged from 61 
to 568 µm
2, with a median value of 124 µm
2 (n=900), and they corresponded to 
the first peak of the combined NK1r-immunoreactive group.  The cross-sectional 
area values for the retrogradely labelled NK1r-immunoreactive cells were 128–
1198 µm
2, with a median of 298 µm
2 (n=441), and these corresponded to the 
second peak of the combined group. The retrogradely labelled cells that lacked 
the NK1 receptor had soma cross-sectional area values that ranged between 137 
and 1129 µm
2 with a median of 272 µm
2 (n=101).  
Differences between these three groups (NK1r
+ non-retrograde, NK1r
+ retrograde 
and  NK1r
-  retrograde)  were  found  to  be  significant  (Kruskal–Wallis  test, 
P<0.001). Post-hoc Mann–Whitney U-tests with sequential Bonferroni correction 
showed  a  highly  significant  difference  between  the  soma  sizes  of  the  NK1r-
immunoreactive neurons that were not retrogradely labelled and those of both 
groups  of  retrogradely  labelled  neurons  (P<0.001).  However,  there  was  no 
significant  difference  between  the  retrogradely  labelled  neurons  that  were 
NK1r-immunoreactive and those that were not immunoreactive (P=0.16).  54 
Nearly  all  (895/900,  99.4%)  of  the  NK1r-immunoreactive  cells  that  were  not 
retrogradely  labelled  had  soma  cross-sectional  areas  that  were  less  than  200 
µm
2. In contrast, only 43/441 (9.8%) of the retrogradely labelled NK1r-positive 
cells had cell bodies smaller than 200 µm
2 (Figure 3-5 and Table 3-3). 
3.3.5 Morphology of NK1r-negative projection neurons 
In order to fulfill one of the aims of this part of the study regarding investigating 
lamina  I  pyramidal  projection  neurons  that  lacked  the  NK1  receptor,  the 
morphology of all the projection cells that were NK1r-negative was examined. 
Within this population (n=101), 15 were classified as pyramidal, 36 as multipolar 
and 24 as fusiform. Of the remainder 26, 13 fell under the ‘unclassified’ group, 
while  13  could  not  be  classified  because  of  incomplete  filling  of  primary 
dendrites.  An  example  of  a  retrogradely  labelled  pyramidal  cell  that  lacked 
NK1r-immunoreactivity  is  illustrated  in  Figure  3-4  (cell  3).  Figure  3-6  shows 
drawings of the cell bodies and proximal dendrites of five of these cells. The 
pyramidal cells were characterized by a triangular cell body, and in most cases 
(11/15) this gave rise to three primary dendrites (one from each pole of the 
soma). Each of the remaining four pyramidal cells had four primary dendrites. In 
one of these cases, two of the dendrites arose from one pole, while in the other 
three cases an additional thin dendrite was given off from the soma (Figure 3-6). 
One  of  these  travelled  dorsally  towards  the  dorsal  columns.  Although  the 
morphology of the retrogradely labelled NK1r-immunoreactive neurons was not 
analysed systematically, many of these cells were also pyramidal (e.g. cells 1 
and 2 in Figure 3-4). In order to compare the soma sizes of NK1r-immunoreactive 
and non-immunoreactive pyramidal projection neurons, the results from the 15 
NK1r-negative pyramidal projection cells seen in this part of the project were 
pooled with data from a study of spinoparabrachial neurons in the L3 segment of 
the rat reported by Al-Khater and Todd (2009). This latter group consisted of 55 
retrogradely labelled  pyramidal cells, of which 37  were NK1r-immunoreactive 
and  18  were  non-immunoreactive.  Soma  sizes  of  the  NK1r-immunoreactive 
pyramidal cells varied from 196 to 616 µm
2 (median 333, n=37) while those of 
the non-immunoreactive cells ranged from 171 to 533 µm
2 (median 285, n=33). 
Although  the  NK1r-immunoreactive  cells  tended  to  be  larger  than  the  non-
immunoreactive  ones  (Figure  3-7),  this  difference  did  not  reach  significance 
(P=0.07, Mann–Whitney U-test). 55 
 
 
 
 
 
Figure 3-1 Drawings of Fluorogold and CTb injection sites in the three 
experiments.  
Injection sites in the three experiments (Fluorogold injected into LPb and CTb 
into  CVLM).  The  drawings  show  the  spread  of  tracer  in  each  of  these 
experiments.  Each  vertical  column  represents  a  single  experiment,  and  the 
experiment number is shown at the bottom of the column. Numbers on the left 
correspond  to  the  position  of  the  section  anterior  or  posterior  (-)  to  the 
interaural plane. Drawings are based on those of Paxinos and Watson (2005). The 
upper four outlines in each column represent the Fluorogold injection, while the 
lower five show the spread of CTb.  
CnF,  cuneiform  nucleus;  Cu,  cuneate  nucleus;  IC,  inferior  colliculus;  KF, 
Kölliker-Fuse nucleus; LPb, lateral parabrachial nucleus; LRt, lateral reticular 
nucleus; MPB, medial parabrachial nucleus; PAG, periaqueductal grey matter; 
py,  pyramidal  tract;  scp,  superior  cerebellar  peduncle;  Sol,  nucleus  of  the 
solitary tract; Sp5, spinal trigeminal nucleus. 
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Figure 3-3 Immunoreactivity of the NK1 receptor, CTb and Fluorogold.  
A horizontal section from the L4 segment of experiment 2. (a) shows a field 
scanned to reveal NK1r-immunoreactivity (green), (b) has been scanned for CTb 
(red)  and  Fluorogold  (FG,  blue),  while  (c)  is  a  merged  image.  The  NK1r-
immunoreactivity is associated with thin elongated profiles, which are dendrites, 
as well as with larger structures, which are cell bodies.  
This  field  contains  the  cell  bodies  of  five  NK1r-immunoreactive  projection 
neurons (asterisks) that were retrogradely labelled from both CVLM and LPb, and 
therefore  contain  both  tracers.  In  addition,  several  smaller  NK1r-
immunoreactive cell bodies are visible, and these are not retrogradely labelled. 
Six of these cells are indicated with arrowheads. The images are projections of 
two optical sections at 2 µm z-separation. Scale bar=20 µm. 
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Figure 3-4 Examples of retrogradely labelled neurons.  
A horizontal section from L4 in experiment 1. (a) A projected image through the 
cell bodies of several retrogradely labelled cells, with CTb shown in red and 
Fluorogold in blue. Most cells have taken up both tracers and therefore appear 
pink, while the cell numbered 1 is labelled only with Fluorogold, and the one 
marked with an asterisk is labelled only with CTb. The three numbered cells are 
pyramidal in shape and single optical sections through the cell bodies of each of 
these are shown in (b–g).  
From these images it can be seen that cells 1 and 2 are NK1r-immunoreactive, 
while cell 3 is not. The image in (a) is a projection of eight optical sections at 2 
µm z-spacing. Scale bar=20 µm. 
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Figure 3-5 Frequency histogram showing the soma cross-sectional areas for 
different groups of lamina I neurons.  
The histogram shows all of the NK1r-immunoreactive cells (All NK1r
+, n=1341), 
those that were NK1r-immunoreactive but not retrogradely labelled (NK1r
+ non-
retrograde,  n=900),  those  that  were  NK1r-immunoreactive  and  retrogradely 
labelled (NK1r
+ retrograde, n=441) and those that were retrogradely labelled and 
not NK1r-immunoreactive (NK1r
- retrograde, n=101).  
In each case, the y-axis represents percentage. The dashed line corresponds to a 
cross-sectional area of 200 µm
2. The NK1r-immunoreactive neurons show a clear 
bimodal distribution, with the first and second peaks corresponding to the non-
retrogradely labelled and the retrogradely labelled populations, respectively. 
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Figure   3-6 Drawings of NK1r-negative retrogradely labelled pyramidal cells. 
Drawings showing five of the 15 retrogradely labelled pyramidal cells that were 
not NK1r-immunoreactive. Cell 1 corresponds to cell 3 in Figure 3-4. Three of 
these cells (1, 3 and 4) each give rise to three primary dendrites. Cell 2 has two 
primary dendrites originating from one pole of the soma, while cell 5 has an 
additional very fine dendrite originating from the soma. Scale bar=20 µm. 
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Figure   3-7 Box and whisker plot of the soma sizes of retrogradely labelled 
pyramidal cells.  
The plot shows the soma sizes of retrogradely labelled pyramidal cells that were 
NK1r-immunoreactive (NK1r
+, n=37) or non-immunoreactive (NK1r
-, n=33). The 
boxes represent the median and interquartile range, while the upper and lower 
error bars show the 90th and 10th percentiles and the filled symbols are values 
outside these ranges.  
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3.4 Discussion 
The  main  finding  of this  part  of the  study  is  that  NK1r-expressing  projection 
neurons  can  be  distinguished  from  NK1r-expressing  interneurons,  in  lamina  I, 
based on their cell body sizes. The great majority of NK1r-expressing cells that 
were not retrogradely labelled from CVLM and/or LPb have soma cross-sectional 
areas of less than 200 µm
2, while most of the retrogradely labelled cells are 
larger than this. 
3.4.1 Choice of the retrograde tracers and injection targets 
In this part of the study, a retrograde labelling technique was used in order to 
identify lamina I projection neurons. It was reported that this technique allows 
both quantitative and qualitative assessments of connections between various 
CNS areas (Vercelli et al., 2000). A combination of two retrograde tracers (CTb 
and Fluorogold), which were injected into two different supraspinal targets on 
one  side,  CVLM  and  LPb,  enabled  targeting  almost  all  lamina  I  projection 
neurons on the contralateral side, for reasons that will be explained shortly.  
It  has  been  shown  from  previous  studies  that  both  CTb  and  Fluorogold  are 
sensitive  markers,  as  evidenced  by  their  ability  to  detect  large  numbers  of 
retrogradely labelled cells, as well as their extensive filling of labelled neurons 
(Spike et al., 2003; Al-Khater and Todd, 2009; Polgar et al., 2010). They are also 
equally efficient, since Spike et al. (2003) reported that the injection of either 
Fluorogold or CTb into the LPb resulted in labelling almost the same number of 
cells. It was observed that Fluorogold may cause necrosis of the tissues to which 
it is injected, this is why it is preferable, that if used with another marker, for it 
to  be  injected  to  the  more  rostral  target,  which  is  the  LPb  in  this  case 
(Akintunde and Buxton, 1992; Bice and Beal, 1997b).  
It has been concluded from previous studies in our laboratory that the injection 
of tracers into both CVLM and LPb labels almost all lamina I projection neurons. 
Ikeda  et  al.  (2006)  suggested  that  lamina  I  spino-PAG  neurons  represent  a 
distinct  population,  since  they  showed  a  functional  difference  compared  to 
lamina I neurons that projected to the LPb. Their study provided evidence for a 
difference in the type of long-term potentiation between lamina I neurons that 71 
were retrogradely labelled from the PAG and those that were labelled from the 
LPb. However, Spike et al. (2003) have shown that nearly all of the cells that 
projected to the contralateral PAG can also be labelled from contralateral LPb. 
This  suggests  that  although  spino-PAG  neurons  may  represent  a  distinct 
functional  population,  they  still  can  be  labelled  from  the  LPb.  It  was  also 
reported that axons from the SDH that travel to the PAG pass through the LPb 
(Bernard et al., 1995; Feil and Herbert, 1995). Therefore, the tracers used in 
both studies (Spike et al., 2003; Ikeda et al., 2006) would have been taken not 
only by axon terminals, but also by fibres of passage. Regarding the thalamus as 
a potential distinct projection target of lamina I neurons, Al-Khater et al. (2008) 
reported that lamina I spinothalamic tract neurons make up only ~3–5% of the 
total number of projection cells in the mid-lumbar segments of the rat. Almost 
all of these cells send axon collaterals to the LPb (Al-Khater and Todd, 2009). It 
was  also  found  that  lamina  I  neurons  can  be  labelled  following  injection  of 
tracer into the dorsal part of the caudal medulla, which is an area that includes 
the DRt and NTS (Menetrey and Basbaum, 1987; Lima, 1990; Todd et al., 2000). 
However, it was recently shown that cells labelled from the dorsal part of the 
caudal medulla are also retrogradely labelled from the LPb (Polgar et al., 2010).  
Regarding  the  percentages  of  labelled  cells,  the  present  study  showed  that 
between  83  and  88%  of  the  retrogradely labelled  lamina  I neurons  contained 
Fluorogold and CTb, indicating that they had been labelled from both LPb and 
CVLM respectively. However, Spike et al. (2003), who used similar injection and 
immunostaining protocols, reported a lower percentage of these labelled cells. 
Their  study  found  that  63–78%  of  labelled  cells  contained  both  tracers.  This 
difference is mainly due to an increase in the number of cells labelled from the 
LPb (94–95% of all retrogradely labelled cells in the present study, compared to 
81–91% in the study of Spike et al. (2003). This may be attributed to a technical 
difference between those two studies, since the method of detecting Fluorogold-
positive cells in the present study seems to be more sensitive. It involved using a 
highly  sensitive  gallium  arsenide  phosphide  photomultiplier  tube  to  detect 
Fluorogold, which was conjugated to Cy5.  
One issue in this part of the study is that some of the retrograde labelling with 
CTb that was seen resulted from uptake of the tracer by fibres passing through 
the  CVLM  before  reaching  their  targets  (Spike  et  al.,  2003).  This  might  be 72 
attributed to the fact that the CTb injections extended into the ventrolateral 
white  matter,  which  contains  many  axons  that  ascend  from  the  spinal  cord 
(Zemlan et al., 1978). However, this did not affect the overall outcome of the 
study, since the purpose of it was to label all projection neurons regardless of 
their supraspinal projection targets.  
3.4.2 NK1r-mmunoreactive neurons 
The present findings strongly support what was hypothesized by Cheunsuang and 
Morris  (2000)  that  lamina  I  NK1r-expressing  neurons  are  divided  into  two 
populations  based  on  their  soma  sizes.  The  present  study  has  identified  a 
population of large NK1r-immunoreactive neurons that are considered projection 
neurons, since virtually all (398/403, 99%) of those with soma areas >200 µm
2 
were  retrogradely  labelled.  In  contrast,  the  size  distribution  for  NK1r-
immunoreactive cells that were not retrogradely labelled indicates that these 
correspond to the population of small neurons. Neurons that were located in the 
most lateral part of lamina I were not analysed, since this part curves around 
the lateral margin of the dorsal horn leading to a different orientation of the 
neurons in this region, which makes it difficult to compare their soma sizes. 
However,  it  was  observed  that  retrogradely  labelled  lamina  I  neurons  in  this 
region  have  a  similar  appearance  to  those  elsewhere  in  the  lamina.  It  is 
therefore unlikely that the lack of data from the lateral part of lamina I affects 
the validity of this conclusion.  
Lamina  I  contains  a  very  large  number  of  the  small  NK1r-immunoreactive 
neurons, and it was not possible therefore to include all of these in the sample 
that was used for analysis. These cells also had weak immunoreactivity, which 
would have made it very time-consuming to identify them all. However, it is 
most  probably  that  the  present  study  did  not  underestimate  the  extent  of 
retrograde labelling within this group, since in all cases a search for retrogradely 
labelled cells was carried out after the sample of NK1r-immunoreactive neurons 
had been collected. Another possible explanation for the absence of retrograde 
labelling in the small cells may be the lack of time for transport of the tracers, 
since the animals were perfused three days after the tracer injection surgery. 
However,  it  was  found  (in  our  laboratory)  that  increasing  the  post-operative 
survival time does not result in any increase in the number of labelled cells or in 73 
the  appearance  of  smaller  labelled  cells  (Todd  and  Polgar,  unpublished 
observations). In addition, this absence of labelling is unlikely to be due to a 
tracer sensitivity issue, since there was a clear distinction between cells that 
were  positive  and  negative  for  CTb  and  Fluorogold.  For  the  reasons  stated 
above,  it  is  unlikely  that  the  present  study  underestimated  the  extent  of 
retrograde  labelling  in  the  small  NK1r-immunoreactive  neurons.  Although 
Cheunsuang and Morris (2000) speculated that the small NK1r-immunoreactive 
cells might be projection cells, it is very unlikely. However, the possibility that 
they  project  to  some  other  brain  region,  other  than  the  CVLM,  LPb,  PAG, 
thalamus, DRt or NTS can not be ruled out, but it is more likely that these cells 
are intrinsic spinal interneurons. 
Of the 5 large NK1r-immunoreactive cells that were not retrogradely labelled, 3 
had cell bodies >300 µm
2, and clearly these do not belong to the population of 
small neurons. Although it is possible that these cells are interneurons, it seems 
more likely that they are projection cells that were not retrogradely labelled 
from either of the injection sites used in these studies. The very low number of 
large (>200 µm
2) NK1r-immunoreactive cells that were not retrogradely labelled 
(5/403,  1%)  provides  additional  support  for  the  suggestion  that  the  two 
injections used in this study labelled the great majority of lamina I projection 
cells on the contralateral side.  
Although  the  small  NK1r-immunoreactive  cells  were  not  quantified 
systematically, these appeared to be much more numerous than the large ones. 
This  presumably  accounts  for  the  fact  that  ~45%  of  lamina  I  cells  are  NK1r-
immunoreactive (Todd et al., 1998) and that projection neurons (~80% of which 
express the NK1r) are thought to make up less than 10% of the total neuronal 
population in this lamina (Bice and Beal, 1997a, 1997b; Spike et al., 2003; Al-
Khater et al., 2008). Although these small cells outnumber the larger projection 
neurons,  more  research  has  been  done  on  projection  neurons,  and  even  the 
studies  that  investigated  lamina  I  interneurons  did  not  distinguish  the  NK1r-
positive from the NK1r-negative smaller cells.    
Little is known about the function of the small NK1r-expressing cells in lamina I. 
However,  since  NK1r-immunoreactive  cells  in  this  lamina  are  not  GABA-
immunoreactive (Littlewood et al., 1995), it is likely that they are glutamatergic 74 
excitatory interneurons. In the next part of this project, it will be shown that 
some of these cells phosphorylate ERK following noxious stimulation. Since they 
only express low levels of the NK1 receptor, it is likely that these cells would not 
have  been  destroyed  by  intrathecal  administration  of  SP-SAP,  and  this 
presumably  explains  why  there  is  no  detectable  reduction  in  the  number  of 
neurons in lamina I following this treatment (Nichols et al., 1999). Additionally, 
A recent study by Choi et al. (2012) reported that after the pretreatment of the 
rats  with  SP-SAP,  ~30%  of  the  NK1r  immunoreactivity,  determined  by  pixel 
count,  remained  in  the  SDH,  which  may  be  attributed  to  the  retained  small 
NK1r-expressing interneurons.     
An important practical outcome from the above results is that soma size can be 
used to identify putative lamina I NK1r-expressing projection neurons in studies 
that have not used retrograde tracing. Although NK1r-immunoreactive cells that 
have soma areas between 150 and 200 µm
2 cannot be classified with certainty, 
those with areas above 200  µm
2 are very likely to be projection cells, while 
those below 150 µm
2 are probably interneurons. A similar approach (without the 
need of retrograde labelling) can be used to identify the large laminae III-IV 
NK1r-immunoreactive  cells  as  projection  neurons,  since  virtually  all  of  these 
were shown to be labelled from the CVLM, with some projecting to LPb and/or 
PoT (Todd et al., 2000; Al-Khater and Todd, 2009). This approach will be used in 
the next Chapter as a means of distinguishing responses of lamina I projection 
neurons from those of interneurons to various types of noxious stimulation.    
3.4.3 Projection neurons that lack the NK1r 
The present study shows that of the 542 retrogradely labelled cells from the 
CVLM and/or LPb, 101 lacked the expression of the NK1 receptor. Although some 
of  these  cells  will  correspond  to  lamina  I  giant  cells  that  were  described 
previously, there are only ~10 cells of this type on each side in the L4 segment in 
the rat, and they therefore constitute only ~3% of lamina I projection neurons 
(Polgar et al., 2008). 
Little is known about the morphology and function of the remaining lamina I 
NK1r-negative  projection  neurons.  Although  Almarestani  et  al.  (2007)  have 
reported  that  ~90%  of  these  neurons  that  projected  to  the  LPb  were  of  the 75 
pyramidal class, with some having a 4
th dorsally-directed dendrite, the present 
study shows that this number may be over-representative. Out of the 88 lamina I 
NK1r-negative projection neurons that could be classified morphologically in the 
present study (13 cells had incomplete filling of their dendrites) only 15 (17%) 
were  classified as  pyramidal.  The  present  study  also  shows  that  from  the  15 
identified  pyramidal  cells  only  one  had  a  4
th  dendrite  that  travelled  dorsally 
towards  the  white  matter.  Almarestani  et  al.  (2009)  provided  evidence  that 
these  pyramidal  cells  can  display  novel  expression  of  the  NK1r  (and  also  an 
increase in innervation by substance P-containing primary afferents) following a 
chronic  inflammatory  stimulus.  However,  there  is  also  a  population  of  large 
pyramidal NK1r-immunoreactive neurons (Cheunsuang and Morris, 2000) that are 
included in the spinoparabrachial population (Spike et al., 2003; Almarestani et 
al., 2007; Al-Khater and Todd, 2009; Almarestani et al., 2009). It may therefore 
be difficult to distinguish pyramidal cells that are normally NK1r-negative and 
up-regulate  the  receptor  after  inflammation  from  those  that  constitutively 
express the receptor. Almarestani et al. (2009) reported that the pyramidal cells 
that normally lack NK1r are smaller than the NK1r-immunoreactive type, and 
typically have a fourth dendrite that emerges from the dorsal aspect of the soma 
and  travels  towards  the  overlying  white  matter.  However,  the  present  study 
shows that there is a considerable overlap in the distribution of soma sizes of 
NK1r-immunoreactive and non-immunoreactive pyramidal neurons, and that the 
difference  between  the  two  populations  is  not  significant.  In  addition,  the 
fourth, dorsally-directed dendrite described by Almarestani et al. (2009) is only 
observed on one of the 15 non-NK1r-immunoreactive pyramidal neurons.  
Further  experiments  are  needed  to  identify  the  function  of  the  remaining 
projection neurons that lacked the NK1 receptor in lamina I.  
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4.1 Introduction 
Superficial dorsal horn neurons respond specifically or preferentially to various 
forms of noxious stimuli. These neurons may receive a direct input from primary 
afferents  (monosynaptic),  and/or  are  indirectly  activated  through  excitatory 
interneurons (polysynaptic). Lamina I is a major termination site for Aδ- and C-
fibre primary afferents. Neurons in this lamina receive input from cutaneous, 
visceral, muscle and joint primary afferents (Cervero and Connell, 1984; Mense 
and Prabhakar, 1986). The primary afferent input to lamina II is mainly from 
unmyelinated fibres innervating cutaneous tissues as well as from Aδ hair follicle 
afferents (Light and Perl, 1979b; Shortland et al., 1989). It was also revealed 
recently that many large afferent fibre terminals enter the inner part of lamina 
II  (Woodbury  et  al.,  2000).  Much  of  the  input  to  laminae  III-IV  is  from  large 
primary  afferents  that  enter  the  cord  and  curve into  the  medial  part  of  the 
dorsal horn (Hamano et al., 1978). Cells in lamina IV have been also reported to 
receive visceral (Pomeranz et al., 1968) and joint (Schaible et al., 1986) inputs. 
In  addition,  these  cells  commonly  have  an  input  from  cutaneous  and  muscle 
receptors (Schaible et al., 1987).  
Christensen and Perl (1970) were the first to record the responses of lamina I 
neurons to noxious stimulation in the cat. The study divided lamina I neurons 
into 3 groups according to their excitatory input. Group I, which responded only 
to  intense  mechanical  stimulation  of  high  threshold  myelinated  primary 
afferents. The 2
nd group, which received afferent input from both Aδ- and C-
fibres, was activated by both intense mechanical and noxious heat stimulation. 
The  3
rd  group  responded  to  the  above  2  stimuli  as  well  as  to  innocuous 
temperature  changes.  Similar  findings  were  seen  in  the  monkey  dorsal  horn 
(Kumazawa and Perl, 1978). It was also reported that in the rat, the marginal 
zone (lamina I) contained cells that were only activated by noxious pinching or 
pin-pricking  stimuli  (Menetrey  et  al.,  1977).  Light  and  Willcockson  (1999) 
recorded in vivo from a sample of 73 neurons in laminae I-II of the lumbar spinal 
cord of the rat. Of these, 39 were classified as nociceptive, responding to heat 
and/or mechanical noxious stimuli, and these were located mainly in laminae I 
and IIo. Most cells in lamina II, in both primates and cat, were activated by hair 
movement (single brush stimulus) or innocuous mechanical stimulation, but some 78 
cells required more intense stimulation (Kumazawa and Perl, 1978; Wall et al., 
1979; Cervero and Iggo, 1980). Laminae III-IV was found to contain narrow- and 
wide-dynamic-range  cells  in  primates  and  cats.  Neurons  in  these  laminae 
responded  to  both  cutaneous  stimulation  and  joint  movements  (Wall,  1967). 
Some  of  these  neurons  responded  only  to  noxious  stimuli  (Kolmodin  and 
Skoglund, 1960), while others were activated just by mechanical stimuli such as 
hair movement, touch, pressure and pinch (Wall, 1967; Brown and Franz, 1969).    
Receptive fields of SDH neurons usually vary in shape and size, and can also be 
modifiable. Excitatory neurons’ receptive fields are often ovoid and larger than 
the receptive fields of primary afferents. The central part of these receptive 
fields is usually the most sensitive, and the application of a strong stimulus to 
the skin adjacent to an excitatory receptive field could produce inhibition (Wall, 
1960). Receptive fields often vary from 1-1000 mm
2 depending on the body part 
encoded. The smallest excitatory receptive field for lamina I neurons can be as 
small as that of a C-fibre nociceptor (<1 mm
2). In contrast, lamina I neurons with 
A-fibre nociceptive inputs have more uniform, continuous receptive fields rather 
than  spot-like  ones,  which  indicate  considerable  convergence  from  primary 
afferent  onto  the  lamina  I  neurons  (Light  and  Lee,  2009).  Further,  noxious 
mechanical stimulation of the region that surrounded an excitatory receptive 
field caused inhibitory postsynaptic potentials in the recorded neuron, and this 
inhibitory  field  faded  out  gradually  as  the  distance  from  the  excitatory  field 
increased (Light and Lee, 2009). Wall (1967) initially described a somatotopic 
organisation of the dorsal horn, with the toes being represented medially, while 
the  lateral  aspect  of  the  foot  and  more  proximal  regions  are  represented 
laterally in the dorsal horn of the cat. It was also found that the receptive fields 
of  some  dorsal  horn  neurons  are  changeable  in  primates,  cats  and  rats.  For 
instance, it was reported that noxious stimulation caused an expansion of the 
receptive fields of dorsal horn neurons, mostly of the wide-dynamic-range class, 
to both innocuous and noxious mechanical stimulation as well as to noxious heat 
(Kenshalo  et  al.,  1979,  1982;  Laird  and  Cervero,  1989;  Simone  et  al.,  1989; 
Simone et al., 1991).       
The  responses  of  dorsal  horn  projection  neurons,  which  were  identified  by 
antidromic activation from contralateral supraspinal targets, to various noxious 
stimuli have been investigated. Many studies were done on STT neurons in the 79 
cat and monkey. It has been shown that lamina I STT cells play an important role 
in  transmitting  both  nociceptive  and  thermoreceptive  information  to  the 
thalamus (Willis et al., 1974). It has also been reported that the receptive fields 
of STT cells in lamina I are generally smaller than those of STT cells in deeper 
laminae (IV-IV) (Apple Baum et al., 1975). Andrew and Craig (2002) studied the 
responses of lamina I spinothalamic neurons in the cat to various stimuli. Of the 
125 lamina I spinothalamic neurons recorded, 33 were classified as nociceptive 
specific,  43  were  considered  polymodal-nociceptive,  since  they  responded  to 
heat,  pressure  and  cold  and  the  remaining  49  neurons  were  classified  as 
thermoreceptive  specific,  responding  to  cooling  and  innocuous  warming.  As 
described  previously,  there  are  not  many  lamina  I  STT  neurons  in  the  rat, 
compared their number in the cat and monkey (Al-Khater et al., 2008). Zhang et 
al. (2006) investigated the responses of 33 lamina I STT neurons in the rat. Of 
these,  30  neurons  were  activated  by  noxious,  but  not  innocuous,  mechanical 
stimuli  applied  to  their  cutaneous  receptive  fields.  Half  of  the  17  thermally 
tested STT cells were activated by both innocuous cooling as well as noxious 
heat and cold, while the other half were nociceptive-specific. The study also 
reported  a  difference  in  the  thalamic  terminations  of  axons  of  cells  that 
responded to innocuous cooling, compared to cells that responded to noxious 
heat and cold. 
The parabrachial area, which surrounds the superior cerebellar peduncle at the 
ponto-mesencephalic junction, has been reported to be one of the major targets 
of lamina I dorsal horn neurons in primates, cats and rats (Hylden et al., 1989; 
Craig, 1995; Spike et al., 2003). Bester et al. (2000) recorded from 53 lamina I 
spinoparabrachial  neurons  in  anesthetized  rats.  Most  of  these  neurons  (75%) 
were nociceptive-specific, while the remainder responded to both noxious and 
innocuous thermal and mechanical stimulation. The majority of these neurons 
(92%) responded to two modalities of noxious stimuli (mechanical and thermal), 
and about a third of the neurons in this group also responded to noxious cold 
stimuli. Andrew (2009) also studied the responses of lamina I spinoparabrachial 
neurons  of  the  rat  to  different  stimuli.  Of  the  40  neurons  studied,  28  were 
nociceptive specific, 6 were polymodal-nociceptive, 4 were wide-dynamic-range 
neurons and 2 were thermoreceptive-specific.   80 
In addition to their responses to noxious and thermal stimuli, Andrew and Craig 
(2001) found that a class of lamina I spinothalamic neurons in the cat responded 
to  pruritic  stimulation,  since  they  were  selectively  excited  by  iontophoretic 
histamine;  an  itch  producing  agent.  However,  recent  studies  in  primates 
recorded from a group of spinothalamic neurons and reported that these were 
polymodal  with  respect  to  their  excitation  by  pruritic  and  painful  stimuli 
(Simone et al., 2004; Davidson et al., 2007).  
The  function  of  substance  P  has  been  studied  at  both  cellular  and  systemic 
levels.  Henry  et  al.  (1975)  reported  that  substance  P,  when  applied  by 
iontophoresis  into  the  vicinity  of  dorsal  horn  neurons,  led  to  a  prolonged 
excitation (lasting for several minutes) of almost half of the neurons tested in 
cats. Subsequently, Salter and Henry (1991) found that iontophoretic application 
of substance P in the cat activated most of nociceptive dorsal horn neurons, but 
not non-nociceptive ones. Substance P also led to a slow depolarisation of dorsal 
horn  neurons,  as  shown  by  intracellular  recordings  in  spinal  cord  slice 
preparation  in  the  rat  (Murase  et  al.,  1982).  The  mechanism  of  action  of 
substance P has been investigated by voltage clamp experiments on dorsal horn 
neurons  in  slice  preparations.  Substance  P’s  action  was  attributed  to  its 
augmentation  of  an  inward  Ca
2+  current  and  its  inhibition  of  the  M-current, 
which is a voltage-sensitive K
+ current, causing depolarisation accompanied by 
an increase in the membrane resistance (Murase et al., 1986). Substance P has 
also been reported to potentiate the action of glutamate on its NMDA receptor 
(Dougherty and Willis, 1991). This long lasting effect of substance P has been 
shown to play an important role in the generation of hyperalgesia and allodynia 
(Woolf, 1983; Dougherty et al., 1995).  
Intrathecal  injection of  substance  P has  been  reported  to induce  nociceptive 
behaviours  that  were  prevented  by  NK1  receptor  antagonists.  Substance  P 
increased the gain of nociceptive flexion withdrawal reflexes (Ma and Woolf, 
1995),  and  decreased  the  latency  of  paw  withdrawal  following  noxious  heat 
(Malmberg  and  Yaksh,  1992).  It  also  led  to  biting  and  scratching  behaviours, 
which  were  similar  to  those  induced  by  the  peripheral  injection  of  noxious 
chemicals (Wilcox, 1988; Bjorkman et al., 1994). NK1 receptor antagonists also 
prevented  behavioural  responses  that  were  associated  with  noxious  visceral 
stimulation and those related to the 2
nd phase of formalin injection (Garret et 81 
al., 1991; Seguin et al., 1995). This prevention of nociception-related behaviours 
was successful only if the NK1 receptor antagonist was given either before or 
during  the  process  of  stimulation.  It  is  therefore  assumed  that  substance  P-
induced activation of the NK1 receptor contributes mainly to the generation, but 
not the maintenance, of hyperalgesia.  
A  number  of  studies  focused  on  the  role  of  NK1r-expressing  neurons  in 
nociception. It was reported that following the injection of formalin into the rat 
hindpaw, the expression of the NK1 receptor gene was increased in the SDH, and 
this increase was blocked following the administration of a specific NK1 receptor 
antagonist (McCarson and Krause, 1996). It has been also shown that natural and 
electrical noxious stimulation, as well as the administration of substance P or 
NMDA  led  to  internalisation  of  the  NK1  receptor.  This  internalisation  was 
stimulus intensity-dependent, occurred within 5-10 minutes, and the receptor 
returned to the cell membrane within 1 hour (Mantyh et al., 1995; Abbadie et 
al., 1997). This NK1 receptor internalisation can be prevented by NK1 receptor 
antagonists  as  well  as  by  NMDA  antagonists,  but  not  by  AMPA  or  kainite 
antagonists (Liu et al., 1997; Marvizon et al., 1997). This therefore suggests a 
role of NMDA in controlling internalisation of the NK1 receptor, which is initiated 
by  substance  P.  Afrah  et  al.  (2001)  also  reported  that  capsaicin-induced 
substance P release (capsaicin in the perfusion fluid for 30 min, a microdialysis 
study) into the dorsal horn of the rat spinal cord was partially dependent on an 
action of NMDA receptors. Their study suggest that capsaicin may activate the 
release of glutamate from primary afferents, which in turn acts on presynaptic 
NMDA receptors located on substance P-containing primary afferents leading to 
the  release  of  substance  P.  Although  it  was  reported  that  GABAB  agonists 
reduced  the  release  of  substance  P  from  primary  afferents,  these  failed  to 
reduce  NMDA-induced  NK1  receptor  internalisation  (Marvizon  et  al.,  1999). 
Trafton et al. (1999) reported that morphine alone produced a modest decrease 
in noxious-pinch induced internalisation of the NK1 receptor in the rat, but when 
combined with an NK1 antagonist, internalisation was almost prevented. Their 
study  suggests  that  opioid  analgesia  may  involve  controlling  non-substance  P 
primary afferents. However, Kondo et al. (2005) showed that the administration 
of spinal µ- and δ-opioid agonists prevented afferent-evoked NK1 internalisation 
both  in  vivo  and  ex  vivo.  More  recently  Beaudry  et  al.  (2011)  reported  that 82 
capsaicin- and formalin-induced NK1 receptor internalisation, which can be used 
as  an  indication  of  substance  P  release,  as  well  as  fos  up-regulation  were 
inhibited by selective spinal activation of the µ- and δ-opioid receptors in the 
mice SDH.  
The involvement of NK1r-expressing neurons in nociception has been also studied 
by using markers of neuronal activity, such as fos and pERK. For instance, it was 
reported that the number of chemical- or electrical-induced dorsal horn neurons 
that up-regulated fos was significantly reduced after the pretreatment of rats 
with  selective  NK1r  antagonists  (Chapman  et  al.,  1996;  Tao  et  al.,  1997; 
Redburn and Leah, 1999). Similarly, De Felipe et al. (1998) reported that in NK1 
receptor-knock-out mice, which were injected with formalin, the number of fos-
positive neurons in the SDH was reduced by 30% compared to the wild type. Lu 
et al. (1995) also found that 2 hours after the injection of formalin into the 
urinary  bladder  of  the  rat,  fos  was  up-regulated  in  NK1r-expressing  neurons, 
which were found mainly in the medial aspects of lamina I and in the dorsal 
commissural  nucleus  and  sacral  parasympathetic  nucleus  of  the  lumbosacral 
cord. This suggests that these neurons receive nociceptive input from the urinary 
bladder  through  substance  P-containing  afferents.  Subsequently,  Seki  et  al. 
(2005) reported that instillation of capsaicin into the urinary bladder of the rat 
up-regulated fos in the SDH of the lumbosacral cord. The study also reported 
that this capsaicin-induced fos expression was reduced after the pretreatment of 
the  rats  with  SP-SAP,  indicating  an  important  role  of  the  NK1r-expressing 
neurons  in  conveying  nociceptive  afferent  information  from  the  bladder  to 
supraspinal relay centres.  
In  contrast  to  the  several  studies  that  showed  fos  up-regulation  in  NK1r-
expressing neurons after noxious stimulation, little is known about the types of 
neurons that contained pERK. For instance, Ji et al.  (2002) reported that 24 
hours after the injection of CFA into the rat hindpaw, most neurons in lamina I 
that  contained  prodynorphin  or  expressed  the  NK1  receptor  were  pERK-
immunoreactive. Ji et al. (2002) suggested that the contribution of pERK in pain 
hypersensitivity  may  be  attributed  to  activation  of  the  MAPK/ERK  pathway, 
which then regulates the expression of the NK1 receptor and prodynorphin, as 
well as other target genes. It was also reported that pERK expression in the SDH 83 
of adult rat spinal slice preparations was increased by 8 to 10 fold after C-fibres 
activation, and that this expression was decreased by blocking the NK1 receptor 
(Kawasaki et al., 2004). Choi et al. (2005) also found that intrathecal injection 
of substance P led to pERK expression in laminae I and II of the spinal cord of the 
mice.  This  expression  was  attenuated  after  the  pretreatment  with  a  MEK1/2 
inhibitor  in  a  dose  dependent  manner,  suggesting  that  ERK  plays  a  role  in 
substance P-induced nociception. Moreover, and in agreement with studies that 
reported fos up-regulation after the stimulation of the urinary bladder, Yoo and 
Hwang (2007) reported that pERK was expressed in lamina I neurons of the rat 
after  both  mechanical  (distension)  and  chemical  (mustard  oil)  noxious 
stimulation of the bladder. Their study also showed that the majority of pERK-
positive  cells  were  NK1r-immunoreactive,  and  received  contacts  from  TRPV1-
positive  primary  afferents,  suggesting  that  these  fibres  may  mediate  ERK 
phosphorylation in the SDH. 
It was described above that some of lamina I giant cells up-regulated fos after 
either formalin injection into the rat hindpaw (Puskar et al., 2001), or exposing 
it to noxious heat (Polgar et al., 2008). Laminae III-IV NK1r-expressing neurons 
also showed NK1 receptor internalisation as well as ERK phosphorylation after 
mechanical, thermal and chemical stimulation in the rat (Polgar et al., 2007). 
Polgar  et  al.  (2007)  reported  that  almost  all  laminae  III-IV  NK1r-expressing 
neurons contained pERK 5 minutes after repeated pinching of the skin of the 
hindpaw, immersion of the hindpaw in hot water or subcutaneous injection of 
formalin  into  the  hindpaw.  The  majority  of  these  cells  also  showed 
internalisation of the NK1 receptor following noxious stimulation, particularly 
following thermal and chemical stimulation. 
Work  done  in  the  previous  Chapter  showed  that  lamina  I  NK1r-expressing 
projection  neurons  can  be  distinguished  from  interneurons,  as  they  were 
generally  larger.  In  this  part,  the  responses  of  lamina  I  NK1r-expressing 
presumed projection neurons and interneurons to cutaneous, deep and visceral 
noxious stimuli were investigated, using pERK as the marker of neuronal activity. 
Responses of lamina I giant cells to cutaneous and deep noxious stimuli were 
also studied. The responses of laminae III-IV NK1r-expressing neurons to deep 
and  visceral  noxious  stimuli  were  investigated,  since  their  responses  to 
cutaneous stimulation have already been demonstrated.  84 
4.2 Experimental procedures 
The first part of the study (Chapter 3) showed that NK1r-expressing projection 
neurons in lamina I could be distinguished from interneurons based on their soma 
sizes.  Specifically,  it  showed  that  99%  of  the  cells  with  soma  cross-sectional 
areas >200 µm
2 are projection neurons, while the great majority (~95%) of those 
below  this  size  are  interneurons.  Therefore,  the  investigation  regarding 
responses of lamina I NK1r-expressing neurons to different noxious stimuli was 
carried out on rats that had not received injections of retrograde tracer, and 
soma size was used to identify NK1r-immunoreactive cells as putative projection 
neurons or interneurons.  
 
4.2.1 Animals and noxious stimulation 
Thirty adult male Wistar rats (250–280 g; Harlan, Loughborough, UK) were used 
for this part of the study. The rats were deeply anaesthetized with 10% urethane 
(1.3 g/kg ip) and the depth of anesthesia was sufficient that the animals did not 
respond  to  gentle  touching  of  the  cornea  (negative  corneal  reflex).  Body 
temperature was maintained at 38.0 ± 0.5°C with an electric blanket and was 
controlled  by  a  body  thermometer.  They  then  received  one  of  the  following 
noxious stimuli:                                                                       
(1) Pinching of folds of skin at 12 points on the left hindpaw (six each on the 
dorsal and ventral surfaces, applied with forceps for 5 s at each point; n=3).                         
(2) Injection of 25 µl of 1% capsaicin* (Sigma-Aldrich, Poole, UK) into the 
plantar surface of the left hindpaw (n=3).                                                                                    
(3) Immersion of the left hindpaw in water at 52°C for 20s (n=3) or 45s (n=3).                     
(4) Injection of 20 µl of 10% mustard oil* (95% Allyl isothiocyanate, Sigma-
Aldrich, Poole, UK) into the left knee joint (n=6), followed by flexion and 
extension of the knee joint (3-5 times).                                                                                                             
(5) Injection of 30 µl of 10% mustard oil to the left gastrocnemius muscle (n=6).               
* 1% capsaicin is made by adding 800 µl of solution A to solution B and mixing well,  
Solution A: 700 µl Tween80 added to 9.3 ml saline and stirred on a magnetic stirrer  
Solution B: 10 mg capsaicin dissolved in 200 µl ethanol  
The dissolved solution is heated for 1hr at 50°C with the lid off to evaporate the alcohol, optional. 
 
* 10% mustard oil is made by dissolving 10.5 µl of 95% Allyl isothiocyanate in 89.5 µl paraffin oil.   85 
(6) Distension of the rectum and colon (colorectal distension, CRD) with a 6-7 cm 
latex balloon at 80 mmHg for 20s (n=3), since CRD at 80 mmHg for 20s has been 
demonstrated behaviourally to be noxious (Ness et al., 1991). The balloon was 
made by connecting the finger of a surgical glove with tygon tubing, using a tight 
ligature.  The  pressure  was  monitored  and  maintained  with  a  handheld 
manometer  attached  to  the  balloon.  Three  additional  rats  were  considered 
controls as a balloon was inserted into their colon but not inflated. The rats that 
underwent visceral stimulation were fasted with unlimited access to water for 
24 hours prior to distension.    
In  each  case,  the  animals  were  maintained  under  general  anaesthesia  for  5 
minutes after the end of the stimulus, and were then perfused through the heart 
with 4% formaldehyde. The first three stimuli were considered cutaneous, while 
mustard oil into joint and muscle was a means of deep stimulation, and CRD was 
the visceral stimulus.  
4.2.2 Tissue processing and immunocytochemistry 
Thoracic, lumbar and sacral spinal segments (T13, L1-L6, S1-S2) were removed, 
post-fixed at 4°C overnight. Apart from the spinal segments from rats that were 
exposed to visceral stimulation, all other segments were notched on the right 
side, in order to distinguish it from the left (stimulated) side.          
4.2.2.1  Lamina I NK1r-expressing neurons and giant cells 
To investigate the responses of lamina I NK1r-expressing neurons and giant cells 
to various noxious stimuli, the appropriate spinal segments (Table 4-1) were cut 
into 60 µm thick horizontal sections with a Vibratome. They were then treated 
for  30  minutes  in  50%  ethanol  and  processed  immunocytochemically.  The 
sections were incubated in mouse monoclonal antibody (mAb) against gephyrin 
(mAb  7a,  1:100,000),  which  was  detected  with  a  TSA  kit  (PerkinElmer  Life 
Sciences, Boston, MA), see below. The mouse mAb 7a was combined with rabbit 
anti-NK1r  (1:10,000)  followed  by  incubation  in  mouse  monoclonal  antibody 
against  pERK  (1:1000).  Sections  were  incubated  in  species-specific  secondary 
antibodies raised in donkey and conjugated to either Cy5 or Alexa 488.  86 
The TSA method was performed by applying one primary antibody, which is the 
mAb 7a in this case, at a level that is too low to be detected with a fluorescent 
labelled  secondary  antibody,  yet  sufficient  for  detection  with  the  tyramide 
system.  This  first  primary  antibody  will  then  be  effectively  neglected  during 
application of a second primary antibody that will be detected by conventional 
fluorescently labelled secondary antibodies (Shindler and Roth, 1996). 
4.2.2.2  Laminae III-IV NK1r-expressing neurons 
To investigate the responses of laminae III-IV NK1r-expressing neurons to various 
noxious stimuli, deep horizontal 60 µm thick sections as well as parasagittal 60 
µm thick sections from the left side of the appropriate segments (Table 4-1) 
were treated with 50% ethanol for 30 minutes. The sections were then incubated 
for 72 hours in a mixture of primary antibodies: rabbit anti-NK1r (1:10,000) and 
mouse monoclonal antibody against pERK (1:1000). Sections were incubated for 
24  hours  in  species-specific  secondary  antibodies  conjugated  to  either 
Rhodamine Red or Alexa 488.  
For reactions that did not involve TSA, antibodies were diluted in PBS containing 
0.3 M NaCl and 0.3% Triton® X-100. For those involving TSA, antibodies were 
diluted  in  PBS  that  contained  0.15  M  NaCl,  together  with  a  blocking  serum, 
which was supplied by the manufacturer. Sections were mounted in anti-fade 
medium and stored at -20°C.The primary antibodies that were used in this part 
of the study, and their characterisations are described in Chapter 2. 
4.2.3 Confocal microscopy and analysis 
4.2.3.1  Lamina I NK1r-expressing projection neurons and interneurons 
To investigate the responses of lamina I NK1r-expressing projection neurons and 
interneurons to noxious cutaneous, deep and visceral stimuli, horizontal sections 
from the ipsilateral side of the appropriate segments were analysed. Sections 
were initially scanned through the confocal microscope (Bio-Rad Radiance 2100) 
at 20× objective lens, and the regions of lamina I that contained numerous pERK-
immunoreactive cells were identified.  87 
These regions were then scanned through a 40× oil-immersion lens to produce 
overlapping fields of image stacks, with a z-separation of 2 µm. Confocal image 
stacks were were analysed with Neurolucida for Confocal software. A sample of 
NK1r-immunoreactive cells was selected, and the outlines of their cell bodies 
and  proximal  dendrites  were  drawn  by  examining  all  of  the  optical  sections 
through each cell. For each of the selected cells, cross-sectional area of its cell 
body was measured and its morphology was assessed. When all of the selected 
cells  in  a  field  had  been  analysed,  the  files  containing  pERK-immunostaining 
were then viewed and the presence or absence of pERK in each of the selected 
cells  was  determined.  Based  on  the  results  from  Chapter  3,  NK1r-
immunoreactive lamina I neurons with soma areas >200 µm
2 were assumed to be 
projection cells, and those with somata <200 µm
2 were putative interneurons. 
4.2.3.2  Lamina I giant cells 
To investigate the responses of lamina I giant cells to noxious cutaneous and 
deep  stimuli,  horizontal  sections  from  the  ipsilateral  side  of  the  appropriate 
segments  were  analysed.  Initially,  the  region  of  lamina  I  that  contained 
numerous pERK-positive cells was determined using 20× objective lens, and then 
all of the giant cells that were present within this region were identified by the 
presence of numerous gephyrin puncta on their cell bodies and dendrites. These 
cells were then scanned through a 40× lens to reveal gephyrin, NK1r, and pERK 
immunoreactivity. They were also examined for their NK1 receptor expression. 
The presence or absence of pERK immunoreactivity in the selected cells was 
determined.  
4.2.3.3  Laminae III-IV NK1r-expressing neurons 
To investigate the responses of laminae III-IV NK1r-expressing neurons to noxious 
deep and visceral stimuli, parasagittal and deep horizontal sections from the 
ipsilateral side of the appropriate segments were analysed.  
Parasagittal sections were initially scanned through a 10× lens to reveal pERK-
immunoreactivity  and  the  sections  from  each  animal  that  showed  maximal 
staining  in  the  superficial  laminae  were  selected  for  further analysis.  At  this 
magnification it was possible to identify the band of pERK-immunoreactivity in 88 
the  superficial  dorsal  horn,  but  individual  pERK-positive  neurons  in  deeper 
laminae were not well seen. This was not applicable for the deep horizontal 
sections  from  the  rats  that  had  received  noxious  visceral  stimulation,  since 
lamina  I  was  absent  in  these  sections.  However,  unlike  joint  and  muscle 
stimulation, CRD produced diffuse, bilateral pERK immunoreactivity in lamina I. 
It is therefore unlikely to select deep horizontal sections from an area that had 
minimal pERK immuoreactivity in lamina I.  
Selected sections were then examined through a 20× lens and all of the NK1r-
immunoreactive neurons with cell bodies in laminae III or IV and dendrites that 
could be traced dorsally into superficial laminae (either in the same section or 
by  following  the  dendrites  through  serial  sections)  were  identified.  Care  was 
taken to avoid double-counting neurons with cell bodies that appeared on two 
adjacent sections. For all of the selected cells, the presence or absence of pERK 
staining in the soma and dendrites was recorded. In this way, the proportion of 
laminae  III-IV  NK1r-immunoreactive  cells  in  each  animal  that  showed  pERK-
immunostaining was determined.  8
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4.3 Results 
4.3.1 pERK in lamina I NK1r-expressing neurons 
After the application of cutaneous and deep noxious stimuli, numerous pERK-
positive cells were seen in lamina I, in the medial part of the dorsal horn on the 
left side (ipsilateral to the stimulus) in the lumbar cord, while very few were 
present on the contralateral side. Following CRD, pERK-positive cells were seen 
in both sides of lamina I of the lumbosacral spinal cord. Table 4-1 shows the 
appropriate spinal segments that were analysed in regard to the stimuli applied.  
 
Most of the NK1r-immunoreactive cells with soma cross-sectional areas >200 µm
2 
were pERK-positive following the pinch stimulus. When data from the three rats 
were pooled, pERK was found in 68% (228 out of 335 cells) of the NK1r-positive 
cells >200 µm
2, and only 28% (109/393) of the cells that were smaller than 200 
µm
2  were  pERK-positive.  In  the  three  rats  that  had  received  the  capsaicin 
injection, 81% (229/283) of NK1r-positive cells with cell bodies >200 µm
2, and 
39% (135/344) of those with somata <200 µm
2 contained pERK. In rats that were 
stimulated with noxious heat (immersion of the hindpaw in 52°C for 20s), almost 
all  (97%,  289/299)  of  the  NK1r-immunoreactive  cells  >200  µm
2  were  pERK-
positive, as were 72% (236/327) of the cells <200 µm
2. After injection of mustard 
oil  into  the  joints  and  muscles,  77%  (61/79)  and  74%  (75/101)  of  the  NK1r-
immunoreactive  cells  with  soma  cross-sectional  areas  >200  µm
2  were  pERK-
positive, respectively. However, only 34% (28/83) and 33% (30/82) of the smaller 
cells, <200 µm
2, were pERK-positive following deep noxious stimulation of the 
joints and muscles, respectively. Following CRD, but not tubal insertion, pERK 
was found in 75% (80/106) of the large NK1r-positive cells (>200 µm
2) while only 
16% (29/180) of the NK1r-immunoreactive cells <200 µm
2 phosphorylated ERK. 
Chi-square  tests  revealed  that  the  expression  of  pERK  differed  significantly 
between cells with somata >200 µm
2 and cells smaller than 200 µm
2 following all 
6  noxious  stimuli  (P<0.05).  Figure  4-1  shows  the  percentages  of  pERK
+  NK1r-
immunoreactive small and large neurons after the exposure to different types of 
noxious stimuli. 
 91 
There was no significant difference in the frequency of pERK expression between 
the three morphological classes (fusiform, multipolar and pyramidal) of lamina I 
NK1r-presumed  projection  neurons  after  the  exposure  to  different  types  of 
noxious stimuli (P>0.05, Chi-square tests, Table 4-2).  
 
After each type of noxious stimulation, many of the NK1r-immunoreactive cells 
showed extensive internalisation of the receptor, which gave rise to numerous 
endosomes in their cells bodies and dendrites, and the great majority of these 
cells were pERK-positive. In some cases, NK1r-expressing neurons that did not 
appear to have significant internalisation showed pERK immunoreactivity, and 
most of these were presumed to be interneurons (soma size <200 µm
2). In rare 
occasions, NK1r-expressing cells that showed clear signs of internalisation did 
not appear to be pERK-immunoreactive. Examples of pERK and lamina I NK1r-
immunostaining are shown in Figures 4-2 and 4-3. 
 
4.3.2 pERK in lamina I giant cells  
After application of cutaneous and deep noxious stimuli, a clear band of pERK-
positive cells was observed in the medial part of lamina I on the ipsilateral sides 
of the appropriate segments (Table 4-1). Giant cells lateral to this band were 
also often pERK-immunoreactive, suggesting that they may have large receptive 
fields. For this reason, in addition to the fact that these cells are scarce, all 
giant cells identified were included in the analysis.  
In the rats that had received the pinch stimulus, the percentages of giant cells 
that were pERK-positive varied from 80 to 92% (mean of 85%). After the injection 
of capsaicin, the mean percentage of giant cells that contained pERK was 84% 
(77-88%). Noxious heat (immersion of the hindpaw in 52°C for 45s) led to the 
phosphorylation of ERK in 74% of the giant cells (67-88%). After the injection of 
mustard oil into the knee joint, 44% of the giant cells were pERK-positive (33-
60%) and only 13% contained pERK after the injection of mustard oil into the 
gastrocnemius  muscle  (0-33%).  Table  4-3  shows  the  proportions  of  giant  cells 
that  expressed  pERK  after  the  exposure  to  the  different  noxious  stimuli. 
Examples pERK-positive giant cells are shown in Figures 4-4, 4-5 and 4-6. The 
intensity  of  pERK-immunostaining  in  the  giant  cells  varied  but  mostly  was 
moderately strong. 92 
 
4.3.3 pERK in laminae III-IV NK1r-expressing neurons 
The  number  of  large  laminae  III-IV  NK1r-immunoreactive  cells  that  were 
identified in parasagittal sections from the ipsilateral side of the appropriate 
segments (Table 4-1) in each of the 6 rats that received mustard oil injections 
into their joints and muscles varied from 6 to 15. In each of the 3 rats that 
underwent CRD, the number of large laminae III-IV NK1r-expressing neurons that 
were identified in deep horizontal sections (both sides) of the lumbosacral cord 
varied  from  38  to  41.  The  dorsal  dendrites  of  all  identified  cells  could  be 
followed to at least as far as lamina II.  
After the injection of mustard oil into the left knee joint, 8 of the 35 large 
laminae III-IV NK1r-expressing neurons identified contained pERK (mean of 23%). 
Following the injection of mustard oil into the left gastrocnemius muscle, 8 of 
the 27 identified large NK1r-expressing cells in laminae III-IV were pERK-positive 
(mean of 30%). Of the 118 large laminae III-IV NK1r-expressing neurons identified 
in the 3 rats that underwent CRD, but not tubal insertion, only 13 were pERK-
immunoreactive (mean of 11%). Table 4-4 shows the proportions of pERK-positive 
laminae  III-IV  NK1r-expressing  cells  after  the  exposure  to  deep  and  visceral 
noxious stimuli. Figure 4-7 shows 2 pERK-positive laminae III-IV NK1r-expressing 
cells after the injection of mustard oil into the knee joint. Figure 4-8 shows a 
laminae III-IV NK1r-expressing cell that did not contain pERK after the injection 
of mustard oil into the knee joint.  
The intensity of pERK-immunostaining in these cells varied from very weak to 
moderately strong. In most of the pERK-positive laminae III-IV NK1r-expressing 
neurons, pERK-immunoreactivity was detected in both cell body and dendrites. 
However,  in  few  of  these  cells,  pERK  staining  was  seen  clearly  only  in  their 
dorsal  dendrites.  pERK  staining  was  often  considerably  stronger  in  the  distal 
parts of the dorsal dendrites compared to the cell bodies of these neurons.  
Most of the laminae III-IV NK1r-expressing neurons showed internalisation of the 
NK1 receptor, mainly of their dorsal dendrites. However, pERK-immunoreactivity 
was not restricted to dendrites that showed internalisation. 
 93 
 
 
 
 
 
Figure 4-1 Histogram showing the percentages of pERK
+ NK1r-expressing 
small and large cells in lamina I after noxious stimulation. 
The histogram shows the percentages of pERK
+ NK1r-immunoreactive cells that 
had soma cross-sectional areas <200 µm
2 and those that had somata >200 µm
2 in 
lamina I following various noxious stimuli. 
The  percentages  of  pERK
+  NK1r-immunoreactive  presumed  projection  neurons 
were significantly higher than those of pERK
+ NK1r-immunoreactive interneurons 
following noxious cutaneous, deep and visceral stimuli (*P<0.05, **P<0.001, Chi-
square tests). In each case, the y-axis represents the total percentage of pERK
+ 
NK1r-immunoreactive cells from the three experiments, and the upper and lower 
error bars show the higher and lower percentages after pooling the results from 
the three animals. 
 
 
 
 
 94 
 9
5
 
 
T
a
b
l
e
 
4
-
2
 
P
r
o
p
o
r
t
i
o
n
s
 
o
f
 
p
E
R
K
+
 
N
K
1
r
-
e
x
p
r
e
s
s
i
n
g
 
p
r
o
j
e
c
t
i
o
n
 
n
e
u
r
o
n
s
 
o
f
 
v
a
r
i
o
u
s
 
m
o
r
p
h
o
l
o
g
i
c
a
l
 
c
l
a
s
s
e
s
 
a
f
t
e
r
 
n
o
x
i
o
u
s
 
s
t
i
m
u
l
a
t
i
o
n
 
S
t
i
m
u
l
u
s
 
P
r
o
p
o
r
t
i
o
n
s
 
(
p
e
r
c
e
n
t
a
g
e
s
 
%
)
 
 
 
 
P
 
v
a
l
u
e
 
 
F
u
s
i
f
o
r
m
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
M
u
l
t
i
p
o
l
a
r
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
P
y
r
a
m
i
d
a
l
 
 
P
i
n
c
h
 
(
n
=
3
)
 
5
9
/
9
5
 
(
6
2
)
 
8
9
/
1
3
1
 
(
6
8
)
 
6
0
/
8
6
 
(
7
0
)
 
P
=
0
.
8
7
3
 
C
a
p
s
a
i
c
i
n
 
(
n
=
3
)
 
9
0
/
1
1
9
 
(
7
6
)
 
8
3
/
9
7
 
(
8
6
)
 
5
0
/
6
0
 
(
8
3
)
 
P
=
0
.
8
1
8
 
H
e
a
t
 
(
n
=
3
)
 
1
0
1
/
1
0
6
 
(
9
5
)
 
1
0
0
/
1
0
3
 
(
9
7
)
 
6
5
/
6
7
 
(
9
7
)
 
P
=
0
.
9
9
5
 
J
o
i
n
t
 
(
n
=
3
)
 
2
9
/
4
0
 
(
7
3
)
 
2
0
/
2
9
 
(
6
9
)
 
1
0
/
1
6
 
(
6
3
)
 
P
=
0
.
9
5
1
 
M
u
s
c
l
e
 
(
n
=
3
)
 
3
0
/
4
2
 
(
7
1
)
 
2
8
/
3
0
 
(
9
3
)
 
1
7
/
2
7
 
(
6
3
)
 
P
=
0
.
5
9
1
 
C
R
D
 
(
n
=
3
)
 
3
9
/
4
5
 
(
8
7
)
 
1
8
/
2
8
 
(
6
4
)
 
1
5
/
2
5
 
(
6
0
)
 
P
=
0
.
5
6
2
 
I
n
 
e
a
c
h
 
c
a
s
e
,
 
p
r
o
p
o
r
t
i
o
n
s
 
f
r
o
m
 
t
h
e
 
3
 
a
n
i
m
a
l
s
 
a
r
e
 
s
h
o
w
n
,
 
w
i
t
h
 
p
e
r
c
e
n
t
a
g
e
s
 
i
n
 
b
r
a
c
k
e
t
s
.
 
T
h
e
 
t
a
b
l
e
 
a
l
s
o
 
s
h
o
w
s
 
n
o
 
s
i
g
n
i
f
i
c
a
n
t
 
d
i
f
f
e
r
e
n
c
e
 
b
e
t
w
e
e
n
 
t
h
e
 
p
e
r
c
e
n
t
a
g
e
s
 
o
f
 
p
E
R
K
+
 
N
K
1
r
-
e
x
p
r
e
s
s
i
n
g
 
p
r
o
j
e
c
t
i
o
n
 
n
e
u
r
o
n
s
 
o
f
 
t
h
e
 
3
 
m
o
r
p
h
o
l
o
g
i
c
a
l
 
c
l
a
s
s
e
s
 
i
n
 
l
a
m
i
n
a
 
I
 
a
f
t
e
r
 
t
h
e
 
e
x
p
o
s
u
r
e
 
t
o
 
c
u
t
a
n
e
o
u
s
,
 
d
e
e
p
 
a
n
d
 
v
i
s
c
e
r
a
l
 
s
t
i
m
u
l
i
 
(
P
>
0
.
0
5
,
 
C
h
i
-
s
q
u
a
r
e
 
t
e
s
t
s
)
.
 96 
 
 
 
 
 
 
Figure 4-2 Examples of pERK-immunoreactivity in lamina I NK1r-expressing 
cells following noxious pinch.  
This Figure shows a projected confocal image stack from a horizontal section 
through the ipsilateral side of the L5 segment. Two large NK1r–immunoreactive 
cells  with  somata  >200  µm
2  cross-sectional  area  are  marked  with  asterisks. 
These  two  cells  were  positive  for  pERK  and  showed  internalisation  of  the 
receptor.    Five  small  NK1r–immunoreactive  cells  with  somata  <200  µm
2  are 
marked with arrowheads, and these were not immunoreactive for pERK. Images 
are projections of 2 optical sections at 2 µm z-spacing. Scale bar=20 µm. 
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Figure 4-7 Examples of pERK-immunoreactivity in lamina III NK1r-expressing 
cells after the injection of mustard oil into the knee joint.  
This figure shows a projected confocal image stack from a parasagittal section 
through the ipsilateral side of the L2 segment. It shows 2 large lamina III NK1r-
immunoreactive  neurons  that  are  also  weakly  pERK-positive.  The  Image  is  a 
projection of 12 optical sections at 2 µm z-spacing. Scale bar=20 µm. 
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Figure 4-8 Example of the lack of pERK-immunoreactivity in a lamina III NK1r-
expressing cell after the injection of mustard oil into the knee joint.             
This figure shows a projected confocal image stack of 15 optical parasagittal 
sections at 2  µm z-spacing through the ipsilateral side of the L2  segment. It 
shows a large lamina III NK1r-immunoreactive cell that is negative for pERK. The 
inset shows a more limited projection of 5 optical sections through a lamina I 
NK1r-expressing cells that is pERK-positive. Scale bar=25 µm. 
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4.4 Discussion 
Several  studies  have  used  immunocytochemistry  or  electrophysiology  to 
investigate  the  responses  of  dorsal  horn  neurons  to  various  noxious  stimuli. 
However, few of these studies attempted to identify the specific population of 
neurons that responded to these noxious stimuli. This part of the project shows 
that a proportion of lamina I NK1r-expressing neurons, both putative projection 
neurons  and  interneurons,  phosphorylated  ERK  within  5  minutes  of  noxious 
cutaneous,  deep  and  visceral  stimulation.  The  study  also  reports  that  the 
responses  of  different  morphological  classes  of  lamina  I  NK1r-expressing 
projection  neurons  did  not  differ  significantly  following  noxious  stimulation. 
These projection cells were more likely to phosphorylate ERK than the presumed 
NK1r-expressing interneurons after the exposure to noxious stimuli. Additionally, 
following noxious deep and visceral stimulation, few of the large laminae III-IV 
NK1r-expressing projection neurons contained pERK. Regarding the giant cells, a 
varying  proportion  of  them  developed  pERK-immunorectivity  after  noxious 
cutaneous and deep stimulation. 
4.4.1 pERK as a marker of neuronal activity  
As described previously, stimuli of different nature have been used to induce the 
phosphorylation of ERK in the spinal cord, and to further study the causes and 
effects of this activation. pERK expression in the SDH was first studied by Ji et 
al. (1999) after the exposure of the rat to different noxious stimuli (thermal, 
mechanical, chemical and electrical). Ji et al. (1999) tested the time course of 
capsaicin-induced ERK phosphorylation, and for how  long this phosphorylation 
lasted. The study reported that ERK was initially activated at 1 minute after 
stimulation  and  this  activation  peaked  at  2  minutes,  was  maintained  for  5 
minutes, but decreased at 10 minutes, and finally reached its basal level at 2 
hours. The study also showed that pERK induction is intensity dependent, since 
the number of pERK expressing neurons increased as the noxious temperature 
increased  from  45  to  55°C.  Fukui  et  al.  (2007)  reported  that  electrically 
stimulating C-fibres at different frequencies induced pERK expression in the SDH 
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In this part of the project, and based on the findings of Ji et al. (1999) as well as 
on  the  findings  from  our  laboratory  (Polgar  et  al.,  2007),  the  animals  were 
perfused 5 minutes after the exposure to noxious stimulation. The short time 
course of ERK phosphorylation, compared to that of fos up-regulation, is one of 
the  advantages  of  using  pERK  as  the  marker  of  neuronal  activity.  The  time 
course of fos up-regulation after noxious stimulation was studied by Herdegen et 
al. (1991). Their study investigated the expression of different proto-oncogene 
proteins, including fos, after electrically stimulating the sciatic nerve of the rat 
at  Aδ/C-fibre  intensity.  Fos  expression  reached  its  maximal  level  in  both 
superficial and deep spinal dorsal horn 1 hour after the electrical stimulus. Fos 
immunoreactivity  decreased  to  basal  levels  between  8  and  16  hours  after 
applying  the  stimulus,  with  its  expression  persisting  longer  in  the  deeper 
laminae. Another technical reason, for preferring pERK over fos, is that pERK 
immunoreactivity occurs in the cell bodies and dendrites of the cells, while fos is 
up-regulated  in  the  nucleus  only.  The  cellular  morphology  of  pERK-positive 
neurons can therefore be easily identified.  
4.4.1.1  Spinal ERK phosphorylation following noxious stimulation  
Several  studies  have  reported  the  effect  of  various  types  of  noxious  stimuli 
(cutaneous, deep and visceral) on spinal ERK activation. Ji et al. (1999) were the 
first to show that phosphorylation of ERK in the spinal cord is stimulus-specific 
and is also activity-dependent. ERK was activated by noxious cutaneous stimuli 
as well as by electrical stimulation of primary afferents at the C- and Aδ-fibre 
range, but not after Aβ-fibre stimulation. The study reported that 2 minutes 
after the application of an intense punctate mechanical stimulus to the hindpaw 
of the rat, pERK was expressed in the SDH. The injection of either capsaicin or 
formalin  into  the  hindpaw  of  anesthetised  or  awake  rats  respectively,  also 
induced pERK mainly in the medial half of laminae I and IIo of the L4-L5 spinal 
segments. In addition, Ji et al. (1999) examined the effect of noxious heat on 
pERK expression in the SDH, and reported that ERK phosphorylation was stimulus 
intensity  dependent,  since  it  varied  with  the  water  bath  temperature.  Few 
pERK-immunoreactive  cells  appeared  at  the  threshold  of  activating  heat-
sensitive  nociceptors  (45°C),  and  the  number  increased  with  increasing 
temperature from 48°C to 55°C. This pERK expression was only partially inhibited 
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through  the  action  of  glutamate  on  non-NMDA  (AMPA,  mGlu)  glutamate 
receptors,  or  through  the  action  of  neuropeptides  or  growth  factors  such  as 
substance  P,  CGRP  or  BDNF.  Galan  et  al.  (2002)  showed  that  intraplantar 
injection of carrageenan into both hindpaws of the rat evoked a peak five-fold 
activation of ERK in the SDH of the lumbar spinal cord at 30 minutes, compared 
to  saline  injection,  which  resulted  in  a  two-fold  activation.  Saline-treated 
animals showed a higher level of ERK activation compared to control animals, 
suggesting that the process of injection itself may be sufficient to activate ERK.  
The  involvement  of  the  MAPK/ERK  cascade  in  central  (spinal  cord)  and 
peripheral  (DRG)  processing  of  chronic  inflammatory  articular  pain  has  been 
reported (Cruz et al., 2005; Seino et al., 2006). The above studies showed that 
passive movement of the inflamed ankle or knee joints (induced by the injection 
of CFA) of anesthetized rats increased pERK-immunoreactivity in both superficial 
and  deep  dorsal  horn  of  the  L3-L5  spinal  segments,  as  well  as  in  the  DRG. 
Additionally, intrathecal and intra-articular injection of a MEK inhibitor reduced 
the joint movement-induced pain behaviour in monoarthritic rats, and decreased 
pERK labelling in the DRG neurons. This suggests that ERK phosphorylation in the 
spinal  cord  or  in  the  DRG  may  play  a  role  in  decreasing  mechanical  pain 
threshold.  Recently,  Tsujimura  et  al.  (2011)  reported  that  the  MAPK/ERK 
cascade was activated following noxious muscle stimulation in the rat. It was 
shown that following the injection of capsaicin into the muscles of mastication, 
a large number of pERK-positive cells were seen in the SDH of the upper cervical 
cord.  The  study  also  showed  a  significant  reduction  in  the  number  of  pERK-
positive  cells  following  the  intrathecal  administration  of  a  MEK1/2  inhibitor, 
further supporting the involvement of this cascade in muscle pain.   
Regarding visceral pain, Zhang et al. (2009) reported that noxious CRD evoked 
pERK expression in the SDH of the lumbosacral cord of rats. This suggests the 
involvement of ERK in CRD-induced neuronal responses in the spinal cord. Lai et 
al. (2011) also studied the effects of noxious distention of the urinary bladder of 
anaesthetized mice with or without a 10-day treatment with cyclophosphamide 
to  pre-sensitize  the  bladder.  The  study  reported  that  after  distending  the 
bladder, pERK was expressed in both superficial and deep laminae of the L6-S1 
cord, and this expression was more profound in the cyclophosphamide-treated 
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bladder pain, suggesting that ERK activation may contribute to the development 
of inflammatory bladder painful conditions. 
4.4.2 Lamina I NK1r-expressing projection neurons 
The present study shows that following noxious cutaneous mechanical, chemical, 
or  thermal  stimulation,  the  majority  of  lamina  I  NK1r-expressing  presumed 
projection neurons (with somata >200 µm
2) phosphorylated ERK. It also shows 
that after the injection of mustard oil into the knee joint or the gastrocnemius 
muscle,  as  well  as  after  noxious  visceral  stimulation,  three-quarter  of  these 
presumed projection neurons contained pERK. Noxious CRD, compared to tubal 
insertion  without  inflation,  led  to  a  large  number  of  bilateral  pERK-
immunostaining in the SDH of the lumbosacral cord mainly, with some labelling 
in the thoracolumbar area. 
4.4.2.1  Input to lamina I NK1r-expressing neurons 
Lamina  I  NK1r-expressing  projection  neurons  represent  80%  of  the  projection 
neurons in this lamina (Todd et al., 2000; Spike et al., 2003; Al-Khater et al., 
2008). These NK1r-expressing projection neurons receive selective monosynaptic 
input from substance P-containing primary afferents (Todd et al., 2002). They 
also  receive  glutamatergic  input  (Todd,  2010),  presumably  from  Aδ  primary 
afferents (Andrew, 2010), as well as from lamina II vertical interneurons (Lu and 
Perl, 2005). Uta et al. (2010) showed that these vertical interneurons receive 
peripheral  inputs  from  TRPA1-expressing  C-fibres,  which  can  be  activated  by 
formalin  (McNamara  et  al.,  2007),  and  from  C-fibres  that  express  TRPV1,  on 
which capsaicin acts (Pingle et al., 2007). Labrakakis and MacDermott (2003) 
used fluorescence-conjugated substance P to label NK1r-expressing neurons in 
lamina  I  of  the  rat  spinal  cord  in  a  slice  preparation.  They  reported  that 
capsaicin increased the frequency of excitatory postsynaptic currents in 73% of 
these  neurons,  suggesting  that  these  cells  also  receive  a  direct  input  from 
capsaicin and heat sensitive nociceptors. Consistent with the above finding, the 
present study shows that 81% of lamina I NK1-expressing neurons contained pERK 
after the injection of capsaicin. Torsney and MacDermott (2006) also reported 
that lamina I NK1r-expressing neurons receive monosynaptic input mainly from 
high-threshold C- (52%) and Aδ- (29%) fibres.  116 
4.4.2.2  Responses of lamina I projection neurons to noxious stimuli; 
electrophysiological studies 
It has been shown in electrophysiological studies that many lamina I projection 
neurons in the rat responded to one or more noxious stimuli. These studies did 
not distinguish between neurons that expressed the  NK1 receptor from those 
that did not. However, since the NK1 receptor is expressed on 80% of lamina I 
projection neurons, the majority of neurons in these studies would presumably 
have been NK1r-positive. As described previously, Bester et al. (2000) showed 
that  almost  all  of  the  spinoparabrachial  neurons  were  activated  by  noxious 
stimuli; of these 75% were nociceptive specific (responding only to stimuli of the 
noxious  range).  The  study  also  showed  that  92%  of  these  projection  neurons 
responded  to  both  noxious  thermal  and  mechanical  stimuli.  Further,  Andrew 
(2009)  showed  that  70%  of  the  spinoparabrachial  neurons  were  activated  by 
noxious thermal and/or mechanical stimulation (nociceptive specific). Zhang et 
al. (2006) also reported that almost all lamina I STT neurons were activated by 
noxious mechanical stimuli, and half of those neurons that were activated by 
thermal stimulation were nociceptive specific (activated only by noxious heat). 
Consistent with the above findings of physiological studies, which suggested that 
almost  all  STT  and  spinoparabrachial  neurons  were  excited  by  noxious 
mechanical  and/or  thermal  stimuli,  the  present  study  shows  that  ERK  was 
phosphorylated in almost all NK1r-expressing projection neurons after noxious 
heat,  and  in  the  majority  of  these cells  following  noxious  pinch  or  capsaicin 
injection.  This  higher  proportion  of  cells  that  responded  to  noxious  heat, 
compared to the other noxious modalities, may be attributed to the fact that in 
case  of  thermal  stimulation,  the  whole  hindpaw  is  immersed  in  hot  water 
covering a larger skin area. In contrast, pinching is a punctate stimulus that is 
not  applied  to  the  entire  hindpaw  and  therefore,  cells  with  receptive  fields 
outside this area would not be activated.  
The present study shows the responses of NK1r-expressing neurons to individual 
noxious stimuli, and therefore avoids the phenomenon of sensitisation, by which 
one stimulus may affect the neuronal responses to a 2
nd stimulus (Campbell and 
Meyer, 1983). It also shows that the majority of the NK1r-expressing projection 
cells are heat or capsaicin or pinch activated, therefore, they are presumed to 
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4.4.2.3  Responses of lamina I NK1r-expressing neurons to noxious stimuli; 
activation of fos and ERK  
Doyle and Hunt (1999) studied the effects of noxious stimuli on fos expression, 
specifically in NK1r-immunorective neurons in both superficial (laminae I, III-IV) 
and deep (laminae V-X) dorsal horn of the rat. It was found that in the SDH, but 
not in deeper laminae, the number of fos
+ NK1r-expressing neurons positively 
correlated  with  the  intensity  of  the  noxious  stimulus.  Their  study  therefore 
suggests  the  involvement  of  laminae  I  and  III-IV  NK1r-expressing  neurons  in 
intensity  discriminative  aspects  of  pain.  Regarding  lamina  I  NK1r-expressing 
neurons,  their  study  showed  that  70-80%  of  these  neurons  up-regulated  fos 
following  topical  application  of  mustard  oil  onto  the  hindpaw,  injection  of 
formalin and immersion of the hindpaw in water at 52°C for 10s. Results from 
the  present  study  show  that  almost  all  lamina  I  NK1r-expressing  projection 
neurons  activated  ERK  following  noxious  heat  (immersion  of  the  hindpaw  in 
water at 52°C for 20s). The higher proportion of pERK
+ NK1r-expressing neurons 
following noxious heat in this study, compared to the proportion of fos
+ NK1r-
expressing cells seen by Doyle and Hunt (1999), may be attributed to more than 
one reason. First of all, Doyle and Hunt (1999) did not distinguish between the 
responses of small and large NK1r-expressing neurons, therefore their sample 
could have included a proportion of small NK1r-expressing cells that did not up-
regulate fos. The number of fos
+ large NK1r-expressing (projection) neurons may 
be therefore underestimated. Secondly, in the present study, a longer duration 
of the stimulus was used: 20s compared to 10s, and Ji et al. (1999) reported that 
pERK expression is intensity-dependent. It has also been found that the number 
of lamina I NK1r-expressing neurons that internalized the receptor, as well as 
the number of endosomes within each NK1r-expressing neuron, was increased as 
the intensity of noxious heat  increased (from 43 to 55°C) (Allen et al., 1997). 
Although Todd et al. (2005) used a similar method to what has been used in the 
present study (immersion of the rat hindpaw in water at 52°C for 20s), 57-69% of 
lamina I spinoparabrachial NK1r-expressing neurons up-regulated fos, compared 
to 97% pERK
+ NK1-expressing neurons in the present study. The overall higher 
number  of  NK1r-expressing  neurons  that  responded  to  noxious  heat  in  the 
present study, compared to Doyle and Hunt (1999) and Todd et al. (2005) studies 
may be attributed to the difference in the markers  of neuronal activity that 
were  used  in  these  studies;  fos  versus  pERK.  It  therefore  seems  that  ERK 118 
phosphorylation  is  more  sensitive,  at  least  in  detecting  the  activity  of  NK1r-
expressing  neurons  after  noxious  heat.  The  present  study  also  shows  that 
following noxious pinch and capsaicin injection, 68 and 81% of lamina I NK1r-
expressing projection neurons contained pERK, respectively. In support of the 
above finding, Mantyh et al. (1995) found that 5 minutes after the exposure of 
rats to similar noxious mechanical and chemical stimuli, 67-70% of lamina I NK1r-
expressing cells internalised the NK1 receptor.  
Doyle and Hunt (1999) also reported that after the injection of mustard oil into 
either the gastrocnemius muscle or the knee joint, 20% or 45% of lamina I NK1r-
expressing neurons up-regulated fos, respectively. The present study shows that 
~75% of the large cells contained pERK after noxious deep stimulation, which 
was of similar quantity and quality to what was used by Doyle and Hunt (1999). 
However, for the reasons described above, the comparison between the present 
study and that of Doyle and Hunt (1999) in regard to the responses of lamina I 
NK1r-expressing neurons to noxious stimuli is not straightforward, because of the 
many variables between the two studies. In support of the present study, it has 
been  reported  that  the  gastrocnemius  muscle  afferents  [mostly  of  the 
unmyelinated  class,  (Langford,  1983)]  distribute  collaterals  to  lamina  I  and 
deeper laminae (IV-IV) in cats and rats (Cervero et al., 1976; McMahon and Wall, 
1985; Mense and Craig, 1988). It was also reported that 50% of the gastrocnemius 
muscle afferents in the L5 DRG contained substance P in the rat, suggesting the 
importance of the NK1 receptor in muscle pain transmission (Perry and Lawson, 
1998). Further, Craig and Kniffki (1985) recorded from lamina I STT neurons in 
the cat and reported that some of these neurons responded either specifically to 
deep  noxious  stimulation  of  the  gastrocnemius  muscle  (algesic  chemical  and 
noxious mechanical stimulation), or to cutaneous noxious and innocuous stimuli 
(polymodal).  Responses  to  noxious  knee  joint  stimulation  have  also  been 
recorded from lamina I neurons in the cat (Schaible et al., 1986), consistent with 
the termination pattern of nociceptive knee joint afferents in the spinal cord; 
laminae I and VI-VI (Craig et al., 1988). Langford (1983) also reported that ~50% 
of the cat knee joint afferents are group IV axons (unmyelinated).  
Previous  studies  have  shown  that  lamina  I  neurons  can  also  be  activated  by 
visceral stimulation. Traub et al. (1992) showed that after repetitive distension 
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were observed in laminae I-II, V-VII and X of the lumbosacral cord, compared to 
what  was  seen  after  the  distension  of  the  colon  to  20  mmHg  only.  In  a 
subsequent  behavioural  study,  Traub  et  al.  (2002)  confirmed  that  CRD  at  80 
mmHg is a noxious stimulus, since it caused avoidance behaviours in rats. In 
contrast,  distending  the  colon  at  20  mmHg  was  considered  innocuous,  since 
there was no difference in the behaviour of these animals compared to the non-
distended controls. Honore et al. (2002) reported that internalisation of the NK1 
receptor was seen in lamina I neurons in the T13 and S1 spinal segments after 
noxious CRD in awake rats. Further, Gamboa-Esteves et al. (2004) specifically 
reported that ~70% of lamina I NK1r-expressing neurons that projected to the 
NTS up-regulated fos after the exposure to noxious visceral stimulation (formalin 
injection into the urinary bladder). The present study shows that 75% of lamina I 
NK1r-expressing neurons phosphorylated ERK following noxious CRD, and that a 
large number of these cells showed internalisation of the receptor. Fewer pERK-
positive cells were seen following tubal insertion, compared to CRD, and these 
were scattered in laminae I and II of the lumbosacral cord.  
It has been suggested that the spinal phosphorylation of ERK may be due to a 
direct action of substance P on the NK1 receptor, as well as the co-release of 
glutamate  from  primary  afferents  and  excitatory  interneurons.  For  instance, 
Choi  et  al.  (2005)  reported  that  the  intrathecal  injection  of  substance  P, 
presumably acting on the NK1 receptor, induced pain behaviour in the mouse 
and led to the expression of pERK in laminae I and II of the spinal cord at 10 
minutes.  This  substance  P-induced  pain  behaviour  was  attenuated  after  the 
blockade of ERK activity by the pretreament of the mice with PD98059. Anderson 
and Seybold (2000) reported that the phosphorylation of cAMP response element 
binding protein (CREB), which is required for the transcription of many neuronal 
genes and long-term synaptic plasticity (Ji and Rupp, 1997), was increased in 
NK1r-expressing neurons in the SDH 30 minutes after the injection of formalin 
into the rat hindpaw. Their study speculated that phospho CREB (pCREB) may 
regulate the expression of the NK1 receptor gene as well as other genes such as 
c-fos (Ji and Rupp, 1997), suggesting an indirect role of pCREB in regulating the 
expression of the NK1 receptor mRNA through the up-regulation of fos. Kawasaki 
et  al.  (2004)  reported  an  additional  indirect  evidence  of  the  involvement  of 
NK1r-expressing  neurons  in  the  activation  of  ERK.  They  showed  that  the 120 
activation of C-fibre primary afferents, in adult rat spinal slice preparation, by 
brief exposure to capsaicin led to an 8 to 10 fold increase in pERK in the SDH 
neurons. This pERK immunoreactivity was reduced by blocking the NK1 receptor. 
Their  study  also  showed  that  C-fibre  stimulation  led  to  ERK-dependent 
phosphorylation of CREB, suggesting that the MAPK/ERK cascade may contribute 
to the production of long-lasting changes in sensory processing. Recently, Choi 
et  al.  (2012)  reported  that  the  carrageenan-induced  phosphorylation  of  Akt, 
which  is  a  serine/threonine  kinase  that  plays  an  important  role  in  various 
cellular processes including nociception, in the deep dorsal horn of the rat is 
dependent on the prior activation of the NK1r-expressing neurons in the SDH. It 
is  therefore  likely  that  NK1r-expressing  projection  neurons,  most  of  which 
phosphorylated  ERK  following  noxious  stimulation,  play  an  important  role  in 
conveying nociceptive information to higher brain centres through pathways that 
involve activation of ERK.  
4.4.2.4  Morphology of lamina I NK1r-expressing projection neurons  
Previous  attempts  to  classify  lamina  I  projection  neurons  based  on  their 
morphology have been controversial. It was suggested that morphology of these 
cells is related to their function; since Han et al. (1998) reported that in the cat, 
pyramidal cells specifically responded to innocuous cooling only, in comparison 
to the other two morphological classes, which were mostly nociceptive-specific. 
Yu  et  al.  (2005)  and  Almarestani  et  al.  (2007)  also  reported  that  lamina  I 
pyramidal neurons that projected to the thalamus or to the parabrachial area 
were seldom NK1r-immunoreactive in the rat. However, it is unlikely that all 
lamina I pyramidal projection neurons in the rat respond to innocuous cooling for 
the reasons stated below. Although it has been reported that spinoparabrachial 
neurons of the pyramidal class make up 23-30% of this population (Almarestani 
et al., 2007; Al-Khater and Todd, 2009), Bester et al. (2000) did not find cells 
that  responded  to  innocuous  cooling  in  a  sample  of  53  lumbar  lamina  I 
spinoparabrachial neurons in the rat. In addition, out of the 40 spinoparabrachial 
cells  that  were  studied  by  Andrew  (2009),  only  2  were identified  as  cooling-
specific, while the majority of those (70%) were nociceptive specific. Further, 
although Zhang et al. (2006) identified cervical spinothalamic lamina I cells that 
were activated by cooling, these cells also responded to noxious stimuli. Todd et 
al. (2002, 2005) also showed that lamina I NK1r-expressing projection neurons of 121 
all three morphological classes up-regulated fos after the exposure to noxious 
chemical (formalin) and thermal (noxious heat and cold) stimulation, with the 
responses of these neurons to noxious cold being more common in the multipolar 
class.  The  present  study  shows  further  evidence  that  morphology  of  lamina I 
NK1r-expressing projection neurons does not correlate with their function. There 
is also no significant difference between the responses of fusiform, multipolar or 
pyramidal lamina I NK1r-expressing cells to various noxious cutaneous (pinch, 
capsaicin or heat), deep or visceral stimuli. 
4.4.3 Lamina III-IV NK1r-expressing projection neurons 
Immunocytochemical studies have revealed a population of large laminae III-IV 
NK1r-expressing  neurons  of  the  rat  spinal  cord  that  have  prominent  dorsal 
dendrites entering the superficial lamina (Bleazard et al., 1994; Brown et al., 
1995; Littlewood et al., 1995; Mantyh et al., 1995). These are also known to be 
projection neurons, since virtually all of them projected to supraspinal targets 
as described previously (Al-Khater and Todd, 2009). There are approximately 20 
cells of this type on each side of the L4 segment in the rat (Todd et al., 2000). 
These cells receive a large input from substance P-containing primary afferents, 
which form numerous synapses on their cell bodies and dendrites (Naim et al., 
1997). They therefore provide a route through which information transmitted by 
nociceptive  primary  afferents  can  be  conveyed  to  deeper  laminae  and  to 
supraspinal  areas  in  the  CNS.  Torsney  and  MacDermott  (2006)  recorded  from 
laminae III-IV NK1r-exressing neurons in spinal cord slices, and were unable to 
demonstrate monosynaptic input from Aδ- or C-fibres on the majority of these 
cells. However, they attributed this to the possibility of recording from neurons 
that did not posses long dorsal dendrites, or to not being able to retain the 
afferent input to these cells during the slice preparation.  
The  involvement  of  laminae  III-IV  NK1r-expressing  neurons  in  transmitting 
nociceptive  information  from  cutaneous  tissues  has  been  demonstrated  by 
internalisation of the NK1 receptor on these cells after the injection of capsaicin 
(Mantyh  et al.,  1995)  or  formalin  (Honor et  al.,  1999)  into the  rat  hindpaw. 
Doyle and Hunt (1999) also reported that 40% of laminae III-IV NK1r-expressing 
cells up-regulated fos following the injection of formalin into the rat hindpaw. In 
contrast, a lower proportion of these cells were fos-positive following the topical 122 
application  of  mustard  oil  onto  the  skin  or  noxious  heat  (immersion  of  the 
hindpaw in water at 52°C for 10s). However, Polgar et al. (2007) showed that 
almost all laminae III-IV NK1r-expressing neurons phosphorylated ERK after more 
intense  noxious  heat  (immersion  of  the  hindpaw  in  water  at  52°C  for  60s), 
noxious pinch or the injection of formalin. 
The involvement of substance P and laminae III-IV NK1r-expressing cells in the 
spinal processing of nociceptive information from the knee joint of the rat has 
been suggested. Neugebauer et al. (1994) recorded from a sample of deep dorsal 
horn  (laminae  IV-VI)  neurons,  which  may  include  some  of  lamina  IV  NK1r-
expressing cells, that responded to pressure applied to the knee joint. Although 
the SDH contained neurons with inputs from the knee, the above study was done 
on deeper laminae neurons, since it was not easy to distinguish neurons with 
joint input from those with input from the skin in the SDH. Their study reported 
that  the  administration  of  substance  P  and  neurokinin  A  led  to  a  transient 
increase  in  the  responses  of  neurons  to  both  innocuous  and  noxious  joint 
stimulation. However, the application of a specific NK1r inhibitor blocked the 
excitatory effects of substance P on neurons that were exposed to noxious, but 
not innocuous, stimuli.  
The present study shows that after the injection of mustard oil into the knee 
joint or the gastrocnemius muscle, less than one-third of the large laminae III-IV 
NK1r-expressing projection neurons contained pERK. Doyle and Hunt (1999) also 
reported  that  less  than  5%  of  all  laminae  III-IV  NK1r-expressing  neurons  up-
regulated fos following deep noxious stimuli of the joint and muscle. This lower 
proportion of fos-positive cells that was seen in Doyle and Hunt (1999) study, 
compared to the present study, following noxious deep stimulation may be due 
to the difference in the criteria of selection of laminae III-IV NK1r-expressing 
neurons. Doyle and Hunt (1999) included in their sample both the large neurons 
that had dorsal dendrites reaching the superficial laminae as well as the smaller 
non-projection ones, which were not included in the present study. This may 
have  led to  an  increase  in  the  sample  size  of  Doyle  and  Hunt  (1999),  and  a 
subsequent decrease in the proportion fos
+ NK1r-expressing projection cells in 
laminae III-IV. 123 
The  present  study  also  reports  a  lower  proportion  of  laminae  III-IV  NK1r-
expressing  neurons  that  phosphorylated  ERK  after  noxious  deep  and  visceral 
stimulation, compared to what was seen following noxious cutaneous stimulation 
(Polgar et al., 2007). In addition, the responses of laminae III-IV NK1-expressing 
neurons to noxious deep and visceral stimulation differed from the responses of 
lamina I NK1r-expressing neurons to the same noxious stimuli. This suggests a 
difference in the type of information (cutaneous versus deep and visceral) that is 
transmitted  to  supraspinal  areas  through  populations  of  NK1r-expressing 
projection neurons in laminae III-IV versus those in lamina I. Hu and Zhao (2001) 
also reported that the injection of turpentine oil into either the hindpaw or the 
gastrocnemius muscle of anesthetised rats led to fos expression in the superficial 
(laminae I-IIo) and deep (laminae V-VI) dorsal horn of the of the L4-L5 spinal 
segments. Their study showed that the number of fos-positive cells, induced by 
the intramuscular injection, was significantly decreased after the pretreatment 
of the animals with an AMPA and kainate receptor antagonist. In contrast, an 
NMDA receptor antagonist decreased the number of fos-positive cells that were 
induced only by intraplantar injection into the hindpaw. This suggests that the 
transmission  of  nociceptive  information  from  various  tissues  (deep  versus 
cutaneous) may be mediated by different glutamate receptors in the spinal cord.   
4.4.4 Lamina I giant cells 
The giant cells represent a distinct population of very large lamina I projection 
neurons that either lack or weakly express the NK1 receptor. These cells can be 
identified by the presence of high density of gephyrin (the glycine and GABA 
receptor-associated protein) puncta on their cell bodies and dendrites (Puskar et 
al.,  2001).  These  giant  cells  receive  inhibitory  input  from  lamina  II  nNOS-
containing  GABAergic  neurons,  which  provide  around  one  quarter  of  their 
GABAergic  input  (Puskar  et  al.,  2001;  Todd,  2010).  They  are  also  densely 
innervated by VGLUT2-immunoreactive boutons that are associated with GluA4-
containing  puncta.  This  glutamatergic  input  is  thought  to  be  derived  from 
excitatory interneurons, since the giant cells receive little direct synaptic input 
from  peptidergic  or  Aδ  primary  afferents,  compared  to  the  NK1r-expressing 
neurons,  which  are  densely  innervated  by  peptidergic  primary  afferents  as 
described earlier (Polgar et al., 2008).     124 
The giant cells have extensive, radiating dendritic trees, as seen in the present 
study and also reported by Puskar et al. (2001). It is therefore more likely that 
these cells have large peripheral receptive fields. In agreement with the above 
finding, results from the present study shows that following noxious pinch, 85% 
of the giant cells phosphorylated ERK, and even those giant cells lateral to the 
band of pERK immunolabelling were often pERK-positive. The present study also 
shows that a large number of the giant cells (74-85%) contained pERK following 
all three noxious cutaneous stimuli (pinch, capsaicin, heat). This, together with 
the fact that the giant cells form a small population that project mostly to the 
parabrachial area (Polgar et al., 2008), suggests that these cells are involved in 
transmitting nociceptive information that alerts about the presence of a noxious 
stimulus, rather than providing accurate (discriminative) information about the 
noxious stimulus itself. These cells, in relation to their projection target, may 
also play a role in the affective and autonomic responses to pain. The fact that 
the giant cells lack, or weakly express, the NK1 receptor makes them resistant 
to being ablated by SP-SAP (Mantyh et al., 1997). Although Mantyh et al. (1997) 
reported  a  dramatic  reduction  in  hyperalgesia  following  SP-SAP  treatment, 
responses to acute noxious stimuli remained intact. It is therefore likely that the 
giant  cells  are  involved  in  transmitting  nociceptive  signals  that  led  to  the 
responses observed by Mantyh et al. (Mantyh et al., 1997).  
The involvement of giant cells in nociception was first shown by Puskar et al. 
(2001). Their study reported that that 87% of the giant cells up-regulated fos 
after the injection formalin into the rat hindpaw. The present study shows a 
similar percentage of giant cells (84%) that contained pERK after the injection of 
capsaicin. Regarding the responses of the giant cells to noxious heat, Polgar et 
al. (2008) reported that 38% of these cells up-regulated fos following thermal 
stimulation  (immersing  the  hindpaw in  water at  52°C  for  45s).  However,  the 
present  study  shows  that  following  noxious  heat,  of  similar  intensity  and 
duration, 74% of the giant cells phosphorylated ERK. This discrepancy between 
the sensitivity of pERK and fos may be due to the possibility that in order for fos 
to be up-regulated, it requires a certain threshold of pERK activity to be reached 
(if  it  is  assumed  that  spinal  fos  activation  is  ERK-dependent).  It  is  likely 
therefore  that  the  occasional  lower  levels  of  pERK  expression,  which  are 
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subsequently up-regulate fos. In agreement with this, noxious heat also led to a 
higher proportion of pERK
+- compared to fos
+-NK1r-expressing neurons. 
Results from the present study show that a lower proportion of the giant cells 
were activated by noxious stimulation of the joint or muscle, in comparison to 
the responses of lamina I NK1r-expressing neurons to noxious deep stimulation. 
This may be attributed to the observation that these cells receive less direct 
input  from  primary  afferents,  including  those  innervating  joints  and  muscles. 
This also suggests that different populations of projection neurons in lamina I 
convey different messages to higher brain centres.  
Puskar et al. (2001) found that most of the giant cells were located in the mid-
lumbar spinal cord in the rat (~10 cells on each side of the L4 segment). In the 
present study, the pERK-immunostaining that was seen after noxious CRD was 
concentrated mainly in L6-S1 spinal segments, with some staining seen in T13-L1 
segments. It was not applicable therefore to assess the responses of giant cells 
to visceral stimulation due to the rarity of these cells in the area that showed 
the highest pERK labelling after noxious CRD.  
4.4.5 Lamina I NK1r-expressing interneurons 
It was described previously that projection neurons in lamina I make up ~5% of 
the neuronal population in this lamina. It is therefore assumed that most lamina 
I cells (~95%) are interneurons. Twenty-five percent of these interneurons are 
found to  be  GABAergic  (Polgar  et  al.,  2003),  suggesting  that  the  majority  of 
lamina I neurons are excitatory interneurons. Todd et al. (1998) reported that 
45% of neurons in lamina I express the NK1 receptor. From the above data, it 
could  be  calculated  that  60%  of  all  excitatory  interneurons  express  the  NK1 
receptor. Despite the large number of interneurons in lamina I, knowledge of 
their organisation and function is very limited. Prescott and De Koninck (2002) 
reported a clear correlation between morphology and firing pattern for a sample 
of small neurons (presumably interneurons) in lamina I. However, little is known 
about  the  relation  between  morphology,  function  and  the  neurotransmitter 
phenotype for lamina I interneurons.  126 
Although Doyle and Hunt (1999) reported that lamina I NK1r-expressing neurons 
up-regulated fos after exposure to various noxious stimuli, the interpretation of 
their  findings  is  complicated,  since  they  did  not  distinguish  between  the 
responses of NK1r-expressing projection neurons from those of NK1r-expressing 
interneurons. However, the present study shows the responses of both the large 
and small (with somata <200 µm
2) NK1r-expressing neurons to various noxious 
cutaneous, deep and visceral stimuli. Following pinch, capsaicin or noxious heat, 
28%, 39% and 72% of these putative interneurons contained pERK, respectively. 
One-third of these cells were pERK-positive after the injection of mustard oil 
into the joint and muscle, and only 16% phosphorylated ERK after noxious CRD.  
The first part of the project showed that the NK1 receptor was weakly expressed 
on  this  interneuronal  population,  while  most  of  the  larger  NK1r-positive 
projection neurons expressed the NK1 receptor more strongly. This suggests that 
these smaller cells may not have been killed by SP-SAP, and may contribute to 
the normal behavioural responses to noxious heat that were seen in rats after 
the treatment with SP-SAP (Mantyh et al., 1997). They may provide excitatory 
input  to  neighboring  giant  cells  or  even  to  other  NK1r-expressing  projection 
neurons  that  had  survived  SP-SAP  treatment.  Overall,  the  results  from  the 
present study suggest that this population of excitatory interneurons in lamina I 
plays a role in modulating and fine tuning nociceptive information before it is 
transmitted to higher brain centres.  
4.4.6 Technical considerations and future directions 
4.4.6.1  Noxious deep stimulation 
One of the technical issues in the present study is the possibility that introducing 
a needle into the skin, rather than the noxious deep stimulus itself (mustard oil), 
may be the cause of activating the large numbers of lamina I NK1r-exressing 
neurons  that  were  seen  after  deep  noxious  stimulation.  Panfil  et  al.  (2006) 
investigated the expression of fos in the SDH of the mice after the injection of 
NGF into the semispinal neck muscle, which was exposed surgically. Following 
the injection, fos-immunoreactivity was increased significantly in laminae I and 
II of the cervical cord, compared to sham-operated and saline injected controls. 
Although NGF was injected into a surgically exposed neck muscle, the number of 127 
fos-positive cells was significantly higher in those operated animals compared to 
the  sham  group,  on  which  a  cannula  needle  was  only  inserted  without  any 
injection. In the present study, mustard oil was injected into the gastrocnemius 
muscle  without  the  need  to  surgically  expose  it  and  risk  the  activation  of 
additional cutaneous afferents.  
4.4.6.2  Use of anaesthetics  
The  validity  of  the  use  of  anaesthetics  in  experiments  that  investigates  the 
responses of neurons to various noxious stimuli has been questioned. Banks et al. 
(1988)  reported  that  although  anaesthesia  may  influence  the  responses  of 
neurons, it succeeded in minimizing the effects of intra-individual variability, 
which occurred while measuring these responses in awake rats. The study also 
showed a difference in the effects of pentobarbital, urethane and ketamine on 
the responses of  mice  to  noxious thermal  stimulation,  assessed  by  measuring 
their tail flick latency. Although pentobarbital had no effect on latencies, in 
comparison with awake mice that received saline, if used in higher doses, which 
resulted in very deep level of anaesthesia, it led to an increase in the latencies. 
Urethane  increased  the  mice  tail  flick  latencies  (decreased  their  levels  of 
nociception), while ketamine decreased the latencies leading to more positive 
responses to noxious heat.  
Anaesthesia may also affect the number of fos/pERK-positive neurons that are 
seen  after  noxious  stimulation,  since  it  was  shown  that  it  may  dampen  the 
responses  of  these  neurons;  resulting  in  false  negative  data.  For  instance, 
Willcockson et al. (1995) reported that the use of anaesthetics (a combination of 
ketamine-xylazine)  increased  the  threshold  of  fos  expression  in  the  SDH  as 
evidenced by the requirement of higher intensities of electrical stimulations in 
order to up-regulate fos in a pattern similar to the pattern of fos expression in 
un-anesthetised rats. It was also reported that the number of formalin-induced 
fos-positive neurons in the SDH of the lumbar cord was decreased in rats that 
were  anaesthetised  with  halothane  or  isofluorane,  compared  to  awake  ones 
(Fukada  et  al.,  1999;  Sommers  et  al.,  2008;  Liu  et  al.,  2011).  However,  a 
number of studies reported that inhalational anaesthesia had failed to decrease 
the number of formalin-induced fos-positive cells in the SDH in rats (Sun et al., 
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In the present study, urethane was used as the anaesthetic, and a large number 
of pERK-positive neurons were seen in the SDH after the exposure of urethane-
anesthetized rats to various noxious stimuli. Specifically, noxious heat induced 
the expression of pERK in almost all large lamina I NK1r-expressing neurons. This 
suggests that urethane is less likely to lead to under-estimation of the number of 
neurons  that  are  activated  following  noxious  stimulation,  at  least  at  spinal 
levels. Abbadie et al. (1994) also showed that under urethane anaesthesia, the 
temperature threshold that induced a consistent fos expression in the SDH of the 
rat was ~46°C. This threshold is similar to the threshold that led to heat-induced 
nociceptive reactions in awake rats, and that also activated C nociceptors.  
Anaesthesia has also been reported to cause unexpected false positive results. 
However, these fos-positive neurons were found in supraspinal areas rather than 
in the spinal cord. Bullitt (1990) showed that prolonged inhalational anaesthesia 
led  to  the  appearance  of  fos-positive  cells  in  unexpected  areas  such  as  the 
olfactory  cortex  in  the  rat.  Additionally,  it  was  reported  that  after urethane 
anaesthesia without stimulation, numerous fos-positive cells were seen in the 
NTS and in the intermediate reticular formation in the rat (Strassman and Vos, 
1993).  Lanteri-Minet  et  al.  (1993)  also  reported  that  controlled  volatile 
anaesthesia alone did not cause fos labelling in the spinal cord of the rat, while 
it was effective in evoking fos in discrete hindbrain regions such as the rostral 
ventrolateral  medulla,  nuclei  of  the  parabrachial  area  and  the  NTS.  In  the 
present  study,  pERK-positive  cells  were  found  mostly  in  the  dorsal  horn, 
ipsilateral to the  stimulus, while the contralateral side showed minimal pERK 
labelling,  suggesting  that  urethane  alone  has  no  effect  in,  at  least,  evoking 
spinal false positive cells.  
Although carrying out experiments on awake rats may seem to prevent unwanted 
effects of anaesthesia, exposing the animals to noxious stimuli without the use 
of  anaesthetics  raises  ethical  issues.  It  has  also  been  reported  that 
experimenting on awake rats may indirectly lead to false negative results. For 
instance, Fukuda et al. (2009) showed that, in awake rats, the number of pERK-
positive cells after the injection of formalin was decreased by the ‘analgesic’ act 
of  licking,  compared  to  the  number  of  these  cells  in  restrained  awake  rats, 
which were unable to lick their hindpaws.  129 
Work from the present study sheds light on specific populations of dorsal horn 
neurons,  as  important  contributors  in  conveying  (projection  neurons)  or 
modulating  (interneurons)  nociceptive  information,  received  from  cutaneous, 
deep  and  visceral  tissues.  Future  work  to  further  investigate  the  effects 
inhibiting specific cascades that activated these neurons is recommended.  130 
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5.1 Introduction 
Glutamate, which is released by primary afferents and local excitatory neurons, 
is the principal excitatory neurotransmitter in the CNS. It acts on both ionotropic 
and metabotropic receptors. Metabotropic glutamate receptors (mGlus) are G 
protein-coupled  receptors.  Their  binding  to  glutamate  regulates  a  series  of 
cellular  activities  including  phosphorylation  of  ion  channels  and/or  gene 
transcription.  There  are  8  cloned  mGlus,  which  are  broadly  classified  into  3 
groups based on their sequence homology, pharmacology and association with 
intracellular effector systems (Conn and Pin, 1997). Group I mGlus (mGlu1 and 
mGlu5)  are  linked  to  phospholipase  C,  an  enzyme  which  hydrolyzes 
phosphoinositide leading to calcium release from intracellular stores. Groups II 
(mGlu2 and mGlu3) and III (mGlu4, mGlu6, mGlu7, and mGlu8) mGlus are linked to 
adenylate cyclase, an enzyme which catalyses the production of cyclic adenosine 
monophosphate  (Simeone  et  al.,  2004).  Each  mGlu  is  composed  of  seven 
transmembrane-spanning domains with a large N-terminal domain.  
mGlus  are  expressed  on  spinal  dorsal  horn  neurons  as  well  as  on  primary 
afferents. For instance, Ohishi et al. (1995) found that some axon terminals of 
primary  afferent  fibres,  which  terminated  in  the  SDH,  expressed  mGlu7. 
Although  primary  afferent  terminals  may  contain  mGlus,  Jia  et  al.  (1999) 
suggested  that  most  of  these  receptors  were  typically  in  dendrites  and  cell 
bodies  of  neurons  within  the  dorsal  horn.  These  mGlus  work  synergistically 
and/or  antagonistically  with  ionotropic  receptors  to  control  the  release  of 
glutamate from primary afferents and interneurons.  
Localization  of  mGlus  subtypes  in  the  spinal  cord  has  been  investigated. 
Regarding  group  I  mGlus,  it  was  reported  that  SDH  neurons  strongly  express 
mGlu5a  and  mGlu5b  (two  alternative  splice  variants),  while  deep  dorsal  horn 
neurons predominantly express the mGlu1a subtype (Valerio et al., 1997; Boxall 
et al., 1998; Berthele et al., 1999; Alvarez et al., 2000). Additionally, in lamina 
II of the rat dorsal horn, mGlu5 was found either at the postsynaptic densities of 
asymmetrical  synapses,  which  have  thickened  postsynaptic  densities  and  are 
thought to be excitatory (Gray, 1959), or localized extrasynaptically at dendritic 
and somatic membranes (Vidnyanszky et al., 1994; Jia et al., 1999; Alvarez et 
al., 2000). Tao et al. (2000) also identified a synaptic relationship of mGlu5–132 
containing neurons in the SDH of the rat with nociceptive primary afferents and 
GABAergic terminals of presumed interneurons. Regarding group II mGlus, it was 
reported that the antibody against mGlu2/3 was found mainly in laminae IIi, III 
and IV (Young et al., 1998; Jia et al., 1999). Additionally, Boxall et al. (1998) 
and Berthele et al. (1999) reported the absence of mGlu2 mRNA from the spinal 
cord of rat. In regard to group III mGlus, it was reported that mGlu4 mRNA was 
expressed in a disperse manner over the grey matter, while mGlu6 mRNA was not 
expressed in the spinal cord (Boxall et al., 1998; Berthele et al., 1999). Their 
studies also showed that mGlu7 mRNA was localized with a high concentration in 
the SDH, in comparison to its lesser expression in deeper laminae.    
Fisher  and  Coderre  (1996a)  reported  that  the  application  of  group  I  mGlus 
agonist DHPG to the rat spinal cord induced spontaneous nociceptive behaviours. 
These behaviours were attenuated after the treatment of rats with antagonists 
acting on groups I and II mGlus, as well as on NMDA. Mechanical and thermal 
thresholds were also increased after the application of group I mGlu antagonists 
to the rat spinal cord (Young et al., 1997). It was also reported that activation of 
groups I and II mGlus enhanced the excitatory responses of spinal neurons to 
ionotropic glutamate receptor (AMPA, kainite and NMDA) agonists both in vivo 
and in vitro (Bleakman et al., 1992; Bond and Lodge, 1995; Budai and Larson, 
1998). The excitability of dorsal horn neurons of the rat was also increased after 
the activation of group I mGlus (Zhong et al., 2000; Park et al., 2004). Park et 
al. (2010) recently reported that the bath application  of DHPG enhanced the 
number  of  fos-immunoreactive  neurons  in  the  spinal  trigeminal  subnucleus 
caudalis  in vitro (brainstem slices). The study also showed that the neuronal 
expression of fos was significantly decreased after the application of an NMDA 
receptor antagonist, as well as protein kinase C (PKC) and ERK inhibitors. This 
facilitatory effect of group I mGlus is either attributed to their interaction with 
ionotropic receptors (Fisher and Coderre, 1996b), or to their direct effect of 
increasing neuronal excitability (Jones and Headley, 1995). However, the role of 
group I mGlus in modulation of nociception is still poorly understood.  
ERK is expressed in dorsal horn neurons and is phosphorylated by noxious stimuli, 
as  described  in  the  previous  Chapter.  It  has  been  reported  that  nociceptive 
behaviour, which resulted from the activation of spinal group I mGlus, was ERK-
dependent (Karim et al., 2001). Karim et al.  (2001) also showed that DHPG-133 
induced activation of group I mGlus led to ERK phosphorylation in mice dorsal 
horn  neurons,  identifying  the  ERK/MAPK  cascade  as  a  potential  mediator  of 
mGlu-induced enhancement of nociception. Hu et al. (2007) also reported that 
ERK  activation  was  induced  pharmacologically  by  activating  group  I  mGlus  in 
mouse spinal cord.  
The role of mGlu5 in modulating nociception is not yet clear. Karim et al. (2001) 
reported  that  nociceptive  behaviours  resulting  from  the  activation  of  spinal 
group I mGlus is ERK-dependent. In this part of the study, phosphorylation of 
ERK  in  mGlu5-expressing  neurons  after  the  administration  of  DHPG  into  the 
lumbar spinal cord was investigated. The study also examined the phenotype of 
these pERK
+ mGlu5-expressing neurons by investigating the colocalisation of pERK 
and mGlu5 with excitatory and/or inhibitory neurochemical markers.  
5.2 Experimental procedures 
5.2.1 Animals and DHPG application 
Eight adult male Wistar rats (250–280 g; Harlan, Loughborough, UK) were used 
for this part of the study. The rats were deeply anaesthetized with 10% urethane 
(1.3 g/kg ip). They were then placed on a heating pad in order to maintain their 
body  temperature.  The  depth  of  anaesthesia  was  monitored  throughout  the 
procedure by occasionally pinching the forepaw and observing the appearance of 
any  withdrawal  reflexes.  A  midline  incision  was  made  over  the  back,  the 
paraspinous muscle was dissected, and a dorsal laminectomy was performed at 
T13 and L1 to expose the mid-lumbar spinal cord. Connective tissue and muscle 
were dissected from the dorsolateral surfaces of T12 and L2 to enable placement 
of vertebral clamps. DHPG [165 nmol (3.3 mM, 30 µg/50 µl), Tocris Cookson, 
Ballwin, MO, (Karim et al., 2001)] was applied to the exposed mid-lumbar spinal 
cord and maintained for 8 minutes (n=3). 100 µl of normal saline was applied to 
the  lumbar  cord  of  the  remaining  5  rats  for  8  minutes.  The  rats  were  then 
perfused with 4% formaldehyde. 134 
5.2.2 Tissue processing and immunocytochemistry 
Lumbar spinal cord was dissected out and post-fixed at 4°C for 24 hours. Mid-
lumbar (L3-L5) spinal segments were cut into 60 µm thick transverse sections 
with a Vibratome. The transverse sections were cut sequentially into 5 bottles 
and were then treated for 30 minutes with 50% ethanol. Spinal sections from one 
of the bottles were reacted for 3 days in rabbit anti-mGlu5 (1:500), and mouse 
monoclonal antibody against pERK (1:1000). Sections from the 2
nd, 3
rd and 4
th 
bottles were reacted in both rabbit anti-mGlu5 and mouse anti-pERK, as well as 
in one of the following primary antibodies: (1) goat anti-calretinin (1:1000) (2) 
goat anti-calbindin (1:500) or (3) guinea pig anti-GABA (1:1000), respectively. 
Sections  were  then  incubated  overnight  in  appropriate  species-specific 
secondary  antibodies  raised  in  donkey  and  conjugated  to  either  Alexa  488, 
Rhodamine  Red,  or  DyLight  649.  They  were  then  rinsed  3  times  with  PBS, 
mounted and stored at -20°C. Characteristics and suppliers of the antibodies 
used in this part of the study are described in Chapter 2.    
5.2.3 Confocal microscopy and analysis 
5.2.3.1  ERK phosphorylation in mGlu5-expressing neurons 
To  investigate  the  proportion  of  pERK
+  mGlu5-expressing  neurons  after  the 
application of DHPG, transverse sections from the mid-lumbar (L3-L5) spinal cord 
were analysed. For this part of the study, Zeiss LSM710 confocal microscope was 
used. Sections from the L3, L4 and L5 spinal segments were initially examined 
with a 20× lens using fluorescence microscopy for the presence of pERK. Three 
sections  from  each  of  the  2  segments  that  showed  the  most  numerous  pERK 
immunoreactive  neurons  were  selected  for  further  analysis.  These  were  then 
scanned throughout the depth of the section using a 40× oil-immersion objective 
lens  to  produce  z-series  consisting  of  24  to  26  optical  sections  at  2  µm  z-
separation. Between 4 and 6 contiguous fields were scanned for each section in 
order to cover the entire cross-sectional area of lamina I and II on one side. Files 
corresponding  to  pERK-immunostaining  were  opened  with  Neurolucida  for 
Confocal  software  and  every  pERK-immunoreactive  cell  in  lamina  II  was 
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presence or absence of mGlu5 in each of the selected pERK–positive cells was 
determined. 
5.2.3.2  mGlu5-expressing excitatory and inhibitory neurons 
The  proportions  of  lamina  II  mGlu5-expressing  neurons  that  were  positive  for 
calretinin,  calbindin  or  GABA  were  investigated.  Three  sections  from  each 
segment  were  scanned  with  the  confocal  microscope  through  a  40×  oil-
immersion objective lens to produce z-series at 2 µm z-separation that covered 
the  entire  area  of  lamina  II  on  one  side.  Sections  were  then  analysed  with 
Neurolucida. The mGlu5 channel was initially viewed, and mGlu5-immunoreactive 
cells  were  selected  from  4  optical  sections  at  the  start  of  the  z-series.  The 
selection was performed by applying a 5 µm × 5 µm grid and choosing the cell 
nearest the lower right hand corner of each grid square. It started at the most 
dorsal part of the lamina working from dorsal to ventral (1
st 4 optical sections) 
and then from left to right. Once the cells had been selected, the calretinin, 
calbindin  or  GABA  channel  was  viewed,  and  the  presence  or  absence  of 
calretinin-, calbindin- or GABA-immunostaining in each of the selected mGlu5-
positive cell was recorded. 
5.2.3.3  Colocalisation of pERK with calretinin, calbindin and GABA in mGlu5-
expressing neurons 
To  investigate  the  proportion  pERK
+  mGlu5-expressing  neurons  that  were 
assumed to be excitatory, sections from the L3-L4 or L4-L5 spinal segments that 
were incubated to reveal pERK, mGlu5 and calretinin or calbindin were analysed. 
Initially,  colocalisation  of  calretinin  or  calbindin  with  mGlu5  in  pERK-positive 
neurons was investigated. All the pERK
+ mGlu5-expressing neurons were selected 
throughout the depth of the section. Files containing calretinin- or calbindin-
immunostaining were then viewed and the presence or absence of calretinin or 
calbindin in each of the selected pERK
+ mGlu5-expressing cells was determined. 
To investigate the proportion pERK
+ mGlu5-expressing neurons that were GABA-
immunoreactive, sections from the L3-L4 and L4-L5 spinal segments that were 
incubated to reveal pERK, mGlu5 and GABA were analysed. Three sections from 
each segment were scanned with the confocal microscope through a 40× oil-
immersion objective lens to produce z-series at 2 µm z-separation that covered 136 
the  entire  area  of  lamina  II  on  one  side.  Since  penetration  of  the  GABA-
immunostaining was extremely limited, only the superficial parts of each section 
were scanned. Sections were then analysed with Neurolucida. The pERK-positive 
neurons  that  were  at  the  surface  of  the  section  were  selected  and  the  files 
containing  mGlu5-  immunostaining  were  then  viewed  and  the  presence  or 
absence of mGlu5 in each of the selected pERK–positive cells was determined. 
The GABA channel was then revealed, and the presence or absence of GABA 
immunoreactivity  in  each  of  the  selected  pERK
+  mGlu5-expressing  cells  was 
recorded. 
In  order  to  determine  whether  differences  in  the  sizes  of  GABA+  and  GABA- 
neurons could have led to a bias in selection, the distance in the z-axis between 
the upper surface of the Vibratome section and the bottom of the nucleus for a 
sample  of  pERK-positive  neurons  was  estimated,  by  counting  the  number  of 
optical  sections  between  these  levels.  The  presence  or  absence  of  GABA-
immunostaining was then recorded.  
5.3 Results 
5.3.1 pERK
+ mGlu5-expressing neurons  
mGlu5 staining was localized in the SDH, mostly in lamina II, consistent with 
previous  studies  that  showed  that  mGlu5  expression  was  concentrated  in  the 
superficial laminae of rats and mouse. mGlu5 immunoreactivity was present as 
numerous granules forming distinct annuli that occupied cellular membranes.  
Following DHPG (but not saline) application, numerous pERK-positive cells were 
seen in the SDH, particularly in lamina II (Figure 5-1). Of the 606 lamina II pERK-
positive cells analysed, 531 (88%, range 81-94%) were mGlu5-immunoreactive.  
Animals  that  received  saline  showed  variable  results.  In  the  first  two  rats, 
scattered pERK-positive cells were seen in both laminae I and II, with more of 
these cells in lamina I. In addition to the difference in the laminar distribution of 
these cells, compared to cells that activated ERK after DHPG, their rostrocaudal 
distribution  differed  too.  They  were  mainly  concentrated  at  one  end  of  the 
exposed lumbar cord: L3 or L5 spinal segment and this segment corresponded to 137 
an external swelling of the cord, which was induced by the laminectomy itself. 
These pERK-positive cells were also larger than those seen after DHPG, and were 
seldom  mGlu5-immunoreactive.  The  other  three  animals  that  received  saline 
showed minimal pERK expression, and this may be attributed to the laminectomy 
procedure after which less swelling of the cord was seen.      
Results  of  the  quantitative  analysis  of  pERK  in  mGlu5-expressing  neurons  in 
lamina II, after DHPG application, are shown in Table 5-1, and an example of 
pERK and mGlu5-immunostaining is seen in Figure 5-2.   
5.3.2 Neurochemistry of mGlu5-expressing cells 
5.3.2.1  Calretinin and calbindin 
In the sections reacted to reveal calretinin, which is expressed by excitatory 
neurons, calretinin-immunostaining was present in the superficial dorsal horn, 
mostly in lamina II. The percentage of calretinin
+ mGlu5-immunoreactive neurons 
in lamina II was 38% (37-39%, Table 5-2). Additionally, of the 578 pERK
+ mGlu5-
immunoreactive cells analysed, only 58 cells (10%, 6-15%) contained calretinin 
(Table 5-2 and Figure 5-3). Table 5-2 also shows a significant difference between 
the  expression  of  calretinin  in  mGlu5-immnuoreactive  cells  compared  to  its 
expression in pERK
+ mGlu5-expressing cells (P<0.001, Chi-square test). 
In  the  sections  reacted  to  reveal  calbindin,  a  marker  for  excitatory  neurons, 
calbindin-positive cells were seen in the SDH, mostly in lamina II. Fifty-seven 
percent  (51-64%)  of  the  mGlu5-expressing  neurons  in  lamina  II  contained 
calbindin (Table 5-3). Additionally, of the 674 pERK
+ mGlu5-immunoreactive cells 
analysed, 138 cells (20%, 13-30%) were calbindin-positive (Table 5-3 and Figure 
5-4). Chi-square test shows that there is a significant difference between the 
expression  of  calbindin  in  mGlu5-immnuoreactive  cells  and  its  expression  in 
pERK
+ mGlu5-expressing cells (P<0.001, Table 5-3). 
5.3.2.2  Gamma-aminobutyric acid (GABA) 
In sections reacted to reveal GABA, which is expressed exclusively by inhibitory 
interneurons, the distribution of GABA immunostaining was very similar to that 
reported  previously  in  the  rat  dorsal horn.  Staining  was particularly  dense  in 138 
laminae I-III, and this region contained numerous immunoreactive cell bodies. 
Non-immunoreactive  cells  were  seen  as  dark  areas,  surrounded  by  strongly 
immunoreactive structures in the neuropil, which presumably corresponded to 
dendrites  and  axonal  boutons  of  GABAergic  neurons.  However,  as  reported 
previously, the penetration of GABA-immunostaining was extremely limited in 
formaldehyde-fixed tissues compared to glutaraldehyde-fixed ones (Somogyi et 
al., 1985; Sardella et al., 2011a), and only cells for which the nucleus appeared 
on the top surface of the section were examined.  
The percentage of GABA
+ mGlu5-expressing neurons in lamina II was 35% (31-43%, 
Table 5-4). However, GABA-immunoreactivity was seen in 79% (74-84%) of the 
pERK
+  mGlu5-expressing  cells.  Results  of  the  quantitative  analysis  of  GABA 
expression in both mGlu5-expressing neurons and pERK
+ mGlu5-immunoreactive 
neurons in laminae II are shown in Table 5-4. Table 5-4 also shows a significant 
difference  between  GABA  expression  in  pERK
+  mGlu5-immnuoreactive  cells 
compared to its expression in mGlu5-expressing cells (P<0.001, Chi-square test). 
An example of GABA, pERK and mGlu5-immunostaining is seen in Figure 5-5.  
Since only pERK-positive neurons that were located in the surface of the section 
were  selected  for  further  analysis,  and  both  GABA
+  and  GABA
-  pERK-
immunoreactive neurons were found in laminae II, it was unlikely to avoid a 
selection bias towards the larger pERK-positive cells. However, the present study 
did not show any significant difference between the sizes of the pERK-positive 
neurons that expressed GABA (8.97 µm, range 6-12 µm, median 9 µm, n=114) 
and those that were GABA-negative (9.01 µm, range 6-13  µm, median 9  µm, 
n=74) (P=0.984, Mann-Whitney U-test). It is therefore unlikely that the estimate 
of the proportion of pERK-positive neurons that were GABA-immunoreactive was 
influenced by this selection bias.  
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5.4 Discussion 
This part of the study reports that following spinal activation of group I mGlus, 
numerous pERK-positive cells were seen in lamina II of the spinal cord, and the 
great majority of these (88%) were mGlu5-positive. It also shows that while 38% 
of lamina II mGlu5-positive neurons contained calretinin, only 10% of these cells 
phosphorylated  ERK  after  DHPG.  Additionally,  more  than  half  of  the  mGlu5-
positive cells (57%) in lamina II are double-labelled with calbindin, but only 20% 
were also positive for pERK following DHPG. Despite the finding that 35% of the 
mGlu5-expressing neurons were GABA-immunorective, a high proportion (79%) of 
the pERK
+ mGlu5-expressing neurons was positive for GABA after DHPG. Overall, 
lamina  II  mGlu5-expressing  neurons  contain  various  proportions  of  calretinin, 
calbindin and GABA. However, activating these cells phosphorylated ERK in a 
lower proportion of mGlu5-expressing excitatory interneurons (calretinin
+ and/or 
calbindin
+),  and  in  a  higher  proportion  of  mGlu5-expressing  inhibitory 
interneurons (GABA
+). This suggests that mGlu5-expressing cells, when activated, 
play a complex role in processing nociceptive information. 
5.4.1 Spinal mGlu5-expressing neurons  
Although it has been well established that ionotropic glutamate receptors are 
involved in the transmission and mediation of spinal nociception (Yamamoto and 
Yaksh,  1992;  Kristensen  et  al.,  1994;  Meller  et  al.,  1996),  the  role  of  spinal 
mGlus in processing nociceptive information is not yet fully understood.   
The  involvement  of  spinal  mGlus  in  nociception  was  initially  supported  by 
pharmacological studies that demonstrated the effects of applying non specific 
AMPA/mGlu  agonists  such  as  quisqualic  acid  into  the  lumbar  spinal  cord 
(Aanonsen  et al.,  1990;  Sun  and Larson, 1991).  Subsequently,  selective  mGlu 
agonists  and  antagonists  were  available,  and  these  helped  in  exploring  the 
specific roles of mGlu groups, as well as the roles of each member of these 
groups. For instance, it has been reported that intrathecal application of DHPG 
(mGlu1/5 receptor agonist) in rats induced spontaneous nociceptive behaviours 
and enhanced formalin-evoked nociception in the 2
nd phase of the formalin test 
(Fisher  and  Coderre,  1996a,  1996b).  DHPG  also  led  to  thermal  hyperalgesia 
(persistent decrease in noxious heat response latency), mechanical hyperalgesia 154 
(vigorous  nociceptive  responses  to  tail  pinch)  and  mechanical  allodynia  (a 
reduction in the 50% response threshold to von Frey hairs) in rats (Fisher and 
Coderre, 1998). In addition, it was reported that the application of relatively 
selective group I mGlu antagonists [(S)-4-carboxyphenylglycine or (S)-4-carboxy-
3-hydroxyphenylglycine] reduced nociceptive responses in the 2
nd phase of the 
formalin test (Fisher and Coderre, 1996b). Furthermore, antisense knockdown of 
spinal  mGlu1  in  rats  decreased  neuronal  responses  to  topical  mustard  oil 
application (Young et al., 1998), and also attenuated thermal hyperalgesia and 
mechanical allodynia in a rat model of chronic inflammation (Fundytus et al., 
2002). Together, the above findings suggest a role of group I mGlus in spinal 
modulation of nociception.  
As described previously, one of the established cellular mechanisms of action of 
group I mGlus are through their activation of phospholipase C, which leads to the 
release of intracellular calcium and subsequently the activation of PKC (Masu et 
al., 1991; Abe et al., 1992). Recent studies also showed that group I mGlus can 
activate other pathways such as the ERK/MAPK cascade, which has been shown 
to be involved in nociception (Ji et al., 1999; Karim et al., 2001; Adwanikar et 
al., 2004). Karim et al. (2001) reported that intrathecal application of DHPG into 
the mouse spinal cord led to spontaneous nociceptive behaviours, which were 
attenuated  by  the  administration  of  selective  mGlu1  or  mGlu5  antagonists. 
Immunoblot analysis of the mouse spinal cord after DHPG administration showed 
a dose-dependent increase in phosphorylation of ERK1 and ERK2, with stronger 
activation of ERK2. The doses of DHPG that were required to activate ERK were 
similar  to  those  that  induced  nociceptive  behaviours,  suggesting  that  group  I 
mGlu activation leads to an ERK-dependent nociceptive behaviour in mice. This 
suggestion  was  further  confirmed  in  a  subsequent  study  by  Adwanikar  et  al. 
(2004) that showed that DHPG-induced nociceptive behaviours were attenuated 
after the pretreatment with a MEK inhibitor, which blocks the activation of ERK.     
Karim et al. (2001) also reported that mGlu5 colocalised with pERK in the SDH 
after  DHPG  administration,  however,  they  did  not  attempt  to  quantify  these 
pERK
+  mGlu5–expressing  neurons.  The  present  study,  on  the  other  hand, 
demonstrates the proportion of these cells and further confirms the involvement 
of group I mGlus as an upstream activator for ERK in rats. Results from this study 
show that the spinal application of DHPG led to the expression of high levels of 155 
pERK, mostly in lamina II. The majority (88%) of these pERK-positive cells were 
mGlu5-immunoreactive, suggesting a direct involvement of mGlu5 in activating 
ERK,  rather  than  mGlu5  indirectly  acting  on  other  dorsal  horn  receptors  and 
subsequently activating ERK.  
The present study also reports that a low proportion (12%) of the pERK-positive 
cells did not express mGlu5 after DHPG. One possible technical reason for this is 
that the mGlu5 antibody used in this study detects only one splice variant of 
mGlu5: mGlu5a or mGlu5b, suggesting that some mGlu5-expressing cells were not 
detected. However, this possibility is ruled out since it is found that the mGlu5 
antibody used detects the last 28 amino acids from the C terminal, which are 
the similar in both splice variants: mGlu5a and mGlu5b (Joly et al., 1995). Another 
explanation for the presence of these pERK-positive cells that lacked mGlu5 is 
that they could be activated by nearby pERK
+ mGlu5–expressing interneurons. It 
can also be attributed to the fact that DHPG is a non-specific group I agonist, 
which activates both mGlu1 and mGlu5, and therefore, suggests that these pERK
+ 
mGlu5-negative cells may express mGlu1. This suggestion is further supported by 
the  finding  of  Karim  et  al.  (2001),  who  showed  that  both  mGlu1  and  mGlu5 
antagonists  attenuated  DHPG-induced  pain  behaviours.  However,  the 
distribution  of  mGlu1a  and  mGlu5a/b  has  been  described  above,  and  mGlu1a  is 
found mainly in deep dorsal horn, compared to the expression of mGlu5a/b which 
is  concentrated  in  the  SDH  (Valerio  et  al.,  1997;  Alvarez  et  al.,  2000).  It  is 
therefore unlikely that those mGlu5 lacking pERK-positive cells express mGlu1a. 
In support of the above finding, Karim et al. (2001) reacted mouse spinal cord 
sections with a selective antibody against mGlu1a and reported no detectable 
mGlu1a-immunostaining in the SDH. Another explanation for these pERK-positive 
cells  that  neither  expressed  mGlu5a/b  nor  mGlu1a  is  that  they  express  other 
known splice variants of mGlu1 such as mGlu1b and mGlu1d. Alvarez et al. (2000) 
also  reported  the  expression  of  low  levels  of  mGlu1b  in  lamina  II  in  the  rat. 
Additionally, Karim et al. (2001) reported the presence of 2 RNA splice variants 
of mGlu1 in the spinal cord dorsal horn of the mouse: mGlu1b and mGlu1d.  
Recent  studies  have  demonstrated  the  involvement  of  activated  ERK  in 
phosphorylating the pore-forming subunit of the potassium channel Kv4.2, which 
is a major contributor to A-type K
+ currents (Adams et al., 2000; Hu et al., 2003; 
Ji et al., 2003; Hu et al., 2006). The down regulation of these A-type currents is 156 
known to enhance neuronal activity (Hu and Gereau,  2003; Hu et al., 2003). 
Subsequently,  Hu et al.  (2007)  showed  that ERK-mediated  phosphorylation  of 
Kv4.2 is downstream of mGlu5 activation. Their study examined the effects of 
DHPG on action potentials evoked by depolarising current injection in spinal cord 
dorsal horn neurons in culture and in acute slices from mice. DHPG application 
decreased first spike latency and increased spike frequency. Their study also 
showed that DHPG decreased A-type currents in dorsal horn neurons from wild-
type  mice,  but  not  in  those  from  Kv4.2  knock-out  mice.  This  DHPG-induced 
inhibition of A-type currents was blocked by ERK inhibitors. Additionally Hu et 
al.  (2007)  reported  that  71%  of  DHPG-induced  pERK
+  neurons  from  three 
different cultures were also positive for Kv4.2, and all Kv4.2-expressing neurons 
contained pERK. It was also found that the blockade of mGlu5, but not mGlu1, 
activation  completely  abolished  the  modulation  of  A-type  K
+  currents  and 
neuronal  excitability  that  were  seen  following  DHPG  application.  Their  study 
concluded that mGlu5, but not mGlu1, modulates A-type currents in the SDH, 
while  the  mechanism  that  explains  the  contribution  of  mGlu1  to  nociceptive 
behaviour remains unclear.  
It has been reported (Ji et al., 1999; Polgar et al., 2007) and also shown in the 
previous  Chapter  that  ERK  is  phosphorylated  in  the  SDH  following  noxious 
stimulation. The present study shows that many of the mGlu5-expressing neurons 
in  the  SDH  did  not  phosphorylate  ERK  following  DHPG.  The  reason  for  the 
presence of these pERK
- mGlu5-expressing neurons is not clear. It may be duo to 
the  possibility  that  these  cells  express  non-functioning  mGlu5,  or  that  DHPG 
activates these pERK
- mGlu5-expressing cells through different pathways other 
than the MAPK/ERK cascade. 
5.4.2 pERK
 in mGlu5-expressing excitatory and inhibitory neurons 
Lamina II contains both inhibitory and excitatory interneurons, and these play an 
important  role  in  modulating  nociception,  by  their  action  on  neighbouring 
interneurons  or  on  projection  neurons  in  neighbouring  laminae  (I  and  III-IV). 
Calcium binding proteins have been used as markers for excitatory (calretinin, 
calbindin) or inhibitory (parvalbumin) neurons, as described in the first Chapter.  157 
The  present  study  is  the  first  to  report  that  one-third  of  lamina  II  mGlu5-
expressing neurons contain calretinin, and more than half of the mGlu5-positive 
cells  in  lamina  II  are  double-labelled  with  calbindin.  Both  calretinin  and 
calbindin are expressed by excitatory neurons, and Albuquerque et al. (1999) 
reported that the majority of calbindin- calretinin-containing neurons were not 
reactive for either GABA or glycine. Antal et al. (1991) also showed that most of 
the  calbindin-positive  cells  in  the  SDH  were  not  GABAergic,  which  further 
confirms  that  these  calretinin-  calbindin-expressing  mGlu5
+  neurons  are  more 
likely to be glutamatergic.  
Polgar et al. (2003) reported that one-third of lamina II interneurons of the rat 
were  inhibitory,  containing  GABA.  The  present  study  shows  that  35%  of  the 
mGlu5-expressing neurons are also GABA-immunoreactive, suggesting that mGlu5 
is expressed on both excitatory and inhibitory neurons in lamina II. Jia et al. 
(1999) used electron microscopy to investigate colocalisation of GABA and mGlu5 
in  SDH  neurons  of  the  rat.  They  reported  that  about  half  of  the  vesicle-
containing profiles immunostained for mGlu5 were stained for GABA.  
Hu and Gereau (2011) recently showed that only 16% of mGlu5-expressing cells 
also  expressed  GAD67-GFP  (inhibitory  cells  marker)  in  cultured  neurons.  This 
discrepancy between the present study and that of Hu and Gereau (2011) may be 
attributed to the different inhibitory markers used, since an unknown proportion 
(estimated between 35% and 67%) of GAD67-GFP neurons represent GABAergic 
neurons (Heinke et al., 2004; Dougherty et al., 2009). However, GABA, which is 
the  marker  of  choice  in  this  study,  presumably  labels  all  inhibitory  neurons. 
Another  reason  of  this  difference  is  that  Hu  and  Gereau  (2011)  results  were 
based on a study done in cultured neurons, which may differ in their responses 
compared to the responses of dorsal horn neurons of rats (in vivo).    
Regarding the phenotype of these DHPG-induced pERK
+ mGlu5-expressing cells, 
results from the present study show that 10 and 20% of these cells contained 
calretinin  and  calbindin,  respectively.  The  majority  (79%)  of  pERK
+  mGlu5-
expressing neurons were GABAergic. The above percentages add up to more than 
a  100%,  however,  it has  been  shown  that  calretinin  and  calbindin  expression 
patterns in the SDH partially overlap (Albuquerque et al., 1999). The finding 
from the present study that a proportion of pERK
+ mGlu5-expressing cells were 158 
excitatory is in agreement with the results by Huang et al. (2005) and Hu and 
Gereau (2011). Huang et al. (2005) reported that almost all Kv4.3-positive cells 
(which also express Kv4.2) in lamina II of the rat expressed mGlu5, and Kv4.3 was 
expressed in a subset of lamina II calretinin
+ (calbindin
- and PKCγ
-) excitatory 
neurons. Hu and Gereau (2011) recently showed in cultured dorsal horn neuron 
that Kv4.2-containing potassium channels, which were modulated by mGlu5-ERK 
signalling  as  described  above,  were  found  primarily  in  excitatory  cells,  since 
these cells expressed VGLUT1/2, PKCγ and NK1r.  
Results  from  the  present  study  suggest  that  the  pronociceptive  effect  of 
activating mGlu5 in the spinal cord is likely to involve a direct action of a subset 
of mGlu5-expressing excitatory interneurons on projection neurons. This effect 
may also involve an indirect inhibition of local inhibitory interneurons by mGlu5-
expressing inhibitory cells, a process of disinhibition. However, the finding that 
DHPG  induced  pERK  expression  in  a  high  proportion  of  mGlu5-expressing 
inhibitory cells speculates that this group of cells may be involved in inhibiting 
other  spinal  pathways  such as  itch,  rather  than their indirect  involvement in 
nociception (Ross et al., 2010; Ross, 2011). This part of the project helps in 
understanding the various mechanisms that underlie the role of mGlu5 in the 
spinal cord. It also shows that there is a balance in the dorsal horn between 
inhibition  and  excitation,  resulting  in  accurately  modulating  nociceptive 
information. Further studies investigating other mechanisms of actions of group I 
mGlus in the spinal cord are required. 
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6. Concluding remarks 
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This thesis highlighted some important aspects regarding different populations of 
spinal cord dorsal horn neurons and their role in nociception. Initially it aimed to 
assess  whether  NK1r-expressing  projection  neurons  can  be  distinguished  from 
NK1r-expressing interneurons, in lamina I of the spinal cord, based on their soma 
sizes. It showed that cell bodies of NK1r-immunoreactive neurons in lamina I had 
a clear bimodal size distribution that is related to the presence or absence of 
retrograde labelling from CVLM and/or LPb. It found that nearly all of the NK1r-
immunoreactive  cells  that  were  not  retrogradely  labelled  had  soma  cross-
sectional areas that were less than 200 µm
2. In contrast, less than 10% of the 
retrogradely labelled NK1r-positive cells had cell bodies smaller than 200 µm
2. 
An important practical outcome from the above results is that soma size can be 
used to identify putative lamina I NK1r-expressing projection neurons in studies 
that have not used retrograde tracing.  
Results from the 1
st part were then used to assess the responses of putative 
lamina I NK1r-expressing interneurons and projection neurons (cell bodies >200 
µm
2) to various noxious stimuli. It reported that both lamina I NK1r-expressing 
projection cells and interneurons phosphorylated ERK after noxious cutaneous, 
deep and visceral stimulation with significantly more of the projection neurons 
were pERK-positive compared to the interneurons. It also showed that there was 
no  significant  difference  in  the  responses  of  various  morphological  classes  of 
lamina I NK1r-expressing projection cells to different types of noxious stimuli. 
The 2
nd part of the project also showed that other populations of projection 
neurons (laminae III-IV NK1r-expressing neurons and lamina I giant cells) in the 
SDH phosphorylated ERK following noxious stimulation. Few laminae III-IV NK1r-
expressing cells were pERK-positive after noxious deep and visceral stimulation 
and these were very weakly labelled. Most of lamina I giant cells contained pERK 
after  noxious  cutaneous  stimulation,  and  a  lower  proportion  of  these  cells 
phosphorylated ERK after noxious deep stimulation. These results indicate that 
different  types  of  projection  neurons  have  different  roles  in  conveying 
nociceptive messages. 
The 3
rd and final part investigated ERK phosphorylation in mGlu5-expressing cells 
following spinal DHPG application. It showed that following spinal activation of 
group I mGlus, numerous pERK-positive cells were seen in lamina II of the spinal 161 
cord, and the great majority of these were mGlu5-positive. It also reported that 
lamina II mGlu5-expressing neurons contained various proportions of calretinin, 
calbindin and GABA. However, activating these cells phosphorylated ERK in a 
lower  proportion  of  mGlu5-expressing  excitatory  neurons  (calretinin
+  and/or 
calbindin
+),  and  in  a  higher  proportion  of  mGlu5-expressing  inhibitory  cells 
(GABA
+).  This  suggests  that  mGlu5-expressing  cells,  when  activated,  play  a 
complex role in processing nociceptive information.  162 
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